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Our genes define who we are. 
By improving our knowledge about DNA/RNA, 
we can impact on our lives. 
 
 
 
 
 
 
Agradecimentos 
 
À Professora Leonor Cancela agradeço a oportunidade de conhecer o mundo 
da ciência e de me acolher no seu laboratório. Agradeço a sua orientação e o 
seu apoio no desenvolvimento deste trabalho. 
 
Ao Daniel, obrigada pelo apoio e orientação ao longo do meu doutoramento. 
Obrigada pelos comentários e sugestões científicas que muito enriqueceram 
este manuscrito. E… obrigada por “partires pedra” comigo no mundo dos 
microRNAs. 
 
À Fundação para a Ciência e Tecnologia pelo financiamento da minha bolsa de 
doutoramento (SFRH/BD/38607/2007), à Fundação Calouste Gulbenkian, 
através do programa ‘‘Na Fronteira das Ciências da Vida’’ pelo co-
financiamento deste trabalho, ao CCMAR e ao Departamento de Ciências 
Biomédicas e Medicina pelo acolhimento.  
 
À Natércia e ao Vincent, agradeço a disponibilidade para esclarecerem as 
minhas dúvidas sempre que vos pedi ajuda. 
 
Ao Gavaia, obrigada por me apresentares os mundos da biologia molecular e 
da histologia, há uns anos atrás! 
 
À Dr. Ana Teresa Maia e à Maria João, obrigada por me introduzirem no mundo 
do ChiP-assay. 
 
A todos os membros do EDGE, obrigada por partilharem esta experiência 
comigo, pelos bons momentos e pela paciência nos dias em que o stress era 
uma constante. Um especial agradecimento ao corredor maravilha (o corredor 
mais procurado do laboratório!!!) pela interajuda e pelos momentos de 
descontracção… Ao corredor verde/azul pelos eppis sempre autoclavados… 
Obrigada especialmente à Íris, pela ajuda com as clonagens e o estudo da 
sintenia. À Andreia pela sua, sempre presente, boa disposição. Ao espanhol, 
 
 
 
as minhas desculpas por o ter “expulsado” da bancada maravilha, a tua vida 
teria sido muito diferente! Obrigada ao Mike… por ser o Mike! À Sara por puxar 
sempre por mim! À Brigite, por todos os artigos que me enviaste e pela 
paciência com tantos e-mails! 
 
À dona Fernanda, o meu obrigada pelo carinho e por estar sempre disponível 
para me ajudar em tudo o que precisei.  
 
Aos meus “raios de sol”… Cátia, Rodrigo, Anabela, Joana, João e Inácio… 
Obrigada pela companhia, pelas longas conversas que tivemos, pelo carinho e 
pela força que me deram, principalmente neste último ano, mas… também 
pelos momentos de paródia que me ajudaram a manter sanidade mental! Sem 
vocês isto teria sido muitoooo mais difícil. João e Anabela, a procrastinação foi 
importante!  
 
Ao João, obrigada por me apoiares sempre e por me obrigares a falar de 
ciência de um modo pouco científico… Obrigada pela compreensão nos 
momentos em que não pude estar presente… Sem ti, este percurso teria sido 
sem dúvida mais doloroso. Obrigada por tudo…  
 
À minha irmã, por existir… por estar presente sempre que preciso… pela 
pressão dos últimos dias…  
 
Aos meus pais, obrigada pelo carinho, apoio e incentivo de sempre. Por 
acreditarem em mim e por toda a força que sempre me transmitiram. Obrigada 
por me ensinarem que na vida nunca nos devemos comparar aos mais fracos 
mas sim aos mais fortes… E que isso faz de nós sempre pessoas melhores e 
maiores.  
 
À minha filhota… a quem devo todo o tempo que não brinquei com ela, todos 
os momentos em que não pude vê-la crescer, todos os momentos que não 
pude viver com ela. Obrigada por me fazeres rir só porque sim… Obrigada por 
seres o meu alento… a minha força… o meu sol. Obrigada apenas por existires 
e seres quem és… Esta tese é dedicada a ti! 
 
 
 
 
 
 
 
 
 
 
 
 
 CONTENTS 
Abstract ………………………………………………………………………………………………15 
Resumo ……………………………………………………………………………………………… 17 
List of abbreviations ……………………………………………………………………………….21  
List of Figures and Tables ……………………………………………………………………….. 23 
CHAPTER 1  General Introduction ……………………………………………………………. 27 
1.1. MICRORNAS ………………………………………………………………………………………………………… 29 
1.1.1. Overview …………………………………………………………………………………………………..... 29 
1.1.2. History of miRNAs ………………………………………………………………………………………….. 30 
1.1.3. miRNA Genes ………………………………………………………………………………………………. 32 
1.1.4. Identification of miRNAs ……………………………………………………………………………………..34 
1.1.5. Biogenesis of miRNAs ……………………………………………………………………………………… 35 
1.1.5.1. miRNA Transcription ………………………………………………………………………………. 35    
1.1.5.2. miRNA Processing ………………………………………………………………………………… 36 
1.1.6. miRNA Mechanism of action ………………………………………………………………………………...39 
1.1.7. miRNA Functions …………………………………………………………………………………………… 42 
1.1.8. Investigating miRNA functions ……………………………………………………………………………… 44 
1.1.8.1. miRNA Profiling ……………………………………………………………………………………………… 44  
1.1.8.2. miRNA Targets: Identification and Validation ……………………………………………………… 45 
1.2. SKELETAL DEVELOPMENT AND MAINTENANCE ……………………………………………………………. 49 
1.2.1. Overview ……………………………………………………………………………………………………. 49 
1.2.2. Control of Chondrogenesis …………………………………………………………………………………. 50 
1.2.2.1. Post-transcriptional Control of Chondrogenesis …………………………………………………… 53  
1.2.3. Control of Osteogenesis ……………………………………………………………………………………. 54 
1.2.3.1. Post-transcriptional Control of Osteogenesis ……………………………………………………… 58 
1.2.4. Control of Bone Remodelling ……………………………………………………………………………….. 59 
1.2.4.1. Post-transcriptional Control of Bone Remodelling …………………………………………………. 61 
1.3. ZEBRAFISH AS A MODEL ………………………………………………………………………………………… 63 
1.3.1. Zebrafish and miRNAs ……………………………………………………………………………………… 64 
1.4. OBJECTIVES ………………………………………………………………………………………………………... 67 
CHAPTER 2  EVIDENCE FOR CONSERVATION OF MIR-223 IN ZEBRAFISH (DANIO 
RERIO): IMPLICATIONS FOR FUNCTION ………................................................................ 69 
2.1. ABSTRACT…………………………………………………………………………………………………………... 71  
2.2. INTRODUCTION…………………………………………………………………………………………………….. 72 
2.3. MATERIALS AND METHODS……………………………………………………………………………………… 74 
2.3.1. Biological Material ………………………………………………………………………………………...... 74 
2.3.2. Total RNA extraction ………………………………………………………………………………………... 74 
2.3.3. Marathon library and molecular cloning of zebrafish miR-223 primary transcript…………………………… 74 
2.3.4. Quantitative real-time PCR (qPCR) analysis ……………………………………………………………….. 75 
 
 
 
2.3.5. In silico analysis …………………………………………………………………………………………….. 75 
2.3.6. Prediction of miR-223 target transcripts ……………………………………………………………………..76 
2.4. RESULTS ……………………………………………………………………………………………………………..77 
2.4.1. Identification of zebrafish miR-223 primary transcript and gene structure ………………………………….. 77 
2.4.2. Genomic context of zebrafish and human mir-223 genes ………………………………………………….. 79 
2.4.3. Precursor of miR-223 contains highly conserved domains in vertebrates ………………………………….. 81 
2.4.4. Zebrafish miR-223 expression analysis …………………………………………………………………….. 85 
2.4.5. Identification of zebrafish putative miR-223 targets ………………………………………………………… 88 
2.5. DISCUSSION ………………………………………………………………………………………………………... 92 
2.5.1. miR-223 is conserved throughout evolution: insights from gene and precursor analysis…………………… 92 
2.5.2. MiR-223 expression is correlated with hematopoiesis in zebrafish ……………………............................. 94 
2.5.3. Evidences for conservation of miR-223 targets and regulatory functions in mammals and zebrafish………. 95 
2.6. CONCLUSIONS ……………………………………………………………………………………………………...97 
2.7. SUPPLEMENTARY MATERIAL …………………………………………………………………………………… 98 
CHAPTER 3  miR-29a is an enhancer of mineral deposition in bone-derived 
systems ………………………………………………………………........................................... 101 
3.1. ABSTRACT …………………………………………………………………………………………………………...103   
3.2. INTRODUCTION ……………………………………………………………………………………………………. 104 
3.3. MATERIALS AND METHODS ……………………………………………………………………………………...106 
3.3.1. Cell culture maintenance …………………………………………………………………………………….106 
3.3.2. Extracellular matrix (ECM) mineralization ………………………………………………………………… 106 
3.3.3. RNA extraction and quantitative real-time PCR (qPCR) analysis ………………………………………… 107 
3.3.4. Establishment of stable fish cell clones overexpressing miR-29a ………………………………………….. 107 
3.3.5. Transient overexpression of miR-29a during ECM mineralization ………………………………………….. 108 
3.3.6. Vector constructions ………………………………………………………………………………………… 108 
3.3.7. Dual-Luciferase Reporter Assays …………………………………………………………………………... 109 
3.3.8. Western Blot analysis ………………………………………………………………………………………. 109 
3.3.9. Statistical analysis …………………………………………………………………………………………...110 
3.4. RESULTS 110 
3.4.1. miR-29 family conservation in vertebrates …………………………………………………………………. 110 
3.4.2. Zebrafish and mouse have similar miR-29 expression patterns …………………………………………… 113 
3.4.3. miR-29a is up-regulated during ECM mineralization of ABSa15 cells ……………………………………… 114 
3.4.4. miR-29a promotes ECM mineralization in ABSa15 cells …………………………………………………… 116 
3.4.5. Seabream sparc is putatively regulated by miR-29a in ABSa15 cells ……………………………………… 119 
3.4.6. -catenin protein levels are up-regulated in ABSa15 cells overexpressing miR-29 ………………………... 121 
3.5. DISCUSSION …………………………………………………………………………………………………….......123 
3.5.1. miR-29 is a generally conserved family of miRNAs ………………………………………………………… 123 
3.5.2. miR-29a promotes ECM mineralization …………………………………………………………………….. 124 
3.5.3. As in mammals, miR-29a is also capable to regulate SPARC and Wnt signalling in fish bone-derived cells 126  
3.6. CONCLUSIONS ……………………………………………………………………………………………………...129 
 
 
 
3.7. SUPPLEMENTARY MATERIAL …………………………………………………………………………………… 130 
CHAPTER 4  miR-214: A new player in chondrogenesis? ……………………………….. 133 
4.1. ABSTRACT ………………………………………………………………………………………………………...... 135 
4.2. INTRODUCTION ……………………………………………………………………………………………………. 136 
4.3. MATERIALS AND METHODS ……………………………………………………………………………………...138 
4.3.1. Analysis of miRNAs expression …………………………………………………………………………….. 138 
4.3.2. In Situ Hybridization (ISH) ………………………………………………………………………………….. 139 
4.3.3. Identification and analysis of miR-214 promoter sequences ……………………………………………….. 140 
4.3.4. Cloning of zebrafish miR-214 5´ end ……………………………………………………………………….. 140 
4.3.5. Plasmid Constructs …………………………………………………………………………………………. 141 
4.3.6. Cell culture ………………………………………………………………………………………………….. 142 
4.3.7. Dual-Luciferase Reporter Assays …………………………………………………………………………... 142 
4.3.8. miR-214 overexpression during ATDC5 cell differentiation ………………………………………………… 143 
4.4. RESULTS ……………………………………………………………………………………………………………..143 
4.4.1. miR-214 is expressed in the skeleton of zebrafish ……………….................................................................... 143  
4.4.2. Comparative sequence analysis of the Dnm3os putative promoter region …………………………………. 147 
4.4.3. Cloning and identification of a functional Dnm3os promoter ……………………………………………….. 150 
4.4.4. Transcriptional regulation of miR-214 in skeletal-related cell lines …………………………………………. 154 
4.4.5. miR-214 is down-regulated during ATDC5 chondrogenic differentiation …………………………………… 156 
4.4.6. miR-214 mitigates chondrogenic differentiation of ATDC5 cells ……………………………………………. 157 
4.5. DISCUSSION ………………………………………………………………………………………………………... 160 
4.5.1. miR-214 is implicated in skeleton formation of mammals and zebrafish …………………………………… 160 
4.5.2. Cartilage and bone related TFs seem to coordinate miR-214 transcription ………………………………… 163 
4.5.3. miR-214, the most recent putative regulator of chondrogenesis ………………………………………........ 166 
4.6. CONCLUSIONS ……………………………………………………………………………………………………...170 
4.7. SUPPLEMENTARY MATERIAL …………………………………………………………………………………… 172 
CHAPTER 5  General Conclusions and Future Perspectives ……………………………. 175 
5.1. OVERVIEW ………………………………………………………………………………………………………...... 177 
5.2. MIR-223 IS ASSOCIATED TO MAMMALIAN HEMATOPOIESIS AND OSTEOCLASTOGENESIS AND 
HAS CONSERVED FUNCTIONS IN ZEBRAFISH …………………………………………………………………… 177 
5.3. MIR-29A INDUCES ECM MINERALIZATION IN BONE-DERIVED SYSTEMS THROUGH CONSERVED 
MECHANISMS IN VERTEBRATES ……………………………………………………………………………………. 180 
5.4. MIR-214 AFFECTS GENES WITH CRUCIAL FUNCTIONS IN CHONDROCYTE DIFFERENTIATION 
AND MINERALIZATION …………………………………………………………………………………………………. 181 
5.5. CONCLUDING REMARKS ………………………………………………………………………………………… 182 
CHAPTER 6  References ………………………………………………………………………... 185 
CHAPTER 7  Annex I - Mir-20a regulates in vitro mineralization and BMP signalling 
pathway by targeting BMP-2 transcript in fish ………………………………………………..217
  
 
 
15 
Abstract 
 
MicroRNAs (miRNAs) are a conserved class of small RNAs providing a 
post-transcriptional mechanism for fine-tuning of intricate physiological and 
pathological cellular processes, such as those affecting development. 
Skeletogenesis however, was so far poorly investigated and mainly focused on 
mammalian models, with a general lack of knowledge concerning other 
vertebrates. We aimed at the identification of bone-related miRNAs and their 
characterization from an evolutionary perspective, using fish (mostly zebrafish) 
as model, in comparison to mammalian systems.  
First, we focused on miR-223, a miRNA that was associated with bone 
remodelling. We demonstrated that miR-223 genomic organization/context and 
primary/secondary structures are largely maintained between human and 
zebrafish. As in mammals, miR-223 expression in zebrafish was highly 
correlated with hematopoietic events and osteoclastogenesis. Finally, miR-223 
targets identified in mammals were also predicted in zebrafish, supporting a 
functional conservation of this miRNA.  
In a second set of experiments, we studied the biological role of miR-29a, 
a bone-related miRNA that was fairly investigated in mammals, but with no 
mineralogenic effects yet demonstrated. We took advantage of our fish bone-
derived systems to explore miR-29a mineralogenic effects through gain-of-
function experiments. We demonstrated a strong stimulation of this process 
through a mechanism probably involving the canonical Wnt signalling. Once 
more, through bioinformatics analysis, patterns of expression and target 
prediction/validation, we provided evidences for miR-29 conservation 
throughout evolution.  
Finally, we explored miR-214 putative roles on skeleton formation in 
vertebrates. Although our initial hypothesis of miR-214 involvement in 
osteogenesis was recently demonstrated by Wang et al. (2013), we proceeded 
with our investigation and finally showed that miR-214 is also associated with 
chondrogenesis. Overexpression of miR-214 in ATDC5 cells mitigated 
differentiation and down-regulated Mgp and Osteocalcin, probably by targeting 
Atf4.  
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This work provides novel evidence that some miRNAs have conserved 
functions across vertebrates and, probably, conserved regulatory mechanisms 
of action. 
 
Keywords: miRNAs; conservation; zebrafish; regulation; expression; bone. 
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Resumo 
 
Nos últimos anos, assistiu-se a uma marcante expansão na área da 
biologia molecular, devendo-se isto principalmente à descoberta de pequenas 
moléculas de RNA não codante e ao seu modo peculiar de intervir na 
regulação genética. Dentro deste grupo de moléculas, os microRNAs (miRNAs) 
são, definitivamente, a classe melhor compreendida, o que se comprova pelo 
crescimento exponencial do número de trabalhos publicados desde a sua 
descoberta. Os miRNAs, na sua forma matura, são RNAs com 
aproximadamente 22 nucleótidos (nt), altamente conservados em vertebrados 
e que asseguram um controlo apertado de vários processos celulares através 
de uma regulação pós-transcricional. Esta regulação ocorre através da ligação 
específica do miRNA à 3’UTR do RNA mensageiro (mRNA). Neste mecanismo, 
destaca-se o envolvimento do complexo RISC (RNA-induced silencing 
complex; associado ao miRNA), a complementaridade da denominada região 
“seed” (extremidade 5’ do miRNA) ao mRNA, e o consequente bloqueio da 
tradução ou degradação do mRNA. Desta forma, cada miRNA pode regular 
centenas de genes transcritos, e de facto, hoje em dia pensa-se que a maioria 
dos genes humanos são controlados por miRNAs. Assim, os miRNAs são 
considerados não só importantes reguladores de múltiplos processos 
biológicos, incluindo desenvolvimento, diferenciação e apoptose celular, mas 
também responsáveis por vários processos patológicos, como o cancro, onde 
se observou que inúmeros miRNAs têm a sua expressão desregulada. Assim, 
a caracterização dos miRNAs (a vários níveis) é fundamental para a 
compreensão das suas funções, permitindo alargar também o conhecimento 
dos processos biológicos e patológicos onde estão envolvidos.  
Apesar do conhecimento sobre miRNAs ter aumentado francamente nos 
últimos anos, o papel dos miRNAs na formação e homeostasia do osso ainda 
está pouco caracterizado, e a maioria dos estudos tem abordado 
principalmente esta forma de regulação em mamíferos, havendo assim uma 
lacuna de conhecimento na regulação destes processos noutros vertebrados. 
Neste sentido, este trabalho focou-se na identificação de miRNAs 
potencialmente envolvidos na regulação do osso e na sua caracterização numa 
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perspectiva evolutiva, usando o peixe (essencialmente o peixe-zebra) como 
modelo, e em comparação com mamíferos.  
 Numa primeira abordagem, focámos a nossa investigação no estudo do 
miR-223, um miRNA anteriormente associado à diferenciação celular da 
linhagem hematopoiética e ao processo de remodelação óssea. Neste estudo, 
demonstramos que a organização e contexto genómicos do miR-223 estão 
preservados em vertebrados, verificando-se uma conservação das estruturas 
primária e secundária do pre-miR-223 em 46 espécies. Este estudo mostra 
ainda que a expressão deste miRNA se correlaciona com determinadas fases 
do desenvolvimento do peixe-zebra onde a hematopoiese e a 
osteoclastogénese são eventos predominantes. Além disso, este estudo mostra 
que o miR-223 apresenta uma expressão elevada no principal órgão 
hematopoético de peixes e ratinhos adultos (rim anterior e medula óssea, 
respectivamente), sugerindo que a função hematopoiética também se encontra 
conservada. Por último, através de análise bioinformática demonstrámos que a 
regulação de genes alvo do miR-223 em mamíferos também deverá estar 
mantida em peixe-zebra. 
Na secção seguinte estudámos o papel biológico do miR-29a, cujo efeito 
osteogénico em mamíferos se encontra bem caracterizado, mas sem nenhum 
fenótipo mineralogénico ainda associado. Neste estudo utilizámos uma linha 
celular derivada do osso de peixe previamente desenvolvida no nosso 
laboratório e com capacidade de mineralização in vitro. A fim de explorar os 
efeitos mineralogénicos do miR-29a foram realizadas experiências de ganho de 
função. O aumento dos níveis endógenos deste miRNA resultaram num 
incremento da mineralização da matriz extra-celular, o que provavelmente terá 
sido devido a uma aceleração da diferenciação celular pelo potenciamento da 
via de sinalização Wnt, tal como evidenciado pela acumulação de um dos seus 
principais componentes, a -catenina. Além disso, foi demonstrada a 
conservação da função deste miRNA através de estudos baseados em 
homologia de sequências, análise de sintenia, padrão de expressão tecidular e 
na manutenção da regulação do SPARC, um alvo previamente descrito em 
mamíferos. Reforçou-se assim a ideia de que o miR-29a é um regulador crucial 
na diferenciação de osteoblastos, induzindo um aumento da mineralização em 
sistemas in vitro. 
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Finalmente, explorámos a hipótese do miR-214 ser regulador da 
formação do esqueleto/osso, em vertebrados. Apesar da nossa primeira 
hipótese, que consistia no envolvimento do miR-214 na osteogénese, ter sido 
entretanto demonstrada através do trabalho realizado por Wang et al. (2013), 
continuámos com este estudo, tentando demonstrar um potencial envolvimento 
deste miRNA na condrogénese, um processo essencial na formação do 
esqueleto de vertebrados. Através do padrão de expressão espacial e temporal 
do miR-214 durante o desenvolvimento do peixe-zebra, verificou-se uma clara 
associação com estruturas cartilagíneas. Adicionalmente, demonstrámos que a 
região reguladora (promotor) do transcrito primário deste miRNA se encontra 
conservada em oito vertebrados, assim como os locais de ligação de factores 
de transcrição (associados à condrogénese e/ou osteogénese) identificados. 
De acordo com a análise funcional deste promotor, concluiu-se que esta região 
reguladora (quer de peixe-zebra quer de humano) é activada e regulada de 
forma semelhante em condrócitos e osteoblastos. Por último, verificou-se que a 
sobreexpressão do miR-214 nas células ATDC5, um modelo in vitro para a 
condrogénese, atenua a diferenciação condrocítica, possivelmente através da 
regulação do gene Atf4. O decréscimo simultâneo de dois marcadores ósseos, 
a Mgp e a osteocalcina, aquando da sobreexpressão deste miRNA sugere que 
a mineralização dos condrócitos poderá estar comprometida nesta condição. 
Assim, propomos que o miR-214 desempenha um papel fundamental na 
formação do esqueleto de vertebrados, não apenas pela regulação da 
osteogénese, mas também pelo controlo da condrogénese, promovendo assim 
a normal e equilibrada formação de estruturas ósseas e cartilagíneas.  
No seu conjunto, estes estudos evidenciam uma conservação na função 
e mecanismos de regulação de muitos dos miRNAs identificados em 
vertebrados. Este conhecimento é bastante importante, por exemplo para a 
investigação de tratamento de patologias, uma vez que permite a utilização de 
modelos alternativos no rastreio de potenciais alvos terapêuticos, com 
particular destaque para as vias reguladas por miRNAs. Nesta perspectiva, em 
doenças como por exemplo a osteoporose, onde se verifica uma perda de 
massa óssea, terapias que estimulem a acção de miRNAs que promovam a 
osteoblastogénese ou que inibam a osteoclástogénese, são atractivas e com 
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grande potencial na estimulação da formação óssea ou na redução da 
reabsorção óssea excessiva, respectivamente.  
 
Palavras-chave: miRNAs; conservação; peixe-zebra; regulação; expressão; 
osso.  
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1.1. MicroRNAs 
 
1.1.1. Overview 
In the last years, only few research areas of biology have witnessed such 
a remarkable expansion as that observed for RNA molecular biology. Although 
this breakthrough has occurred through many fronts, one of the areas where 
major progresses were obtained concerned the discovery of the mode of action 
and impact of small non-coding RNAs (ncRNAs) on the regulation of genes and 
genomes. Since the first discovery of double-stranded RNA (dsRNA) ability to 
regulate gene expression by antisense base-pairing to target messenger RNA 
(mRNA), a process named RNA interference (RNAi) (Fire et al., 1998), an 
enormous increase in the number of identified small ncRNAs was observed, 
and these have been found in animals, plants, fungi and viruses. Despite the 
existence of various classes of small ncRNAs, these molecules are generally 
divided in three main categories based on their biogenesis, structure, 
associated effector proteins and biological functions (Bartel, 2009; Moazed, 
2009): (i) short interfering RNAs (siRNAs), which are processed by Dicer from 
long dsRNAs into duplexes of 21-25 nucleotides (nt) in length and act through 
the RNAi pathway to regulate gene expression (Ambros et al., 2003; Reinhart 
and Bartel, 2002); (ii) piwi-interacting RNAs (piRNAs) which are longer RNAs of 
about 25-30 nt that interact with Piwi proteins (Aravin et al., 2007); and (iii) 
microRNAs (miRNAs) (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and 
Ambros, 2001; Lee et al., 1993), which will be described in detail in the next 
sections. MiRNAs are the best understood of these three classes, and the 
emergent perception of their importance led to a boost on publications in the 
past years with over 32500 scientific reports currently recorded and from them 
more than 30000 were published during the course of the work here presented 
(last checked on the 23 of June 2014 at PubMed database, 
http://www.ncbi.nlm.nih.gov/pubmed) (Figure 1.1). 
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Figure 1.1. Graphical representation of the number of publications in the PubMed 
database per year. The keywords microRNA, microRNAs and miRNA were searched in the title 
and/or abstract of articles available. Note that for 2014, the number of publications refers to 
publications until the 23 of June 2014.  
 
 
A perspective on animal miRNA discovery, genomics, biogenesis, 
mechanisms and functions will be described in the following sections. 
 
1.1.2. History of miRNAs 
The central dogma of molecular biology which considered that RNA 
molecules acted as simple messengers between DNA, encoding cellular 
instructions, and proteins, the end-products which executed those instructions 
(Crick, 1970), started to be questioned when researchers realized that ncRNA 
molecules could interfere with gene expression. The biological phenomenon of 
antisense control mechanisms was first recognized in the late 70s and early 80s 
when scientists found that exogenous oligonucleotides with a complementary 
sequence to ribosomal RNA could prevent ribosome function in Echerichia coli 
(Eckhardt and Lührmann, 1979; Jayaraman et al., 1981). More then ten years 
later, Ambros and colleagues discovered that lin-4, a gene known to be 
essential for developmental timing of the nematode worm Caenorhabditis 
elegans larvae, did not encode a protein, but rather produced a pair of small 
RNAs, one containing 22 nt and another containing ~61 nt sequence with a 
predicted stem loop structure and proposed to be the precursor of the shorter 
(~22 nt) molecule (Lee et al., 1993). Both RNAs were found to have antisense 
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complementarity with multiple sites in the 3’-untranslated region (UTR) of lin-14 
transcript (Lee et al., 1993; Wightman et al., 1993). Based on this information, 
lin-4 putative binding and regulation of lin-14 was proposed (Wightman et al., 
1991). However, it was only in 1993 that this mechanism was demonstrated, 
when lin-14 transcript levels were shown to be constant throughout 
development of C. elegans, whereas LIN-14 protein levels were not, indicating a 
post-transcriptional regulation (Wightman et al., 1993). The authors 
demonstrated that: (i) the post-transcriptional regulation of lin-14 by lin-4 
generated a temporal gradient of Lin-14 protein during C. elegans development; 
(ii) lin-14 3’UTR was essential and sufficient for lin-4-mediated temporal 
regulation; and that (iii) multiple conserved elements in the lin-14 3’UTR were 
complementary to, at least, a core of 7 nt in the 5´-end of lin-4, mediating part of 
the temporal gradient activity of the lin-14 3´-UTR (Wightman et al., 1993). This 
regulatory process was later proven to be essential for worms to proceed from 
their first larval stage to the second, as reviewed by Rougvie (2005). It took 
seven years to discover that this mechanism was not an isolated event, until a 
second small regulatory RNA, let-7, was identified (Reinhart et al., 2000). 
Similarly to lin-4, let-7 was shown to operate by specific binding to the 3’UTR 
and repression of lin-41 and hbl-1 mRNAs (Lin et al., 2003; Reinhart et al., 
2000; Slack et al., 2000; Vella et al., 2004). By then, let-7 was found to be 
highly conserved throughout metazoan (Pasquinelli et al., 2000), contradicting 
the general idea that lin-4 and let-7 were a worm-specific peculiarity. 
Meanwhile, dsRNA mediated gene down-regulation in C. elegans was reported 
to be far more potent than single-stranded antisense RNA (ssRNA) (Fire et al., 
1998), which brought new insights into the putative mechanisms of RNA 
interference (RNAi), as it will be described next in detail. These findings 
propelled intense genome-wide searches to identify additional endogenous 
small regulatory RNAs, which ended to be demonstrated in 2001 (Lagos-
Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001). This finally led 
to the recognition that microRNAs (miRNAs) represent a distinct, conserved and 
abundant class of regulatory genes. The importance of non-coding RNA was 
further supported when the draft of the human genome project was concluded, 
and revealed that the extent of protein-coding genes covers only about 2% of 
the human genome (Lander et al., 2001). Remarkably, while the number and 
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size of protein-coding genes was shown to not vary substantially with increasing 
developmental complexity, this was not the case for non–protein coding 
sequences in genomes, indicating that these sequences may enclose 
increasingly intricate regulatory information (Taft et al., 2007).  
Nowadays, RNA molecules are known to function not only as 
messengers of protein production, but also as key features of the gene 
regulatory networks with 30424 mature miRNAs identified so far in animals, 
plants, algae, amoeba, diatom and viruses, and deposited in the miRNA 
database (miRBase Release 20, http://www.mirbase.org/). MiRNAs are now 
known to be involved in a variety of biological processes, including cell 
proliferation and differentiation (Yang et al., 2011d), apoptosis (Li et al., 2011a), 
organogenesis (Giraldez et al., 2005; Papaioannou et al., 2013), and also in 
pathological processes, such as cancer (Plaisier et al., 2012; Wang et al., 
2013b) and infection / inflammation / immunity (Baltimore et al., 2008; 
Haneklaus et al., 2013). Outstandingly, bioinformatics predictions suggest that 
miRNAs control up to 60% of all human protein-coding genes (Friedman et al., 
2009), further confirming an essential role in eukaryotic gene regulation. 
 
1.1.3. miRNA Genes 
Our knowledge about miRNA biology has been significantly increased 
following the discovery of let-7. Most of the studies, however, have been 
focusing on processing and targeting by miRNAs. In this regard, despite being 
important regulatory steps in miRNA biogenesis, miRNA genomics and 
transcription regulation are still poorly understood. MiRNAs are endogenous 
small non-coding RNAs (~22 nt) generated from conserved hairpin structures 
that are transcribed from diverse regions of the genome as long primary 
transcripts (pri-miRNAs), scattered in all chromosomes from humans to 
zebrafish (Bartel, 2004; Kim et al., 2005; Pillai, 2005; Thatcher et al., 2008). The 
first miRNAs identified, lin-4 and let-7, were shown to be located in non-coding 
regions in-between genes and transcribed from unidentified promoters, leading 
to the initial thought that most miRNA genes were located in intergenic regions 
(Lagos-Quintana et al., 2001; Lau et al., 2001) and thus named intergenic 
miRNAs (Fig. 1.2a). However, the identification of several intronic miRNAs in C. 
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elegans, mouse an human genomes (Ambros et al., 2003; Rodriguez et al., 
2004) and the demonstration of gene silencing mechanisms associated to 
miRNAs derived from introns (Ying and Lin, 2004), evidenced a new miRNA 
category: intronic miRNAs (Fig. 1.2 b). In fact, new technology and refined 
mapping demonstrated that the vast majority of mammalian miRNAs reside 
within the intronic regions of either protein-coding genes or non-coding 
transcripts (Griffiths-Jones et al., 2008; Rodriguez et al., 2004). Although this 
estimation varies between species, the location of several intronic miRNAs is 
quite conserved among different organisms (Kim and Nam, 2006). Intronic 
miRNAs are generally sense orientated with their host gene and expression of 
both miRNA and host gene largely coincides, suggesting a co-regulation and 
generation from a common precursor transcript (Baskerville and Bartel, 2005).  
 
 
Figure 1.2. Genomic organization of miRNA genes. miRNA genes can reside (a) in-between 
genes, named intergenic miRNAs (alone or clustered); (b) in the intron of ncRNA or protein-
coding genes (alone or clustered), called intronic miRNAs; (c) in a short intron, the mirtrons; or 
(d) in the exon of ncRNAs, which are called exonic miRNAs. Adapted from Kapinas and Delany 
(2011). 
 
 
A few miRNA precursors, called ‘mirtrons’, comprise the full intron size 
and, when spliced, are able to bypass the first cleavage step in miRNA 
processing (Berezikov et al., 2007) (Fig. 1.2 c). Also, a small subset of miRNAs, 
approximately 10%, is located within exons of non-coding genes (Kim et al., 
2009; Rodriguez et al., 2004) (Fig. 1.2 d). In addition, 36% to 47% of known 
miRNAs are found in clusters and might be transcribed as single polycistronic 
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primary transcripts in vertebrates (Griffiths-Jones et al., 2008; Olena and 
Patton, 2010; Thatcher et al., 2008) (Fig. 1.2 a, b). Clustered miRNAs are 
frequently related to each other in sequence, suggesting that miRNA clusters 
might be a consequence of gene duplication. Exceptionally, some clusters 
contain representatives of different miRNAs families without apparent sequence 
homology (Kim and Nam, 2006). A possible explanation for this relies on the 
ability for clustered miRNAs to target the same gene or different genes in the 
same pathway (Yuan et al., 2009b).  
 
1.1.4. Identification of miRNAs 
Nowadays, both biological and bioinformatics approaches for miRNA 
identification have yielded many thousands of miRNA sequences and novel 
miRNAs still appear almost on a daily basis. Identified miRNAs are deposited in 
miRBase (www.mirbase.org/) (Kozomara and Griffiths-Jones, 2011), a widely 
known public database for published miRNA sequences and respective 
annotation (miRBase database), and also for new miRNA genes prior to their 
publication (miRBase Registry). Each miRBase entry matches a predicted 
hairpin fraction of a miRNA transcript and contains information on the location 
and sequence of the mature miRNA, its genomic location, target prediction, 
conservation and experimental validation (Griffiths-Jones et al., 2008; 
Kozomara and Griffiths-Jones, 2011). The current version of miRBase (Release 
20, updated in June 2013) contains 24521 entries, which express 30424 mature 
miRNAs in 206 different species.  
The first miRNAs were identified by forward genetic screens (Lee et al., 
1993; Reinhart et al., 2000). Directional cloning can be applied in every 
organism, which can be an advantage when the available genomic information 
is scarce or non-existent. Combined cloning and bioinformatics approaches 
proved to be particularly valuable in the first years of miRNA research. 
Nevertheless, with the recent advances in next-generation sequencing, deep 
sequencing has been applied to both miRNA discovery and quantification in 
several organisms (Bizuayehu et al., 2013; Castellano and Stebbing, 2013; Wei 
et al., 2012). In fact, this technology boosted the number of miRNAs identified in 
different species, further increasing the challenge of functional annotation and 
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driving a considerable advance in bioinformatics approaches for miRNA target 
prediction and systems-based analysis of miRNA function.  
 
1.1.5. Biogenesis of miRNAs 
 
1.1.5.1. miRNA Transcription 
Characterization of miRNAs genomic organization, transcription and 
regulation is still ongoing. MiRNAs transcription is known to be mostly mediated 
by RNA polymerase II (Pol II), with primary transcripts (pri-miRNAs) bearing Pol 
II signatures such as a 7-methyl guanylate cap at the 5' end and poly (A) tail at 
the 3' end (Cai et al., 2004; Davis and Hata, 2009; Ozsolak et al., 2008). RNA 
Pol III has also been found to be involved in the transcription of some miRNAs, 
but this mechanism has been rarely observed (Borchert et al., 2006; Ozsolak et 
al., 2008). Supporting this, a large scale analysis of intergenic miRNAs 
structures and mapping of human miRNA promoters (involving chromatin 
immunoprecipitation) indicated that miRNA promoters display all features 
commonly associated with Pol II-mediated transcription, such as CpG islands, 
TATA boxes, transcription factor IIB recognition sites, initiator elements and 
histone modifications (Corcoran et al., 2009; Ozsolak et al., 2008; Saini et al., 
2007). Besides having dedicated promoters, miRNAs were demonstrated to be 
first transcribed as long pri-miRNAs, with 3-4 kb (kilobase pairs) in length (Gu et 
al., 2006; Ozsolak et al., 2008) and containing transcript start sites (TSSs) and 
poly(A) signals located within approximately 2 kb upstream and downstream of 
the miRNA precursor (pre-miRNA), respectively (Fig. 1.3) (Saini et al., 2007). 
Ozsolak and colleagues also demonstrated that about one third of intronic 
miRNAs have their own promoter regions, enabling a different regulation from 
the host gene (Ozsolak et al., 2008). Furthermore, coupling between 
transcription and processing has been verified for both intergenic and intronic 
miRNAs. An important difference however, relies on the fact that intergenic 
miRNAs co-transcriptional processing is coupled with termination (Ballarino et 
al., 2009), while intronic miRNAs processing seems to occur co-transcriptionally 
in cooperation or preceding splicing of the primary transcript (Janas et al., 2011; 
Kim and Kim, 2007; Morlando et al., 2008).  
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Figure 1.3. Representation of a canonical intergenic pri-miRNA. Intergenic pri-miRNAs 
(green) have dedicated promoters with TATA boxes, transcriptional start sites (TSS), CpG 
islands (CpG) and transcription factor (TF) binding sites. Pri-miRNAs transcripts can contain 
one or several pre-miRNAs and more then one polyadenylation (Poly A) sites. Adapted from 
Saini et al. (2007). 
 
 
Regarding transcriptional regulation, mRNAs and miRNAs also present 
important similarities. Indeed, the network of transcription factors (TFs) that 
control protein coding genes is also found to regulate miRNA transcription, 
orchestrating cell-fate decisions, cell differentiation and tissue and 
developmental stage-specificity (Schmeier et al., 2009). In addition, as in 
protein coding genes, TF-binding sites (TFBS) are 8-15 base pairs (bp) long 
and are generally located nearby TSSs, close to the pre-miRNA. Furthermore, 
60% of human miRNAs have clustered TFBS  preferentially located within a 1-
kb region (Saini et al., 2007). Interestingly, emerging evidence indicates that 
miRNAs have a common tendency to regulate transcription factors that drive 
their expression, cooperating in complex regulatory networks through feedback 
loops to regulate cell decisions (Fazi et al., 2005).  
In summary, regulation of pri-miRNA transcription is one of the most 
important features controlling miRNA abundance and a full understanding of 
that process requires a comprehensive characterization of the genomic location 
and extent of pri-miRNAs, including TSSs, promoters and TFBS. 
 
1.1.5.2. miRNA Processing 
As mentioned before, transcription of miRNA genes by RNA Pol II 
originates long, capped and polyadenylated pri-miRNAs which can contain one 
or more miRNAs (Cai et al., 2004). Once transcribed, pri-miRNAs fold into 
imperfectly base-paired stem-loop (also known as hairpin) structures that are 
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further processed. In animals, maturation of miRNAs occurs in two processing 
steps, each one catalyzed by a ribonuclease III (RNase III) endonuclease in 
cooperation with a double-stranded RNA-binding domain (DsRBD) protein. This 
process is summarized in Fig. 1.4 and will be described next. 
 
Figure 1.4. Biogenesis of miRNAs. 
Transcription of miRNA genes by 
RNA Poll l originates capped and 
polyadenylated transcripts that fold 
into hairpin structures (pri-miRNAs). 
Cleavage by Drosha in the nucleus 
generates a smaller miRNA 
precursor (pre-miRNA) which is then 
exported into the cytoplasm and 
further processed by Dicer to  
generate a miRNA:miRNA* duplex. 
Once this duplex is assembled into 
RISC, the miRNA* is discarded, and 
the mature miRNA guides this 
complex to the target mRNA. 
Translation inhibition or mRNA 
degradation occurs by binding of the 
miRNA to the 3’UTR of target 
mRNA. In Davis and Hata (2009). 
 
  
 
 
 
 
 
 
 
 
 
 
 
The first step of miRNAs processing is catalysed by the nuclear RNase III 
Drosha, which cleaves the stem-loop structures in pri-miRNAs to originate a 
~70 nt pre-miRNA (Han et al., 2004; Lee et al., 2002, 2003, 2006). The 
accuracy and efficiency of this process is assured by the cooperation of 
DiGeorge syndrome critical region in gene 8 (DGCR8) (known as Pasha in 
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Drosophila and C. elegans), which interacts with Drosha forming a pri-miRNA 
processing complex named the Microprocessor complex (Faller et al., 2010; 
Han et al., 2004, 2006). Efficient processing by Drosha requires (i) an hairpin 
with a large terminal loop (≥ 10 nt); (ii) two helix turns (~22 nt) that encode the 
miRNA:miRNA* duplex plus (iii) one helix turn (~11 nt) of the lower stem (Han et 
al., 2006; Zeng et al., 2005b) (see Fig. 1.5). Cleavage by Drosha occurs 
approximately 11 nt away from the ssRNA-stem loop junction, defining one end 
of the mature RNA. The resulting pre-miRNA has a 5’ phosphate group and a 2-
3 nt 3’ overhang characteristic of RNase II cleavage of dsRNA (Han et al., 2004, 
2006; Zeng et al., 2005b). 
 
Figure 1.5. Representation of pri-miRNAs structure and Drosha cleavage. Pri-miRNAs fold 
into stem-loop structures with a central stem of approximately 33 nt (3 helix turns). The lower 
stem consists of one helix turn, flanked by ssRNA, and the upper stem (which encodes the 
miRNA duplex) comprises 2 helix turns, flanked by a terminal loop. Drosha cleavage sites are 
indicated in the pri-miRNA by verticals arrowhead and arrow. The miRNA duplex is represented 
by red and blue lines in the upper stem. Adapted from Zeng et al. (2005b). 
 
 
After Drosha processing, Exportin-5 (XPO5), a nuclear export factor, 
recognizes the characteristic end structure of pre-miRNAs and exports it to 
cytoplasm in a Ran-GTP (RAs-related Nuclear protein) dependent manner, 
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through nuclear pore complexes (Bohnsack et al., 2004; Lund and Dahlberg, 
2006; Lund et al., 2004). In the cytoplasm, the pre-miRNA is further processed 
by another highly conserved RNase III, Dicer, together with its dsRBD partners, 
which are apparently required for miRNA stability and effector complex 
formation (Lee et al., 2013; Pilotte et al., 2011). Then, Dicer cleaves the pre-
miRNA at the terminal loop, liberating a ~22 nt-long RNA duplex (Bartel, 2004; 
Macrae et al., 2006; Pillai, 2005). This miRNA duplex contains the mature 
miRNA and the miRNA* (which is by definition the small RNA in the opposite 
side of the pre-miRNA stem loop), which are partially paired due to the 5’ and 3’ 
overhangs resulting from both Drosha and Dicer cleavages. Evidences 
collected in the last few years indicate that Dicer processing involves the 
binding of TRBP (trans-activator RNA (tar)-binding protein) to the miRNA duplex 
and, after cleavage, TRBP recruits Argonaute 2 (Ago2). Ago2 along with Dicer 
contribute to the assembly of RISC (RNA induced silencing complex) forming 
the RISC loading complex (RLC) (Chendrimada et al., 2005; Wahid et al., 
2010). Once the miRNA duplex is loaded into Ago protein of RISC, the RNA 
strand with the lowest thermodynamic stability at its 5’-end (called guide strand) 
remains bounded to this complex while the miRNA* (passenger strand) is 
degraded (Schwarz et al., 2003). In some cases miRNAs* can be loaded into 
RISC and originate functional miRNAs. The precise mechanism through which 
the RNA loading into Ago occurs is still not understood. Concerning Ago2, this 
is the only one of the four Ago proteins in humans that is known to have 
endonucleolytic activity, being widely described as the RISC slicer (Song et al., 
2004). However, Ago2 is also known to participate in the removal of miRNA 
passenger strand (Diederichs and Haber, 2007). Interestingly, all four Ago 
proteins are known to enhance production or stability of mature miRNAs 
(Diederichs and Haber, 2007). Finally, the mature miRNA guides the RISC to its 
target transcript, leading to its degradation or translation repression. 
 
1.1.6. miRNA Mechanism of action 
The first identified miRNA, lin-4, was shown to down-regulate the protein 
levels of LIN-14 (Lee et al., 1993). Five years later, Mello’s group showed that 
dsRNA was far more effective in inhibiting the expression of specific mRNA 
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than ssRNA, uncovering the phenomena of RNAi (Fire et al., 1998). Although at 
that time these authors speculated that the inhibition process was based on a 
catalytic mechanism (Fire et al., 1998), miRNAs mode of action was later 
demonstrated to rely mostly on translation inhibition. However, the mechanism 
by which miRNAs regulate gene expression is still under debate. Indeed, 
different studies have demonstrated that down-regulation of protein levels can 
occur by either inhibition of translation initiation or elongation, premature 
termination of translation or co-translational inhibition (Eulalio et al., 2008). 
Additionally, miRNAs can induce target mRNA degradation (Schmitter et al., 
2006) and also sequester mRNAs into cytoplasmatic foci called P-bodies, for 
storage or degradation (Castilla-Llorente et al., 2012) (Fig. 1.6). Recent 
mechanistic models proposed that miRNA-mediated gene silencing might occur 
by successive steps, combining translation inhibition and mRNA degradation 
(Béthune et al., 2012; Djuranovic et al., 2011).  
  
 
Figure 1.6. Putative mechanisms for miRNA-mediated post-transcriptional regulation. 
Translational repression occurs when miRNAs bind to their target mRNAs by partial 
complementarity. Protein production can be blocked by interference with the initiation, 
elongation or termination steps. A near perfect base pairing between miRNA and target mRNA 
can originate cleavage of the target mRNAs leading to mRNA decay. Both translation 
repression and mRNA cleavage can occur in P-bodies, where storage or degradation of mRNAs 
occurs. Adapted from Pedroza-Torres et al. (2014). 
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Despite the different mechanisms for miRNAs regulation of gene 
expression, a common feature was generally shown to be associated to this 
process, i.e. miRNAs binding to the 3’UTR of target mRNAs through imperfect 
complementarity. In few exceptional cases however, this regulation involves 
binding to the 5’UTR or to the coding sequencing of mRNA targets (Duursma et 
al., 2008; Ørom et al., 2008). The complementarity between miRNAs and 
mRNA targets is generally confined to the 5’ region (nucleotides 2-8) of the 
miRNA, which has been named the ‘seed region’, illustrating its contribution to 
target mRNA binding (Lewis et al., 2003a, 2005; Pillai, 2005) (Fig. 1.7).  
 
 
Figure 1.7. Representation of miRNA:mRNA interaction in animals. Binding of miRNAs to 
target mRNAs requires perfect complementarity between the seed region (nucleotides 2-8, red 
rectangle) and the 3’UTR of the mRNA (green rectangle). Possible base pairing involving the 3’ 
end of the miRNA might occur (pink rectangles), contributing for a best stabilization of the 
miRNA:mRNA duplex. The presence of a central bulge prevents the cleavage of the mRNA by 
Ago2. In Filipowicz et al. (2008). 
 
 
This limited complementarity between miRNA and its target mRNA was 
proven to be an advantage in gene expression regulation, since the short length 
of miRNA seed region allows the simultaneous inhibition of hundreds of target 
mRNAs (Baek et al., 2008; Lewis et al., 2005; Selbach et al., 2008). Therefore, 
the biological effects of miRNAs can reflect synergistic effects through 
simultaneous regulation of different targets. The rules governing miRNA:mRNA 
Watson–Crick base pairing are quite complex, and though perfect pairing 
between seed regions and target 3’UTRs is crucial for gene regulation, 3′-end 
pairing might contribute to target recognition (Fig. 1.7), particularly when sites 
have weaker miRNA seed matches (Li et al., 2008). Imperfect miRNA:mRNA 
interactions with central bulges (nucleotides 9–12) facilitate translational 
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inhibition or exonucleolytic mRNA decay (Fig. 1.7), whereas the outcome of 
highly complementary binding sites is normally target regulation and slicing 
(Brodersen and Voinnet, 2009). Furthermore, the presence of multiple binding 
sites is though to enhance the degree of repression by miRNAs.  
In the last few years, our knowledge about miRNA functions has greatly 
increased and some surprising modes of action have been identified. For 
instance, Zardo and colleagues demonstrated that miRNAs can regulate gene 
expression also at the transcriptional level, as was the case for miR-223 binding 
to the NFIA (nuclear factor I/A) promoter which repressed its transcription 
during granulopoiesis (Zardo et al., 2012).  
Nevertheless, while miRNA-mediated gene regulation mechanisms are 
still under investigation, several other factors can influence miRNAs effects on 
their target miRNAs, but are not within the scope of this work and therefore will 
not be addressed here. 
 
1.1.7. miRNA Functions 
As key regulators of gene expression, miRNAs have been implicated in a 
variety of developmental, physiological and pathological processes, including 
cell proliferation, apoptosis, differentiation and cell fate decisions (Erson and 
Petty, 2008; Fatica et al., 2008; Ivey and Srivastava, 2010; Wang et al., 2013b; 
Wienholds and Plasterk, 2005; Wu et al., 2012; Xiong et al., 2010). Insights 
about the role of miRNAs in animals have been obtained through diverse 
approaches, including gain- and loss-of-function genetic screens in C. elegans 
and Drosophila (Brennecke et al., 2003; Lee et al., 1993; Reinhart et al., 2000; 
Slack et al., 2000), reverse genetic approaches by miRNA knockout or 
knockdown (Lee et al., 2005; Meister et al., 2004), miRNAs expression profiling 
(Bak et al., 2008; Chen et al., 2005a), mRNA target identification and validation 
(Jia et al., 2011; Wang et al., 2013a) and bioinformatics inference (Liu et al., 
2012). Moreover, crucial evidences about miRNA essential roles resulted from 
approaches involving silencing of Dicer and consequent mature miRNAs 
depletion in several model systems. While Dicer-mutant mouse embryos failed 
to produce multipotent stem cells and ~50% died by day 7.5 (Bernstein et al., 
2003), inactivation of zebrafish Dicer resulted in an inhibition of pre-miRNA 
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processing, loss of miRNA accumulation and abnormal morphogenesis, which 
was mainly attributed to miR-430 loss of function (Giraldez et al., 2005; 
Wienholds et al., 2003). Both studies evidenced the importance of miRNAs in 
vertebrate development. In particular organs and systems, conditional deletion 
of Dicer enabled to understand the role of miRNAs during embryonic stem cell 
proliferation (Murchison et al., 2005), formation of normal cartilage and bone 
(Gaur et al., 2010; Kobayashi et al., 2008), heart function (Roy et al., 2013) and 
neuronal function (Dorval et al., 2012).  
Several studies have also implicated miRNAs in disease (Carissimi et al., 
2009; Saito and Saito, 2012) and, in this field, cancer has been in the spotlight 
in the last years. In such pathological contexts, miRNAs can behave either as 
tumour suppressors or oncomiRs that become deregulated. Also, altered 
expression levels of Drosha, DGCR8, Dicer, XPO5, Ago2 and TRBP, which are 
crucial genes for the miRNA biogenesis machinery (see section 1.1.5), have 
been correlated with several cancer types including ovarian, lung, breast and 
prostate cancer (reviewed in Huang et al., 2014). This strongly suggests that 
the majority of miRNAs is implicated in cancer, supporting numerous studies 
that already demonstrated the tumorigenic effects of particular miRNAs 
(reviewed in Anwar and Lehmann, 2014; Bi and Chng, 2014; Calin and Croce, 
2006; Christodoulatos and Dalamaga, 2014; Esquela-Kerscher and Slack, 
2006; Pedroza-Torres et al., 2014).  
Ultimately, miRNAs have emerged as biomarkers for cancer and other 
pathologies (Cao et al., 2014; Christodoulatos and Dalamaga, 2014), due to 
their ability to circulate in blood, either in blood cells or in a free state, 
transported by exosomes, lipoproteins or bound to proteins (Khalyfa and Gozal, 
2014). These findings opened new doors for non-invasive miRNA-based 
detection strategies for disease diagnosis and prognosis, as well as for the 
development of new therapeutic tools (De Guire et al., 2013). 
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1.1.8. Investigating miRNA functions 
 
1.1.8.1. miRNA Profiling 
Characterization of miRNA temporal and spatial expression patterns is 
essential to understand miRNA function. Several studies have demonstrated 
that high expression of miRNAs in a specific cell type, tissue or developmental 
stage normally correlates with a regulatory function of that miRNAs in that 
system. In that sense, a range of techniques is currently available for profiling 
miRNAs according to their expression levels. Northern blotting was used in the 
first studies, where small RNAs from different samples were detected through 
labelled DNA probes complementary to miRNA sequences (Ambros et al., 
2003; Lagos-Quintana et al., 2001). The use of highly sensitive and specific 
Locked Nucleic Acid (LNA) modified probes has improved this technique 
(Kloosterman et al., 2006; Válóczi et al., 2004) and further enabled to localize / 
detect miRNAs in tissues by in situ hybridization (ISH) (Kloosterman et al., 
2006). None of these techniques however, allowed the detection of low 
abundant miRNAs and in fact, both require hard labouring when characterizing 
several miRNAs.  
Recently, development of easy and high-throughput quantification 
methods has facilitated large-scale expression profiling of miRNAs. In this 
regard, microarray analysis was shown to be powerful method that was based 
on antisense oligonucleotides specifically binding to previously labelled mature 
miRNAs. This originated a signal which intensity can be quantified from 
scanned images using appropriate software (Baskerville and Bartel, 2005). This 
technique is still currently employed for miRNA profiling in different cell types, 
tissues, developmental stages and also diseases. Another currently used 
technique is the real time-PCR (qPCR), a highly sensitive method that allows 
the quantification of mature miRNAs with higher accuracy. Although this 
technique is widely used to validate microarray data, its major disadvantage 
concerns its inability to quantify miRNAs (and transcripts in general) in a high-
throughput manner  
The most recent advance in miRNA profiling is next-generation 
sequencing, a technique that allows quantification and sequencing of up to 
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million molecules. Its accuracy and sensitivity allows the detection of very low 
abundant miRNAs. The major drawback of this technique is the cost of each 
analysis. Even though, there are numerous examples of the successful use of 
this technique in miRNA profiling in different model organisms as reviewed by 
Cullum et al. (2011).  
 
1.1.8.2. miRNA Targets: Identification and Validation 
Functional characterization of miRNAs is largely based on the 
identification of their target genes. This can be a true challenge since a single 
miRNA can regulate hundreds of targets and one gene is normally modulated 
by more then one miRNA (Bartel, 2004; Filipowicz et al., 2008; Pillai, 2005; 
Rajewsky, 2006). Furthermore, it is now thought that most genes are regulated / 
controlled by miRNAs (Friedman et al., 2009). The majority of animal miRNAs 
pair imperfectly with their cognate targets and the identification of important 
biological targets is complex. The key element for identification of 
miRNA:mRNA interactions relies on the perfect pairing of the seed region 
(nucleotides 2-8) of the miRNA to the 3’UTR of the target mRNA. In the last 
years, several bioinformatics algorithms based on seed pairing and evolutionary 
conservation have been developed and became a powerful tool to identify 
miRNA targets (Bartel, 2009; Friedman et al., 2009; Lewis et al., 2003b, 2005). 
Among these are TargetScan, PicTar, miRanda, RNAhybrid, and many others. 
These algorithms use at least one of the following criteria to predict mRNA 
targets: (i) perfect or near perfect complementarity to the miRNA seed region; 
(ii) evolutionary conservation of the binding site (BS); (iii) free energy of the 
miRNA:mRNA duplex; (iv) multiple BSs in one single mRNA; (v) mRNA 
sequence features outside the target site (Chen and Rajewsky, 2006; Duursma 
et al., 2008; John et al., 2004; Lewis et al., 2003b, 2005; Thomas et al., 2010; 
Zhao et al., 2005). Algorithms such as TargetScan and PicTar, initially relied on 
the seed region in miRNA targeting. Thus, for example, TargetScan requires a 
perfect match to at least 7 nt of the seed sequence and evolutionary 
conservation is also considered (Friedman et al., 2009; Lewis et al., 2003b, 
2005). In addition, a ‘context score’ is provided, based on features in the 
surrounding mRNA; targets with a high context score or multiple predicted BSs 
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are more prone to be truly regulated by a given miRNA (Grimson et al., 2007). 
Recently, this algorithm extended target prediction to zebrafish 
(TargetScanFish) allowing a deeper analysis on evolutional perspective (Garcia, 
et al. 2011; Grimson et al., 2007; Lewis et al., 2005; Ulitsky et al., 2012). Other 
algorithms, such as PITA, account for target site accessibility (Kertesz et al., 
2007), estimating the free energy cost to unfold secondary structures 
surrounding the mRNA target site. An important advantage of PITA is the option 
for uploading both miRNAs and mRNAs of interest, allowing the study of new 
non-annotated miRNAs and genes unavailable in databases. 
Robust comparisons of prediction algorithms are missing and, although 
many experimentally validated targets were found to be enriched in exact 
miRNA seed matches, high-throughput experimental analyses of Ago-bound 
miRNA-mRNA pairings (‘pull-down’) suggest that around 25%–45% of BSs lack 
a perfect seed match (Chi et al., 2009), indicating that filtering target genes by 
perfect seed mach criteria most likely eliminates bona fide targets. Regardless 
of some limitations, prediction algorithms are crucial starting points for the 
identification of putative miRNA targets. Nevertheless, posterior experimental 
validation using an in vitro and/or in vivo system has to be addressed in order to 
identify true miRNA targets. Experimental validation of targets is labour 
intensive and is normally based on: (i) validation of miRNA:miRNA interactions 
through reporter assays; (ii) confirmation of miRNA and target mRNA co-
expression; (iii) miRNA effect on target protein and (iv) miRNA effects on target 
biological function (Kuhn et al., 2008). Outcome of prediction algorithms may 
result in multiple putative miRNA BSs, which can be tested using reporter 
assays. Briefly, the 3’UTR of the target gene is inserted in a plasmid 
downstream of the luciferase (Firefly or Renilla), green fluorescent protein 
(GFP) or another reporter open reading frame (ORF). Reporter construct and a 
mimic of the miRNA of interest are then transiently transfected into a host cell 
and the activity of the reported is measured. Alternatively, the reporter construct 
can be transfected into cells endogenously expressing the relevant miRNA. 
Binding of the miRNA to its target will repress reporter protein production, 
decreasing reporter activity, which is then normalized and compared to several 
controls (Kuhn et al., 2008). Further confirmation of bona fide BSs can be 
performed through point mutation approach or by specific knockdown of 
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miRNAs of interest. In order for the miRNA to repress its target, they both have 
to be co-expressed in the same cell / tissue which is normally demonstrated by 
Northen blotting, qPCR or in situ hybridization (Inose et al., 2009; Wang et al., 
2013a). If a particular mRNA is a real target of a specific miRNA, modulation of 
miRNA levels should result in alteration of target protein levels. Therefore, a 
typical approach to validate biological targets is gain- or loss-of-function 
experiments followed by Western blot using a specific antibody against protein 
of interest (Wang et al., 2013a). Gain-of-function experiments consist in 
transfecting cells or microinjecting embryos with a miRNA mimic 
(oligonucleotide with an identical sequence to the mature or pre-miRNA). In 
loss-of-function experiments, a miRNA of interest is knocked down by delivering 
antisense oligonucleotides (antagomiRs, anti-miRs or morpholinos (MO)), which 
can block miRNA processing of the pri-miRNA or the pre-miRNA and/or impair 
the activity of mature miRNAs (Kloosterman et al., 2007; Velu and Grimes, 
2012). Furthermore, generation of transgenic in vivo models has proved to be a 
valuable tool to study the function of miRNAs (Giraldez et al., 2005; Wang et al., 
2013a; Watanabe et al., 2008).  
It is commonly accepted that when a miRNA is up-regulated its targets 
will be down-regulated; similarly, miRNA knockdown will result in the up-
regulation of its targets. Since miRNAs regulate gene expression by both 
translational repression and mRNA cleavage (Eulalio et al., 2008; Schmitter et 
al., 2006), the effect of a miRNA should be assayed at both protein and mRNA 
level. Once miRNA regulation of a target gene has been experimentally 
confirmed, a change in a specific biological function should be investigated. 
This can be challenging because in many systems miRNAs actions are 
redundant and their functions are assumed by other miRNAs of the same 
family.  
In summary, the number of validated targets has increased in the past 
years but is still very low considering the number of expected targets predicted 
by bioinformatics tools. It is noteworthy however, that in the last years these 
approaches have been successfully applied to identify disease-specific miRNAs 
(Carissimi et al., 2009; Hong et al., 2012; Ventura and Jacks, 2009) allowing to 
uncover novel therapeutic strategies. In that sense, the search and identification 
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of new miRNAs, and validation of their target genes, is an important and 
critically imperative field of research. 
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1.2. Skeletal Development and Maintenance 
 
1.2.1. Overview 
The vertebrate skeleton is composed of multiple elements of various 
shapes and origins spread throughout the body. Skeletogenesis, the process of 
skeleton formation during vertebrate development, starts when mesenchymal 
cells from ectoderm and mesoderm migrate to particular positions in the body 
and commit to skeletal fate. The skeleton of vertebrates is composed by two 
distinct tissues, cartilage and bone, and three main cell types, chondrocytes 
(associated to cartilage), osteoblasts and osteoclasts (both found in bone) (Fig. 
1.8). While osteoclasts derive from the hematopoietic lineage, chondrocytes 
and osteoblasts derive from multipotent mesenchymal cells, thus sharing a 
common progenitor (reviewed in Karsenty & Wagner, 2002). Both chondrocytes 
and osteoblasts participate in a process called endochondral bone formation 
that occur mainly in long bones of vertebrates and where bone is initially formed 
from a cartilage template. Conversely, flat bones are formed by another 
process, intramembranous ossification, where osteoblasts differentiate directly 
from condensed mesenchymal precursors (Crombrugghe et al., 2001; Karsenty 
and Wagner, 2002). Several factors elaborately control the process of 
osteochondroprogenitors proliferation and differentiation that ultimately results 
in cartilage and/or bone formation. A resumed description of these molecules is 
presented in the next sections. 
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Figure 1.8. Endochondral bone formation and bone remodeling in mammalian systems. 
Proliferative and hyperthrophyc chondrocytes are observed in the zone of cartilage proliferation 
and hyperthrophy, respectively. Calcified cartilage is eventually replaced by bone, upon blood 
vessel invasion and osteoblast recruitment. Bone resorption performed by a multinucleated 
osteoclast is indicated in the bottom of the image. H&E, x280. Adapted from Ross and Pawlina 
(2011). 
 
 
1.2.2. Control of Chondrogenesis 
Mammalian skeleton is mostly formed through endochondral bone formation, 
including the vertebral column and long bones from limbs. Chondrogenesis, the 
process of cartilage formation, is a multi-step cellular process essential for 
endochondral bone formation. It consists in commitment of undifferentiated 
mesenchymal cells to the chondrogenic lineage, cellular condensation, 
chondrocyte proliferation, matrix proteins production, maturation and 
hypertrophic conversion, followed by bone replacement (Fig. 1.9) (Karsenty and 
Wagner, 2002; Kronenberg, 2003; Michigami, 2013). Expression of adhesion 
molecules such as N-cadherin facilitate aggregation (Oberlender and Tuan, 
1994) during cellular condensation, a process governed by transforming growth 
factor-beta (TGF-), Wnt canonical signalling and sex determining region Y-box 
(Sox) 9 (Akiyama et al., 2000, 2004; Chun et al., 2008; Tuli et al., 2003). Then, 
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aggregated cells stop expressing adhesion molecules, restart proliferation, and 
begin to produce an extracellular matrix (ECM). Proliferating chondrocytes form 
organized parallel columns in growth zones, and express several collagens, 
including type II, IX, and XI, integrins and proteoglycans, such as aggrecan 
(Michigami, 2014). Early chondrocyte differentiation is driven by Sox5, Sox6, 
and Sox9 transcription factors (Akiyama, 2008; Goldring et al., 2006). 
Expression of Sox9 begins at the mesenchymal osteochondroprogenitors stage, 
preceding expression of Sox5 and Sox6. The three TFs cooperate for the 
activation of genes specific of proliferating chondrocytes, such as collagen type 
II alpha 1 (Col2a1) (Lefebvre et al., 1997). Bone morphogenetic protein (BMP), 
Indian hedgehog (Ihh) and fibroblactic growth factor (FGF) are likely to 
cooperate for the activation of Sox9 in precursor and/or primary chondrocytes 
(Murakami et al., 2000; Zeng et al., 2005a), whereas Wnt/-catenin signalling 
was found to block Sox9 and thus low levels of -catenin seems to be required 
for chondrocyte lineage commitment (Akiyama et al., 2004; Hill et al., 2005). 
When chondrocytes become hypertrophic, they begin to produce high levels of 
alkaline phosphatase and type X collagen. Ultimately, terminally differentiated 
chondrocytes undergo apoptosis, and the cartilaginous matrix is mineralized 
and replaced by bone (Kronenberg, 2003; Michigami, 2013). These 
chondrocytes express vascular endothelial growth factor (VEGF), which induce 
blood vessel invasion, and matrix metalloproteinases (MMPs), which are 
important for cartilaginous matrix degradation (Stickens et al., 2004; Zelzer et 
al., 2004). Hypertrophic maturation of chondrocytes requires the expression of 
runt-related transcription factor (Runx) 2 and Runx3 transcription factors as well 
as a decrease of Sox proteins (Yoshida and Komori, 2005; Yoshida et al., 
2004). Runx2 is known to drive transactivation of Ihh, collagen type X alpha 1 
(Col10a1) and matrix metallopeptidase 13 (collagenase 3) (MMP13) 
(Selvamurugan et al., 2004; Yoshida et al., 2004; Zheng et al., 2003). Recently, 
Sox9 was shown to repress Runx2 and β-catenin signalling, thus inhibiting 
chondrocytes hypertrophy (Dy et al., 2012). The basic helix-loop-helix (bHLH)  
twist family transcription factor 1 (Twist-1) also functions as a repressor of 
Runx2 in the perichondrium thus controlling chondrocyte maturation (Bialek et 
al., 2004).   
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Figure 1.9. Sequence of multi-step events during chondrogenesis. The different stages of chondrogenesis are represented schematically and associated 
main growth and differentiation factors (in light blue) and the transcription factors (dark blue) at each stage are indicated. Important extracellular matrix 
proteins which characterize the different stages are shown at the bottom. Adapted from (Kelc et al., 2013). 
CHAPTER 1  General Introduction 
 
 
53 
In general, in the last decades, chondrogenesis was shown to be a highly 
complex process, tightly regulated by numerous transcription factors, growth 
factors and signalling pathways. Nevertheless, recent advances in molecular 
and genetic research have clearly indicated that this complexity is extended to 
the post-transcriptional level. Such regulatory mechanisms in chondrogenesis 
are described next. 
 
1.2.2.1. Post-transcriptional Control of Chondrogenesis 
The crucial roles of miRNAs in chondrogenesis were first revealed when 
severe skeletal growth defects were observed in transgenic mice lacking Dicer 
gene in cartilage (directed by Col2a1 promoter) (Kobayashi et al., 2008). 
Cartilage growth plates from this Dicer-null mice presented a general decreased 
in chondrocyte proliferation, while differentiation was accelerated (Kobayashi et 
al., 2008). Since then, an increasing number of specific miRNAs was shown to 
regulate chondrocyte differentiation. The cartilage-specific miR-140 was shown 
to positively regulate chondrogenesis in zebrafish through platelet-derived 
growth factor (PDGF) signalling (Eberhart et al., 2008). In mice, miR-140 
deletion not only resulted in decreased statures, but also induced osteoarthritis-
like phenotypes either related to age or stress induced in surgical models. The 
main target associated to these changes was a disintegrin-like and 
metalloprotease (reprolysin type) with thrombospondin type 1 motif 5 (Adamts-
5). With these results, miR-140 was associated to regulation of both 
development and homeostasis of cartilage (Miyaki et al., 2010). Another 
important example of miRNAs involvement in chondrogenesis was 
demonstrated in human chondrocytes from healthy donors. Apparently, in this 
system, miR-675 was up-regulated by Sox9 during chondrogenesis, suggesting 
a crucial involvement in this process. This miRNA up-regulated COL2a1 
expression through a mechanism yet to be determined (most likely via targeting 
a col2a1 repressor) (Dudek et al., 2010). In two other studies developed in vitro, 
two negative regulators of chondrogenesis were identified: miR-199a, by 
targeting Smad1 (Lin et al., 2009), and miR-145, which inhibits Sox9 (Yang et 
al., 2011a). Nevertheless, information regarding miRNA involvement in 
chondrogenesis is still scarce. In that sense, miRNA arrays-based studies are 
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currently being developed which is expected to bring new insights into the 
complex regulatory network controlling chondrogenesis. 
 
1.2.3. Control of Osteogenesis 
As previously described, most bones in vertebrate skeleton are 
originated from endochondral ossification, while only a few, including the skull, 
are formed by intramembranous ossification. During this process, osteoblasts 
derive from mesenchymal stem cells (MSCs), which can also differentiate into 
chondrocytes, adipocytes or myocytes, depending on specific signalling 
pathways activation and/or inhibition (de Gorter and ten Dijke, 2013). 
Commitment of MSCs into osteochondroprogenitors seems to require Sox9 
expression since its inactivation before mesenchymal condensation results in 
complete absence of both cartilage and bone and abolishes Runx2 expression 
(Akiyama et al., 2002). Since they share a common precursor, chondrocytes 
and osteoblasts also share several regulatory factors and signalling pathways 
during skeletogenesis including BMPs, transforming growth factor beta (TGF-β), 
Wnt, Hedgehog (Hh), parathyroid hormone (PTH), insulin-like growth factors 
(IGFs) and FGFs. 
The commitment of osteochondroprogenitors to the osteoblast lineage is 
driven by Runx2, the master regulator of osteogenesis acting in all stages of 
osteoblast differentiation (Fig. 1.10) (Komori et al., 1997; Otto et al., 1997). The 
role of Runx2 in osteogenesis was first evidenced by Runx2-deficient mice 
which skeleton was fully deprived of osteoblasts (Komori et al., 1997) and 
studies of cleidocranial dysplasia in which heterozygous loss, insertion, deletion 
or mutations of the Runx2 gene was shown to result in defective bone formation 
(Lee et al., 1997; Mundlos et al., 1997). Exactly how many key factors are 
involved in the process of MSCs commitment into the osteoblast lineage is yet 
to be determined. However, this process seems to involve signals from BMP, 
Wnt, FGF and Hedgehog pathways, which are thought to participate in the 
control of Runx2 expression (Karsenty et al., 2009; Komori, 2011). For instance, 
the absence of Ihh in MSCs results in down-regulation of Runx2, which 
consequently inhibits commitment into osteoprogenitors (St-jacques et al., 
1999). Also, canonical Wnt signalling up-regulation by glycogen synthase 
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kinase-3 beta (GSK3β) knockdown in mice induces Runx2 expression, and as a 
consequence, bone formation increases (Kugimiya et al., 2007). Furthermore, 
expression of -catenin in MSCs was demonstrated to favour 
osteochondroprogenitor cell differentiation into osteoblasts and to prevent their 
differentiation into chondrocytes (Day et al., 2005; Hill et al., 2005).  
Following lineage commitment, osteoprogenitor cells undergo proliferation and 
differentiate into pre-osteoblasts, a process governed by Runx2 and 
characterized by the production of proteins such as collagen type I, fibronectin, 
histones, proto-oncogene c-Fos (c-Fos) and c-Jun (c-Jun) and cyclin-dependent 
kinase inhibitor 1 (p21) (Shalhoub et al., 1989). At this stage, BMPs play a 
significant role, increasing alkaline phosphatase (ALP) activity and osteocalcin 
(Oc) synthesis (Neve et al., 2011). After growth arrest, pre-osteoblast 
differentiation proceeds towards osteoblast maturation, a process in which the 
zinc finger transcription factor Osterix (Osx, also known as Sp7) plays a critical 
role (Fig. 1.10). Like Runx2, Osx is required for osteoblast differentiation and is 
essential for bone formation (Nakashima et al., 2002). Osx-null mice die at birth 
due to general lack of mineralized structures. Remarkably, despite its 
importance in bone formation, information regarding its transcriptional 
regulation, functional partners or targets is limited. Nevertheless, Osx is known 
to act downstream of Runx2 (Nakashima et al., 2002; Nishio et al., 2006), to 
interact with nuclear factor of activated T-cells cytoplasmic calcineurin-
dependent 1 (NFATc1) to activate collagen type I alpha 1 (Col1a1) (Koga et al., 
2005) and to repress the canonical Wnt signalling (Zhang et al., 2008) during 
osteoblast differentiation. Inhibition of Wnt/-catenin signalling, which plays a 
crucial role in stimulating osteoblast proliferation, by SP7, might explain its 
negative effect on osteoblast proliferation, which favours differentiation (Zhang 
et al., 2008). Early osteoblast maturation is marked by the expression of genes 
such as ALP, bone sialoprotein (BSP) and type I collagen. At this stage, 
osteoblasts begin to produce an organic non-mineralized matrix called osteoid. 
At the end of differentiation, osteoblasts express genes implicated in 
mineralization of the ECM such as Oc, osteopontin (OPN) and collagenase.. 
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Figure 1.10. Sequence of multi-step events during osteogenesis. The different stages of osteogenesis are represented schematically and associated 
main effectors at each stage. Important extracellular matrix proteins which characterize the different stages are shown in blue at the bottom. Lines with 
arrowheads indicate a positive action and lines with bars indicate an inhibition. Vertical arrow indicates stimulation of bone matrix genes expression. 
CHAPTER 1  General Introduction 
 
 
57 
A major regulator of mature osteoblasts is activating transcription factor 4 
(ATF4) (Fig. 1.10), a member of the cAMP response element-binding protein 
(CREB) family of basic leucine zipper domain (B ZIP) proteins. Although 
dispensable for early osteoblast differentiation, ATF4 is required for osteoblast 
terminal differentiation and function (Yang et al., 2004). In fact, ATF4 regulates 
osteoblast ability to synthesize collagen type I (Col 1), the main constituent of 
the bone matrix, and drives the expression of Oc, by cooperative interaction 
with Runx2 and special AT-rich sequence-binding protein 2 (SATB2) (Dobreva 
et al., 2006; Xiao et al., 2005; Yang et al., 2004), and SP7, through a PTH-
dependent mechanism (Yu et al., 2009). At the final stage of osteogenesis, 
matrix mineralization takes place and some osteoblasts become trapped in 
lacunae within the matrix. These cells, known as osteocytes, are connected by 
a system of canaliculi and express several inhibitors of the Wnt pathway, 
including sclerostin (SOST) (Burgers and Williams, 2013). The remaining 
osteoblasts lie on the surface of bone, constituting bone lining cells (Ehrlich and 
Lanyon, 2002).  
Several other factors and signalling pathways govern osteoblast 
differentiation, generally by controlling one of the three main osteoblast specific 
transcription factors. For instance, Twist1 and Twist2 interact with Runx2, 
inhibiting its binding to DNA and preventing early osteoblast differentiation 
(Bialek et al., 2004). BMPs are known inducers of osteoblast differentiation and 
in this regard, BMP-2 was demonstrated to induce the expression of both 
Runx2 and SP7, and also ALP, Col 1 and Oc (reviewed in Yamaguchi et al., 
2008). FGF and Wnt signalling pathways are also implicated in several stages 
of osteoblast differentiation. Fibroblast growth factor receptor (FGFR) 1 promotes 
osteoblast early differentiation whereas FGFR2 and FGFR3 support osteoblast 
maturation. While FGF2, 4 and 8 are essential in skeletogenic mesenchyme, 
FGF18 promotes osteoblast proliferation and maturation (Ornitz, 2005). The 
Wnt/-catenin pathway, not only participates in the osteochondroprogenitor cell 
fate decision into either osteoblasts or chondrocytes, but also is known to boost 
osteoblast differentiation (Hill et al., 2005; Karsenty et al., 2009). Conversely, 
Notch signalling inhibits osteoblastogenesis through several mechanisms, 
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including inhibition of Runx2 function and Wnt/-catenin signalling pathway 
(Zanotti and Canalis, 2010; Zanotti et al., 2008).  
In addition to other factors and pathways which were not addressed here 
(including IGF, TGF and parathyroid hormone-related protein (PTHrP) 
signalling and, CREB, c-mycproto-oncogene (c-Myc), activator protein 1 (AP1), 
e T cell factor/lymphoid enhancer factor (TCF/LEF), specificity protein 1 (SP1), 
c-Fos, Jun and signal transducer and activator of transcription (STAT) families 
of transcription factors) several studies have revealed cross-talks between 
different signalling pathways further increasing the complexity of the 
mechanisms involved and providing further insight towards a better 
understanding of osteoblast differentiation (Guo and Wang, 2009; Hartmann, 
2006; Jensen et al., 2010; Karsenty et al., 2009; Yamaguchi et al., 2008). 
Interestingly, this complexity was taken into another level with the discovery of 
novel players in osteoblastogenesis: the miRNAs.  
 
1.2.3.1. Post-transcriptional Control of Osteogenesis 
Like in chondrogenesis, the fact that miRNAs are involved in the control 
of osteogenesis was first demonstrated following a conditional deletion of Dicer 
in osteoprogenitors (directed by Col1a1 promoter) and mature osteoblasts 
(directed by Oc promoter) of mice (Gaur et al., 2010). Ablation of Dicer in 
osteoprogenitors compromised fetal survival after E14.5, and ex vivo studies 
revealed a general decrease of osteoblast markers and ECM mineralization in 
committed osteoblasts. Conversely, in vivo ablation of Dicer in mature 
osteoblasts produced viable mice with delayed bone mineralization in early 
development. Surprisingly, adult mice showed a dramatic increase in bone 
mass (Gaur et al., 2010). This study suggested different roles for Dicer and 
miRNAs during distinct stages of skeleton development and osteoblast 
differentiation. While a diverse set of miRNAs in the fetal skeleton seems to be 
required for osteogenesis; miRNAs in mature osteoblasts apparently play major 
roles in regulating bone homeostasis by controlling of bone matrix protein levels 
in the adult skeleton (Gaur et al., 2010).  
In sum, Dicer knockout in mice osteoblasts was very important to 
demonstrate the general roles of miRNAs in osteogenesis. However, it failed to 
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establish the functions of particular miRNAs in this process. In recent years, 
several studies have identified a panel of miRNAs that act either as negative or 
positive regulators of osteoblastogenesis and bone formation. For instance, 
miR-206 targeting of connexin43 (Cx43) was shown to inhibit osteoblast 
differentiation both in vitro and in vivo (Inose et al., 2009). A set of 11 miRNAs 
was found to target the master regulator of osteogenesis, Runx2, in both 
osteoblasts and chondrocytes, and to inhibit osteoblast differentiation (Zhang et 
al., 2011c). Repression of SP7 by miR-637, was shown to promote commitment 
of human MSCs into the adipocyte lineage, while it inhibited osteoblast 
differentiation (Zhang et al., 2011a). Furthermore, miR-214 was shown to 
repress ATF4, which consequently inhibited osteoblast activity and matrix 
mineralization in vitro and bone formation in vivo (Wang et al., 2013a). 
Regarding positive regulation of osteoblast differentiation, miR-2861 
overexpression was shown to enhance osteoblastogenesis in mouse bone 
marrow stromal cells, while its silencing in vivo decreased Runx2 protein levels 
and inhibited bone formation, by targeting histone deacetylase 5 (HDAC5) (Li et 
al., 2009a). In another work, Zhang and co-workers demonstrated that miR-335-
5p is able to repress dickkopf WNT signalling pathway inhibitor 1 (DKK1) and 
consequently potentiate the Wnt signalling and promote osteogenic 
differentiation (Zhang et al., 2011b). The miR-29 family was also shown to 
promote osteoblast differentiation by targeting several inhibitors of osteoblast 
differentiation (Li et al., 2009b; Trompeter et al., 2013), by regulating several 
proteins crucial for ECM maintenance (Kapinas et al., 2009; Li et al., 2009b; 
Rossi et al., 2013) and by potentiating the Wnt canonical signalling through a 
feedback-loop (Kapinas et al., 2010). 
 
1.2.4. Control of Bone Remodelling 
Bone remodelling is a dynamic and continuous process in which bone 
resorption is coupled to bone formation, through delicate balancing between the 
number and activities of osteoblasts and osteoclasts. While osteoblasts are 
responsible for bone formation (see section 1.2.3.), osteoclasts are 
multinucleated bone-resorbing cells of hematopoietic origin that also undergo 
distinct stages of differentiation (Fig. 1.11). Briefly, osteoclast progenitors 
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differentiate into mononuclear tartrate-resistant acid phosphatase (TRAP)-
positive cells which then become cathepsin K-positive osteoclasts and 
differentiate into mature multinucleate osteoclasts (Lerner, 2000). In detail, 
mononuclear precursor cells are stimulated by c-fms/MCSF (macrophage 
colony stimulating factor) to express receptor activator of nuclear factor κ 
B (RANK) (Crockett et al., 2011a); simultaneously, RANK ligand (RANKL) is 
expressed by osteoblasts in close vicinity with these precursors, in response to 
PTH and 1,25 Vit D3 stimulation (Leibbrandt and Penninger, 2008). This results 
in activation of several transcription factors, e.g. nuclear factor kB (NF-kB), AP1 
and NFATc1 (Humphrey et al., 2005), that drive the expression of crucial 
osteoclast genes, such as dendritic cell-specific transmembrane protein (DC-
STAMP), TRAP, cathepsin K, matrix metalloproteinase 9 (MMP-9) and 3 
integrin. This process leads to final differentiation and fusion of precursors, 
which become fully functional multinucleated osteoclasts (Crockett et al., 
2011b). 
 
 
 
Figure 1.11. Sequence of multi-step events during osteoclast differentiation. The different 
stages in of osteoclast differentiation from hematopoietic precursor towards active osteoclast 
are illustrated associated with key transcription and regulatory factors at each stage. In Lian et 
al., 2012. 
 
 
Similarly to other cells of hematopoietic origin, osteoclasts are recruited 
to bone surface upon release of cytokines at particular sites where remodelling 
is necessary / occurring. After adherence, osteoclasts create an acidic 
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microenvironment in the space beneath them to dissolve the mineralized 
constituent of the bone matrix. Then, the organic matrix is depredated by 
cathepsin K (Ross, 2008). In the reversal phase, mononuclear cells assemble 
the bone surface for new osteoblasts and secrete signals for their recruitment; 
proliferation and differentiation of new osteoblast will lead to new matrix 
deposition.  
Again, as previously described for chondrocytes and osteoblasts, 
differentiation of osteoclasts was shown to be governed at the post-
transcriptional level by miRNAs. Such regulation is described below. 
 
1.2.4.1. Post-transcriptional Control of Bone Remodelling 
The relevance of miRNAs in osteoclast differentiation and function has 
been confirmed by deletion of Dicer and DGCR8 in mice models, although this 
was only demonstrated for few miRNAs. Indeed, mice with osteoclast-specific 
Dicer gene deficiency (directed by cathepsin K) were shown to present a 
decreased number of active osteoclasts and increased bone mass, suggesting 
a crucial function of Dicer or Dicer dependent pathway in osteoclasts formation 
(Mizoguchi et al., 2010). Moreover, mice with osteoclast-specific deletion of 
DGCR8, the partner in Drosha processing, also had impaired formation of 
osteoclasts and bone resorption, confirming the previous report (Sugatani et al., 
2014). In other studies, four miRNAs with particular roles in the regulation of 
osteoclastogenesis were identified. Thus, in mouse RAW264.7 cells both 
knockdown and overexpression of miR-223 inhibited the formation of 
osteoclast-like cells as induced by RANKL, suggesting that proper levels of 
miR-223 are required for normal osteoclastogenesis (Sugatani and Hruska, 
2007, 2009). Furthermore, while stimulation of osteoclast precursors by 
macrophage colony stimulating factor (M-SCF) induces proviral integration 
oncogene (PU.1), which subsequently stimulates both miR-223 and RANK 
(Fukao et al., 2007), miR-223 was suggested to repress nuclear factor 1 A-type  
(NFI-A), a suppressor of osteoclastogenesis (Sugatani and Hruska, 2009). 
Interestingly, miR-21 was also shown to be up-regulated during RANKL-induced 
osteoclastogenesis, a process mediated by c-Fos. As consequence, miR-21 
apparently represses programmed cell death 4 (PDCD4) to establish a positive 
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feedback loop involving c-Fos/miR-21/PDCD4 to positively regulate 
osteoclastogenesis (Sugatani et al., 2011). In other studies, miRNAs were 
shown to be repressors of osteoclastogenesis. For instance, miR-155 is 
apparently decisive for determining the cell fate of monocytes, promoting 
macrophage formation in spite of esteoclasts (Blüml et al., 2011). In miR-155 
knockout mice, levels of local bone loss were considerably reduced, hich was 
apparently correlated with reduced number of osteoclasts (Blüml et al., 2011). 
In another study, miR-146a, a miRNA mostly known as a negative regulator of 
immune/inflammatory responses, was found to significantly diminish the number 
of TRAP-positive multinucleated cells in human peripheral blood mononuclear 
cells, suggesting an inhibition of osteoclastogenesis (Nakasa et al., 2011). 
In general, these studies prove that miRNAs are indeed important factors 
for bone remodelling. However, it also became patent that many others miRNAs 
remain to be identified. Remarkably, miRNAs have been shown to be able to 
circulate in blood and promote their effects in an endocrine/autocrine/paracrine 
manner (De Guire et al., 2013). This feature not only increases the complexity 
of miRNAs, but also increases their potential to regulate all physiological 
processes, including those associated to the skeleton. It is widely accepted now 
that miRNAs can be used as biomarkers for many diseases, including bone-
related diseases such as osteoporosis and osteosarcoma (Cao et al., 2014; 
Yuan et al., 2012).  
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1.3. Zebrafish as a model 
Teleost fish represent one of the most successful groups in vertebrate 
evolution, with more then 25000 species (Volff, 2005; Witten and Huysseune, 
2009a). They are also considered to be good models for the investigation of 
vertebrate development, including skeletogenesis (Spoorendonk et al., 2010). In 
that sense, teleosts not only present several anatomic, physiologic and genetic 
similarities with mammals, allowing extrapolation of information, but also 
present several experimental advantages, including larvae transparency (crucial 
for developmental characterization of systems), large progeny and easy 
manipulation (e.g. transgenic preparation) 
Among teleosts, zebrafish (Danio rerio) is currently the most used model 
for studies of vertebrate development, gene and function and human disease 
(Haffter et al., 1996; Lieschke and Currie, 2007). Initially, zebrafish was used to 
study embryogenesis and morphogenesis. The research and understanding of 
these processes led to the implementation of large-scale mutagenic screens 
which resulted in several disorders, related to zebrafish mutants, and allowing 
for an extended knowledge of gene function (Dodd et al., 2000). As a research 
model, zebrafish not only presents the same advantages as other teleosts, 
including rapid and external embryonic development (Dodd et al., 2000), but it 
was also one of the first vertebrates to have a sequenced genome. 
Interestingly, comparison between human and zebrafish genomes revealed that 
most genes have corresponding orthologs in both species, and share similar 
chromosomal structures (Howe et al., 2013). This fact, combined with 
availability of zebrafish transgenic strains and an increasing number of specific 
molecular tools such as antibodies and dedicated vectors associated to the 
recent development of several cell lines (Sing-Yee et al., 2014; Vijayakumar et 
al., 2013), opened new doors for molecular studies using this organism as a 
model for biological and biomedical research (Dodd et al., 2000; Lieschke and 
Currie, 2007; Nasevicius and Ekker, 2000; Shin and Fishman, 2002). In that 
sense, using zebrafish to investigate miRNAs was one of the most recent 
examples of the suitability of this model in biomedical and biological research 
(Fjose and Zhao, 2010). Such studies are briefly described in the following 
section.
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1.3.1. Zebrafish and miRNAs 
Since the beginning of miRNA research, it was demonstrated that most 
miRNAs are conserved across vertebrate evolution (Guerra-Assunção and 
Enright, 2012). This fact not only suggested that miRNA functions should be 
conserved in vertebrates, but also indicated that alternative vertebrate models, 
including zebrafish, could be used to facilitate the investigation of miRNAs. In 
fact, the first models that were used to elucidate the general roles of miRNAs 
were zebrafish specimens lacking Dicer. Apparently, targeted selected gene 
inactivation of Dicer 1 resulted in impaired miRNA expression and 
developmental arrest around day 10 post-fertilization (dpf) (Wienholds et al., 
2003). Although the existence of maternally produced Dicer enzyme still 
enabled generation of mature miRNAs during the first few days, developmental 
arrest in subsequent stages was important to evidence the crucial roles of 
miRNAs in early development. Conversely, maternal–zygotic dicer mutants 
(MZdicer) were incapable of producing mature miRNAs (Giraldez et al., 2005), 
causing morphogenesis defects. In this study, several miRNAs were screened 
for a possible rescue of MZdicer zygotic defects. Interestingly, microinjection of 
miR-430 duplexes partially rescued this phenoptype, revealing a critical role for 
this miRNA in morphogenesis. In a subsequent study, it was demonstrated that 
miR-430 family members bind to several hundred maternal mRNAs leading to 
their deadenylation and degradation (Schier and Giraldez, 2006). It was 
concluded that the absence of miR-430 in homozygous MZdicer embryos 
should delay degradation of maternal mRNAs and should consequently affect 
early development.  
Many other miRNAs were identified in zebrafish, at first by sequencing of 
small-RNA cDNA libraries (Chen et al., 2005b; Kloosterman et al., 2006) and, 
more recently, by next-generation sequencing (Soares et al., 2009). 
Determining miRNAs expressions in zebrafish revealed high tissue specificity, 
suggesting specific roles in tissue differentiation and identity but also evidenced 
specific functions in zebrafish development. For instance, miR-196 was shown 
to be a regulator of axial patterning and pectoral appendage initiation in 
zebrafish (He et al., 2011). In heart development, miR-218 seems to be a 
crucial mediator of T-box 5 (Tbx5), and its dysregulation should be responsible 
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for severe cardiac abnormalities (Chiavacci et al., 2012). In regenerating 
zebrafish fins, miR-203 was shown to repress Lef1, an inhibitor of the canonical 
Wnt signalling, consequently blocking this process (Thatcher et al., 2008). 
These and many more studies evidence that zebrafish is a valuable model for 
miRNA research.
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1.4. Objectives 
The main objectives of this work were to identify and characterize 
relevant miRNAs in bone formation and homeostasis using fish as models and 
mammalian systems for comparison and validation of results. In this regard, a 
combined literature search and preliminary experimental data revealed a set of 
miRNAs with a putative involvement in different stages of bone formation and/or 
homeostasis. Preliminary experiments included analysis of selected miRNAs in 
different fish bone systems. This thesis focused on the investigation of three 
miRNAs that highlighted from the initial set of identified miRNAs. 
 
At the beginning of this work, I integrated a pilot study ongoing in our 
laboratory at that time, which allowed me to acquire experience in some of the 
techniques described in this thesis and to develop some expertise in miRNA 
work. In particular, I was involved in the development of stable cell clones 
overexpressing miRNAs and in the characterization of miRNA gene expression 
through real-time quantitative PCR. This study, in which I am co-author, 
involved the investigation of miR-20a role in osteogenesis, through the 
characterization of three stable clones overexpressing this miRNA, in a fish 
bone-derived cell system and is now published (ANNEX I).  
 
Regarding the three miRNAs selected for this investigation, first, we 
focused on miR-223 (CHAPTER II), a miRNA that has been associated with 
bone remodelling in mammalian systems, where it was shown to regulate cell 
fate decisions of the hematopoietic lineage. In this regard, although miR-223 
was shown to be a crucial miRNA for osteoclastogenesis, its role in this process 
was so far poorly characterized. Therefore, we evaluated i) the suitability of 
zebrafish for the investigation of miR-223 function in vertebrates, and its 
particular involvement in ii) hematopoiesis and iii) osteoclastogenesis, always in 
direct comparison with mammalian systems. For that, miR-223 conservation 
was investigated regarding its gene organization, primary structure, secondary 
structure of the precursor, and genomic context. MiR-223 spatial and temporal 
distribution and predicted targets were also explored.  
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In a second stage of this work, we studied the biological role of miR-29a 
(Chapter III), a bone-related miRNA that was quite extensively investigated in 
mammals, but for which no mineralogenic effects where so far demonstrated. 
Thus, we investigated the biological effects of miR-29a through gain-of-function 
experiments in a fish bone-derived cell line, the ABSa15 cells, capable of in 
vitro mineralization. For a better understanding of the involved mechanisms and 
possible conservation of processes from mammals to fish, we investigated the 
expression of genes associated to osteogenic differentiation. The main targets 
of miR-29a in mammalian osteogenesis were also explored. Finally, miR-29 
conservation in vertebrates was investigated regarding its sequence homology, 
gene synteny, expression patterns and target conservation.  
 
In the third and final stage of this work, we explored miR-214 putative 
roles in vertebrate skeleton formation (Chapter IV). MiR-214 was previously 
found to regulate Hedgehog signalling, a crucial pathway in bone formation. 
Although our initial hypothesis of miR-214 involvement in osteogenesis was 
recently demonstrated by Wang et al. (2013) we proceeded with our 
investigation focusing on other skeletal-related processes, including 
chondrogenesis. We started by studying miR-214 expression throughout 
zebrafish development and collected evidences suggesting a possible 
involvement in chondrogenesis. Then, we investigated human and zebrafish 
miR-214 promoters for the presence of conserved binding sites for transcription 
factors associated to osteogenesis and chondrogenesis. At last, in order to 
demonstrate an involvement of miR-214 in chondrogenic differentiation, we 
performed miR-214 gain-of-function experiments in chondrocytic ATDC5 cells. 
Several chondrogenesis marker genes and putative targets of miR-214 were 
explored.
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2.1. Abstract  
MicroRNAs (miRNAs), an abundant and conserved class of small RNAs, 
have been shown to play important regulatory functions by interacting with the 
3’ untranslated region (UTR) of target mRNAs. Through this mechanism, miR-
223 was shown to post-transcriptionally regulate genes involved in mammalian 
haematopoiesis, both in physiological and pathological contexts. Essential for 
normal myelopoiesis in mammals, miR-223 promotes granulocyte, osteoclast 
and megakaryocyte differentiation and suppresses erythropoiesis. There is 
however a general lack of knowledge regarding miR-223 function in other 
vertebrates, which could help to clarify its role in other processes, such as 
development. In this work, we explored the functional conservation of miR-223 
using zebrafish as a model. We show that mir-223 gene structure and genomic 
context have been maintained between human and zebrafish. In addition, we 
identified 22 novel sequences of miR-223 precursor and demonstrate that it 
contains highly conserved domains among vertebrates, suggesting function 
preservation throughout evolution. Furthermore, collected evidences show that 
miR-223 expression is highly correlated with hematopoietic events and 
osteoclastogenesis throughout zebrafish development. In adults, zebrafish miR-
223 tissue distribution mimics that of mice, with high levels of expression in the 
major hematopoietic organ, the head kidney. These results suggest that miR-
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223 role in hematopoiesis has been maintained in zebrafish. Furthermore, 
validated targets of miR-223 in mammalian models were investigated and 
defined as putative targets in zebrafish, by in silico analysis. Our data compiles 
critical evidence showing that miR-223, which is highly conserved between 
species, appears to have also similar regulatory functions throughout evolution. 
 
2.2. Introduction 
MiRNAs are a conserved class of noncoding small RNAs, encoded in 
long primary transcripts (pri-miRNA) transcribed mostly by RNA polymerase II 
(Lee et al., 2004). Processing by the nuclear RNase III Drosha originates a 
miRNA precursor (pre-miRNA) which is further catalyzed in the cytoplasm by 
Dicer, generating a double-stranded 20-23 nt product (Davis and Hata, 2009; 
Du and Zamore, 2005). After loading into the RNA induced silencing complex 
(RISC), mature miRNAs guide the complex to target mRNAs and promote 
binding to complementary sequences in the 3’ UTR, leading to translation 
inhibition or cleavage of RNA transcripts (Du and Zamore, 2005; Kim et al., 
2009). As key regulators of gene expression, miRNAs have been implicated in a 
variety of developmental, physiological and pathological processes, including 
cell proliferation, apoptosis, differentiation and cell fate decisions (Erson and 
Petty, 2008; Fatica et al., 2008; Ivey and Srivastava, 2010; Wang et al., 2013b; 
Wienholds and Plasterk, 2005; Wu et al., 2012; Xiong et al., 2010). MiR-223 is a 
highly conserved miRNA known to be essential for normal myeloid cell 
differentiation (Chen et al., 2004; Johnnidis et al., 2008). In that sense, miR-223 
was demonstrated to trigger granulocyte differentiation by targeting nuclear 
factor I/A (NFIA) and insulin-like growth factor 1 receptor (IGF1R) (Fazi et al., 
2005; Lu et al., 2013), and to block erythrocytic differentiation by silencing LIM 
domain only 2 (rhombotin-like) (LMO2) (Felli et al., 2009). Furthermore, miR-
223 was shown to be a key player in the maturation of granulocytes, through 
modulation of myocyte enhancer factor 2C (MEF2C) (Johnnidis et al., 2008) 
and in osteoclast differentiation by regulation of a NFIA/macrophage colony 
stimulating factor receptor-like (M-CSFR) mechanism (Sugatani and Hruska, 
2009). Despite the recent progress towards elucidation of miR-223 function in 
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mammals, characterization of miR-223 regulatory network and function during 
development could help to clarify its hematopoietic and osteoclastogenic role in 
vertebrates and elucidate its mechanisms in human diseases, such as 
leukaemia and lymphoma. Zebrafish is a widely used model for studies of 
vertebrate development, gene function and human disease (Haffter et al., 1996; 
Lieschke and Currie, 2007). The rapid external embryonic development, 
transparency and survival of embryos without circulating blood cells for several 
days (Weinstein et al., 1996) and availability of mutants and transgenic lines 
(Sood and Liu, 2012) make zebrafish an ideal model to study hematopoiesis 
throughout development. In addition, zebrafish hematopoiesis presents 
anatomic, physiologic and genetic conservation with that of mammals 
(Carradice and Lieschke, 2008), which also experience two waves of 
hematopoiesis: primitive and definitive. Primitive hematopoiesis occurs in two 
phases: first, primitive macrophages arise from cephalic mesoderm and migrate 
onto the yolk ball; then, erythrocyte precursors develop in the intermediate cell 
mass (ICM) (Bertrand and Traver, 2009; Davidson and Zon, 2004; de Jong and 
Zon, 2005). Definitive hematopoiesis also occurs in two phases: first generating 
transient erythroid-myeloid progenitors (EMPs) in the posterior blood island 
(PBI) (Bertrand et al., 2007); and then producing hematopoietic stem cells 
(HSCs) in the AGM (aorta-gonad-mesonephros) region, which migrate to the 
caudal hematopoietic tissue (CHT) to support larval definitive hematopoiesis 
and to thymus and kidney to support adult definitive hematopoiesis (Bertrand 
and Traver, 2009; Jin et al., 2007; Paik and Zon, 2010). Despite all the 
similarities between zebrafish and mammalian hematopoiesis and the 
advantages of using this fish model to study this process, no data about miR-
223 function is available in zebrafish.  
In this work, we have investigated the possible functional conservation of 
miR-223 between zebrafish and mammalian models (human and/or mouse) by 
characterizing and comparing its gene organization, primary and secondary 
structures of the precursor and genomic context. Furthermore, we also explored 
the conservation of miR-223 spatial and temporal distribution and predicted 
targets. Our data shows that all miR-223 analysed features are generally 
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conserved between mammals and zebrafish, indicating that the zebrafish can 
be an excellent model to study miR-223 role in hematopoiesis throughout 
development. 
 
2.3. Materials and Methods 
 
2.3.1. Biological Material 
Wild-type zebrafish were reared at 28.5ºC on a 14:10 hour light:dark 
cycle and zebrafish eggs obtained by natural spawning. Larvae were 
maintained and raised at standard conditions, as previously described 
(Westerfield, 2000). Individuals were collected randomly at regular intervals, 
from hatching to adult stages. Fish were euthanized with a lethal dose of MS-
222 (Sigma) and either frozen in liquid nitrogen and preserved at -80ºC, or fixed 
in 4% buffered paraformaldehyde (PFA) at 4ºC for further processing. 
Adult mice tissue samples were obtained from Mus musculus specimens 
maintained at the University of Algarve animal facilities. 
 
2.3.2. Total RNA extraction 
Total RNA was extracted following the Chomczynski and Sacchi method 
(Chomczynski and Sacchi, 1987). Total RNA samples were treated with RQ1 
RNase-free DNase (Promega), according to manufacturer’s instructions, and re-
purified in phenol/chlorophorm/isoamyl alcohol (25:24:1) mixture. Total RNA 
was quantified by UV spectrophotometry (NanoDropND-1000) and its quality 
analysed in agarose gel electrophoresis. 
 
2.3.3. Marathon library and molecular cloning of zebrafish miR-223 
primary transcript 
Zebrafish specimens (48 hours post fertilization (hpf), 20 days post 
fertilization (dpf), 25 dpf, 40 dpf, two adult males and two adult females) were 
collected for total RNA extraction (see previous section). RNA was then used to 
construct a MarathonTM cDNA library (Clontech), following manufacturers’ 
protocol. The 5’ and 3’ ends of zebrafish miR-223 were achieved by rapid 
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amplification of cDNA ends (RACE) using Advantage cDNA polymerase mix 
(Clontech) according to manufacturer’s conditions. Specific forward and reverse 
primers (Dre pri-miR-223 Fw1 and 2, Rev1 and 2; listed in Supp. Table 2.1) 
were designed according to expressed sequence tag (EST) sequence available 
in National Center for Biotechnology Information (NCBI database) 
(http://www.ncbi.nlm.nih.gov) and combined with universal adapter primers 
(AP1 and AP2 universal primers; Supp. Table 2.1). Amplified PCR products 
were subsequently inserted into pCRII-TOPO (Invitrogen) and then cloned and 
further analysed by standard DNA sequencing. 
 
2.3.4. Quantitative real-time PCR (qPCR) analysis 
Total RNA was isolated from different adult tissues of zebrafish 
specimens (brain, heart, muscle, head kidney, branchial arches, skull and 
vertebrae) and mice specimens (ear, femur, calvaria, vertebrae, brain, muscle, 
heart, bone marrow). Regarding developmental stages, total RNA was 
extracted from a pool of up to twenty zebrafish larvae and juveniles at the 
following stages: 1 k-cell (approximately 3 hpf), 18 somites (approximately 16 
hpf), 24, 31, 32, 33, 35 and 36 hpf, 2, 3, 4, 6, 15, 30, 45, 54, 60, 63, 69 and 81 
dpf. Total RNA from one adult male and one adult female was also extracted.  
For qPCR analysis of mature miRNAs, total RNA (1 μg) was polyadenylated 
and reverse-transcribed using the NCode miRNA First-Strand cDNA Synthesis 
kit (Invitrogen), according to manufacturer’s instructions. PCR amplifications 
were performed using 2 l of the reverse transcribed RNA (1:10 diluted), 
miRNA-specific primers and the NCODE qPCR kit (Invitrogen), according to 
manufacturer’s instructions. Relative expression was determined through the 
ΔΔCt method (Livak and Schmittgen, 2001). Mature miRNA relative expression 
was normalized using U6 small nuclear RNA transcript. Primers and respective 
sequences are listed in Supp. Table 2.1. 
 
2.3.5. In silico analysis 
Precursor and mature miR-223 sequences from different vertebrate 
species were obtained from miRbase database release 20 
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(http://www.mirbase.org). EST and whole genome shotgun (WGS) sequences 
were obtained from NCBI database. Precursor sequences were aligned using 
Clustal Omega tool (http://www.ebi.ac.uk/Tools/msa/clustalo/) set for RNA and 
default parameters. This alignment was displayed as a logo using Weblogo 
facilities (http://weblogo.berkeley.edu/logo.cgi) and used to generate a 
consensus secondary structure using RNAalifold Web Server 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAalifold.cgi). Pairwise sequence identity 
among different pre- and mature miR-223 sequences was determined using the 
Sequence Manipulation Suite 
(http://www.bioinformatics.org/sms2/ident_sim.html). Values were calculated as 
percentage of identical nucleic acids over the total number of aligned nucleic 
acids. Individual structural analysis of miR-223 precursors was performed using 
Sfold software (http://sfold.wadsworth.org/cgi-bin/srna.pl). Finally, Ensembl 
genome database (http://www.ensembl.org/index.html) was used to identify the 
loci and the flanking regions of each mir-223 gene. Synteny was then 
established by comparing flanking genes of mir-223 from zebrafish and human. 
Genes were designated syntenic if one or more genes were conserved between 
zebrafish and human chromosomes, irrespective of orientation or order. 
 
2.3.6. Prediction of miR-223 target transcripts 
Pubmed database, available at NCBI 
(http://www.ncbi.nlm.nih.gov/pubmed/), was used to search for known targets of 
miR-223 in mammals. Then, zebrafish orthologs were retrieved from NCBI and 
3´UTR of putative targets were fed to three different target prediction 
algorithms: i) TargetScanFish Release 6.2 (http://www.targetscan.org/fish_62/), 
based on conserved sites in mRNA 3´UTR matching the seed region of miRNA, 
and ranking according to combinatorial scores of number of sites, type and 
context (Garcia, et al. 2011; Grimson et al., 2007; Lewis et al., 2005; Ulitsky et 
al., 2012); ii) PITA algorithm 
(http://genie.weizmann.ac.il/pubs/mir07/index.html), which computes the 
difference between free energy associated to miRNA-target duplex and free 
energy associated to unpairing the target to make it accessible to the miRNA 
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(Kertesz et al., 2007) and iii) RNAhybrid (http://bibiserv.techfak.uni-
bielefeld.de/rnahybrid/submission.html), based on the minimum free energy of 
hybridization of a long and a short RNA (Rehmsmeier et al., 2004). Putative 
targets were considered whenever the same binding sites were predicted by at 
least 2 of the algorithms used. 
 
2.4. Results 
We analysed whether zebrafish could be a valid model to study miR-223 
function, and if data available in other models, namely in mammals, could be 
further confirmed and, more importantly, extended using zebrafish as a model. 
For that, conservation of miR-223 was investigated from different perspectives: 
from sequence to structure, from gene organization to genomic context, and 
from levels of expression to mRNA targets.  
 
2.4.1. Identification of zebrafish miR-223 primary transcript and gene 
structure 
Human and zebrafish pre-miR-223 sequences were initially collected 
from miRBase database. However, as for other pre-miRNAs, pre-miR-223 
constitutes only a partial sequence of the full-length transcript. In order to 
identify the sequences of both the complete transcripts and possible variants, 
human and zebrafish pre-miR-223 were used as queries in BLAST tool from 
NCBI database to search for non-annotated cDNA fragments. While searching 
for human sequences we retrieved two complete mRNA sequences (accession 
numbers DQ680071 and DQ680072), corresponding to different variants of full-
length miR-223 transcript, and possibly resulting from alternative splicing events 
(Fig. 2.1). However, in zebrafish, only a single EST (accession number 
EB991492) was found, matching pre-miR-223 sequence. Since the zebrafish 
cDNA sequence was partial, it was used as template to design specific primers 
and identify the complete transcript. After RACE-PCR amplification, cDNA 
cloning and standard sequencing, a full-length sequence spanning 1146 base 
pairs (bp) and matching zebrafish miR-223 was identified and submitted to 
NCBI database (accession number KJ634046). Then, human and zebrafish 
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miR-223 transcripts sequences were used to search genomic sequence 
available in Ensembl database. After comparing and aligning genomic and 
transcript sequences using Splign tool available in NCBI, human and zebrafish 
mir-223 gene structures were determined (Fig. 2.1). According to this analysis, 
the zebrafish mir-223 gene is located in chromosome 5 (Chr 5, - strand), it 
spans approximately 11.8 kilobase pairs (kb) and is composed of 3 exons. Pre-
miR-223 is inserted in the third exon and, so far, only one variant has been 
identified (Fig. 2.1). This structure is maintained in human (Fig. 2.1), where the 
corresponding gene is also composed of 3 exons spanning 5 kb and located in 
the X chromosome (sex chromosome; Chr X, + strand). As mentioned before, 
the two human cDNA fragments appear to result from alternative splicing events 
and structure analysis suggests alternative splicing of exon 2, which is either 
present or absent in human miR-223 transcript.  
 
 
 
 
Figure. 2.1. Structural organization of mir-223 gene. A schematic representation of human 
and zebrafish mir-223 genes located, respectively, in Chr X and 5, is presented. Bellow human 
gene structure, 2 annotated transcript variants are represented (accession numbers DQ680071 
and DQ680072). Bellow zebrafish gene structure, the primary transcript here cloned and 
annotated (accession number KJ634046) and an EST (accession number EB991492) are 
schematized. Boxes represent exons 1, 2 and 3 indicated in white, black and dark grey 
respectively. Pre-miR-223 is indicated in a light grey box, within exon 3.  
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2.4.2. Genomic context of zebrafish and human mir-223 genes 
The genomic context of zebrafish mir-223 gene was analyzed and 
compared to its human counterpart. According to information available in 
Ensembl and miRbase, the zebrafish mir-223 gene is located in the negative 
strand of Chr 5, at position 24 Mb (5: 24017735-24017833 [-]), while the human 
mir-223 gene is located in the positive strand of Chr X at position 65 Mb 
(chrXq21.1: 65238712-65238821 [+]). Zebrafish Chr 5 spans approximately 
75.68 Mb and contains 427 non-coding genes, whereas human Chr X spans 
approximately 155.27 Mb and accounts for 735 non-coding genes. According to 
miRbase, a total of 23 and 118 miRNAs are assigned to zebrafish Chr 5 and 
human Chr X, respectively. A more detailed analysis of the genomic context of 
mir-223 gene revealed strong conservation between both species. In this 
regard, the upstream flanking regions of both human and zebrafish mir-223 loci 
are composed by a group of eight common genes presenting a similar spatial 
organization: moesin (MSN), lethal in the absence of Ssd1 (LAS1)-like (LAS1L), 
zinc finger CCCH-type containing 12B (ZC3H12B), zinc finger C4H2 domain 
containing (ZC4H2), myotubularin related protein 8 (MTMR8), ankyrin repeat 
and SOCS box containing 12 (ASB12), family with sequence similarity 123B 
(FAM123B) and Cdc42 guanine nucleotide exchange factor (GEF) 9 
(ARHGEF9) (Fig. 2.2). Downstream of mir-223 gene, the order of gene loci was 
much less preserved, although several genes were still conserved between the 
two species. Conserved genes downstream mir-223 include: non-POU domain 
containing, octamer-binding (NONO), uracil phosphoribosyltransferase (FUR1) 
homolog (UPRT), bromodomain and WD repeat domain containing 3 (BRWD3) 
and KIAA2022 (Fig. 2.2). 
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Figure. 2.2 Schematic representation of the genomic context of human and zebrafish mir-
223 genes using data from the Ensembl project. The physical localization of the genes 
present in the vicinity of mir-223 gene is indicated for human and zebrafish. Genes ID are listed 
at the right with mir-223 indicated in bold. Eight genes conserved in the same order are 
highlighted with a blue box in the chromosomes of both species and in the IDs list. Chr – 
chromosome. 
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2.4.3. Precursor of miR-223 contains highly conserved domains in 
vertebrates  
In order to further investigate the conservation of miR-223 among 
different vertebrate species (mammals, amphibian, birds, reptiles and teleost 
fish), the corresponding sequences of its precursor (pre-miR-223) were 
collected from miRbase and their pairwise identities determined. According to 
this analysis, pre-miR-223 displayed different homologies among different taxa, 
varying from 80% (Saguinus labiatus versus Gallus gallus) to 47.66% 
(Ornithorhynchus anatinus versus zebrafish), clearly showing higher sequence 
conservation among mammalian species. Regarding zebrafish pre-miR-223, 
sequence identity ranged from 57 to 64% when comparing to mammalian 
species (excluding O. anatinus), from 51 to 57% when comparing to 
amphibian/birds/reptiles, and from 55 to 69% when comparing to other teleost 
fish (Supplementary Fig. 2.1a). These data suggested a similar conservation 
between zebrafish and other species from the same taxa (i.e. teleost fish), and 
also between zebrafish and species from other taxa (e.g. mammalian). To 
further complement this analysis, additional sequences were collected from 
EST and WGS available in NCBI, thus compensating the poor availability of 
sequences in certain taxonomic groups (e.g. birds and teleost fish). In total, 46 
miR-223 precursor sequences were collected, i.e. 24 sequences previously 
annotated / available in miRbase, and 22 new sequences that were identified in 
the present study. For the latter, hairpin precursors were inferred based on: i) 
nucleotide, size and position similarity, when compared with species from the 
same taxa; and ii) hairpin minimum free energy. Then, precursor sequences 
were aligned using Clustal Omega and used to generate logos using WebLogo 
(Fig. 2.3a). Finally, a consensus secondary structure based on the previous 
alignments (Fig. 2.3b) and individual secondary structures (Fig. 2.4) were 
predicted using RNAalifold and Sfold, respectively. This analysis enabled us to 
conclude that some domains of miR-223 precursor sequence are generally 
conserved among vertebrates, while others are less conserved and therefore 
are specific of certain taxa. Not surprisingly, the most conserved domain 
corresponded to consensus mature miR-223 sequence (5’ – 
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Figure 2.3.  
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Figure 2.3. Conserved features of miR-223 hairpin among vertebrate species. a) Alignment 
of predicted pre-miR-223 from 46 species using WebLogo. Sequence logos are presented as a 
graphical display where the height of each letter is made proportional to its frequency in each 
position and black letters in the logo indicates nucleotides that are 100% conserved. b) Mir-223 
hairpin alignment using Clustal Omega is displayed together with taxonomic tree (left) and 
consensus secondary structure in dot-bracket notation (bottom, where dots and brackets 
represent unpaired and paired bases, respectively). Mature miR-223 sequence is highlighted in 
dark grey with the first 17 nucleotides, 100% conserved, enclosed in a box. Other conserved 
domains among species are highlighted in soft grey. A domain only conserved within the same 
group of species, preceding star strand, is indicated with a grey box. Consensus boundaries of 
pre-miR-223 are indicated as dashed lines at the bottom. Species corresponding to sequences 
retrieved from miRbase are indicated in bold. Taxonomic groups investigated were: 
Actinopterygii (A), Acanthopterygii (Ac), Amniota (Am), Amphibia (Ap), Artiodactyla (Ar), Aves 
(Av), Beliniformes (Be), Coelacanthimorpha (C), Carnívora (Ca), Cetacea (Ce), Cypriniformes 
(Ci), Columbiformes (Co), Cyprinodontiformes (Cy), Diapsida (D), Eutheria (E), Euteleostei (Eu), 
Falconiformes (Fa), Galliformes (G), Gasterosteiformes (Ga), Holacanthopterygii (H), 
Lepidosauria (L), Marsupialia (M), Monotremata (Mo), Osteichthyes (O), Ostariophysi (Os), 
Protacanthopterygii (P), Passeriformes (Pa), Perciformes (Pe), Perissodactyla (Pi), Primates 
(Pr), Psittaciformes (Ps), Rodentia (Ro), Sarcopterygii (S), Synapsida (Si), Testudines (T), 
Tetraodontiformes (Te). 
 
UGUCAGUUUGUCAAAUACCCC – 3’) (Fig. 2.3 and Supplementary Fig. 2.1b). 
This conservation is more notorious in the 5’ end of the sequence (100% 
conservation in nucleotides 1 to 17; box in Fig. 2.3b), which should be related to 
functional aspects, namely specific interactions with target transcripts, as 
previously described (Pillai, 2005). Nevertheless, three species from different 
taxa showed important differences in the 3’ end of the mature miR-223 (up to 3 
different nucleotides), which could be related to evolutionary divergence of 
species. For instance, O. anatinus, which belongs to the monotremata order, 
diverged in 1 nucleotide (C-T) in the 3’ end; A. carolinensis, a reptile, diverged 
from remaining species analysed by specific changes in the 19th (C-A) and 21st 
(C-A) positions of mature miR-223; Ictalurus punctatus lacked 2 nucleotides in 
the 3’ end of the mature sequence. In the last example, it remains unclear 
whether this unique feature represents a true divergence or if corresponds to an 
incomplete sequence. Another important conserved domain is the miR-223 star 
strand (although miR-223 star is only described in 5 species: H. sapiens, M. 
musculus, R. norvegicus, O. anatinus and A. carolinensis, miR-223 star strand 
will be here referred as the sequence corresponding to the putative miR-223 
star) (Fig. 2.3). Nevertheless, in miR-223 star strand some degree of 
divergence was obvious, especially among actinopterygii group, where 7 out of 
14 species contained up to 5 different nucleotides. Finally, high conservation 
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Figure 2.4. Pri-miR-223 secondary structure conservation among vertebrates (predicted by Sfold). Two species representative of each taxonomic 
group, one retrieved from miRbase (Homo sapiens, Anolis carolinensis, Gallus gallus, Xenopus tropicalis and Danio rerio) and another described / 
identified here (Tursiopa truncates, Pelodiscus sinensis, Pseudopodoces humilis, Sparus aurata), were selected to illustrate conservation of predicted 
stem loops. Important features of the stem loop are indicated in the Homo sapiens pri-miR-223 structure. ΔG represents free energy at a folding 
temperature of 37ºC. 
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was also evident among flanking sequences of mature miR-223 at both 5’ 
(consensus GAG) and 3’ ends (consensus AAGUG), as also observed for the 
sequence flanking the 3’ end of star strand sequence (consensus GACACUC) 
(Fig. 2.3).  
Regarding less conserved domains, relatively high conservation was still 
evident within the same taxa or in some cases among different taxa. An 
example of this is the flanking sequence preceding the star strand, which 
contains at least 11 conserved nucleotides within species of the same group: 
mammalian, birds, amphibian and teleosts (first group of shaded columns on 
Fig. 2.3b). Concerning analysis of miR-223 precursor secondary structures, all 
analysed sequences resulted in prediction of stem-loops (Fig. 2.4), which is a 
characteristic feature of pre-miRNAs. Some motifs of the predicted stem-loops 
were highly conserved, including: i) terminal loop, ii) bulge in 5´ arm and iii) 
internal loop containing the last nucleotides of 3´ end of mature miR-223 (Fig. 
2.4). This conservation was confirmed by consensus secondary structure 
illustrated in Fig. 2.3b. A common feature in all analysed species was that 
mature miR-223 was maintained in the 3p arm of all stem-loops (Figs. 2.3 and 
2.4). 
 
2.4.4. Zebrafish miR-223 expression analysis 
In mammals, miR-223 was clearly associated with hematopoiesis (reviewed by 
(Haneklaus et al., 2013)) and osteoclastogenesis (Sugatani and Hruska, 2007, 
2009). In zebrafish, crucial events of hematopoiesis were previously described 
between 10 hpf and 6 dpf, (Bertrand et al., 2007, 2008; Paik and Zon, 2010; 
Sood and Liu, 2012), while osteoclastogenesis was shown to occur from 20 dpf 
until adulthood (Witten et al., 2001). qPCR analysis of miR-223 from blastula to 
larval stages of zebrafish development revealed that miR-223 expression is 
strongly up-regulated from 31 to 35 hpf (peak at 32 hpf) and 4 to 6 dpf, while it 
is only mildly increased at 24 hpf, 36 hpf, 2 dpf and 3 dpf (Fig. 2.5). In juveniles, 
i.e. after 30 dpf, miR-223 levels of expression were consistently elevated, with a 
peak being reached at approximately 60 dpf (Fig. 2.5). In general, miR-223 up-
regulation was maintained until adulthood, and both male and female showed 
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Figure. 2.5. Analysis of mature miR-223 expression levels during development of zebrafish. Levels of miR-223 gene expression were measured 
by qPCR using RNA samples from different stages of zebrafish development, normalized to levels of zebrafish U6 small RNA and using 18 somites (18 
S) as reference sample. Values are the mean of at least 3 independent replicates; hpf indicates hours post fertilization; dpf indicates days post 
fertilization, N.D. indicates non-detected. Gap in the y axis separates two different scales.
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similar levels of expression (Fig. 2.5). In adult zebrafish, miR-223 expression 
was investigated in calcified (i.e. branchial arches, skull and vertebrae) and soft 
(i.e. brain, muscle, heart, and head kidney) tissues (Fig. 2.6a). Although miR-
223 expression was detected in all analysed tissues, it was remarkably higher in 
the head kidney (Fig. 2.6a), a well-described hematopoietic organ in zebrafish, 
equivalent to bone marrow in mammals (Paik and Zon, 2010; Sood and Liu, 
2012). Relatively high levels of expression were also observed in vertebrae, 
muscle, and heart. Since miR-223 has been related with differentiation of 
hematopoietic lineages, higher levels of expression in heart or muscle could be 
associated to their high degree of vascularization (probably due to circulation of 
immature cells). Alternatively, miR-223 could be associated to specific functions 
of these organs. In mammals, miR-223 expression is also known to be 
increased at sites of hematopoiesis (Chen et al., 2004). Here, miR-223 
expression was also analysed in several tissues from adult mice: 4 calcified 
tissues, i.e. ear, femur, calvaria and vertebrae, and 4 soft tissues, i.e. brain, 
muscle, heart and bone marrow. The obtained results not only confirmed 
previous studies (Chen et al., 2004), but also showed that the miR-223 pattern 
of expression in adult mice (Fig. 2.6b) resembles that observed in zebrafish, i.e. 
presence of miR-223 in all analysed tissues, and highest expression clearly 
associated to major sites of hematopoiesis (here represented by bone marrow). 
High expression levels were also observed in femur, calvaria, vertebrae, muscle 
and heart (Fig. 2.6b). Like in zebrafish, brain and cartilaginous tissues in mice 
were the ones presenting lower levels of miR-223 expression (Fig. 2.6a and b). 
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Figure 2.6. Analysis of mature miR-223 expression levels in zebrafish (a) and mouse (b) 
adult tissues. Levels of miR-223 gene expression measured by qPCR in zebrafish and mouse 
tissues were normalized to levels of respective U6 small RNA and using brain as reference 
sample. Values are the mean of at least 3 independent replicates. 
 
 
2.4.5. Identification of zebrafish putative miR-223 targets 
In order to further complement previous data showing miR-223 functional 
conservation between zebrafish and mammals, miR-223 targets were 
investigated in the literature through extensive search of Pubmed database, 
using the following keywords: miR-223 and target (last checked in November 
18, 2013). Each miRNA can regulate hundreds of genes (Pillai, 2005; 
Rajewsky, 2006), and accordingly, miR-223 was previously demonstrated to 
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regulate several mammalian mRNAs (reviewed by Haneklaus et al., 2013). 
Although our search retrieved a total of 92 reports, 56 publications were 
excluded from this analysis due to lack of one or more of the following inclusion 
criteria: i) presence of respective ortholog in zebrafish; ii) knowledge of full-
length cDNA sequence in zebrafish; iii) association of targets to mammalian 
hematopoiesis (miR-223 role was shown to be mainly associated to this 
process in mammals). The remaining studies, 36 in total, corresponded to a 
total of 9 miR-223 targets identified in mammalian systems (Table 2.1). The 
zebrafish orthologs of these targets were searched and retrieved from NCBI 
database and analysed for putative miR-223 binding sites using three different 
bioinformatic tools (Table 2.2): i) TargetScanFish, ii) PITA algorithm and iii) 
RNAhybrid. Potential binding sites were considered if identified by at least two 
algorithms. In Table 2.1, miR-223 targets identified in mammalian systems were 
listed along with the respective reports, whereas Table 2.2 resumes the in silico 
analysis of corresponding zebrafish ortholog genes. According to this analysis, 
both zebrafish orthologs of RAS p21 protein activator (RASA1) (rasa1a and 
rasa1b) and stathmin 1 STMN1 (stmn1a and stmn1b) contained putative 
binding sites for miR-223, while only one zebrafish ortholog for IGF1R and 
MEF2C fit the criteria established in this study (Table 2.2). While predicting 
these targets, it was common to find one or more paralogs also predicted as 
miR-223 targets (data not shown) in zebrafish (7 of the 9 targets), which could 
be related to genome-wide duplication events in zebrafish lineage that occurred 
300-500 million years ago (Meyer and Schartl, 1999; Taylor et al., 2003). 
Although paralog genes may not share exactly the same function, it is likely that 
some of these genes might complement each other, or their functions partially 
overlap, as previously described for other paralogs (Boucherat et al., 2013; 
Solomon and Fritz, 2002; Yuan et al., 2010). 
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Table 2.1. Mammalian target genes of miR-223 analysed in this study.  
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Table 2.2. Resume of in silico analysis of zebrafish miR-223 putative target genes. Position of seed match refers to counting from first nucleotide 
after stop codon.  
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Regarding gene function, zebrafish predicted targets were associated to 
two main molecular functions: regulation of transcription (nfia, mef2cb, foxo1a – 
forkhead box O1a) and of different signalling pathways (F-box and WD repeat 
domain containing 7, E3 ubiquitin protein ligase (fbxw7), igf1ra). The following 
biological processes were associated to these genes: i) cardiovascular system 
formation (igf1ra, mef2cb, lmo2, fbxw7, rasa1); ii) hematopoiesis (lmo2); and iii) 
embryo development (igf1ra) (Table 2.2). Unfortunately, zebrafish ortholog of 
E2F transcription factor 1 (E2F1) has not been functionally annotated yet. 
Altogether, the available data suggest that miR-223 targets and function 
may have been conserved from zebrafish to mammals. 
 
2.5. Discussion 
This work focused on exploring the functional conservation of miR-223 
throughout evolution, from mammals to zebrafish. MiR-223 gene structure, 
primary and secondary structures of its precursor, its genomic context, spatial-
temporal expression and putative targets were characterized in zebrafish and 
compared to those from human and/or mouse models. Our results indicate that 
zebrafish has an orthologue to human miR-223 gene, and expression and 
analysis of predicted targets point towards a functional conservation in 
hematopoiesis and osteoclastogenesis. 
 
2.5.1. miR-223 is conserved throughout evolution: insights from gene and 
precursor analysis 
In order to investigate the putative miR-223 conservation in vertebrates, 
the zebrafish full-length primary transcript of miR-223 was identified and 
mapped to the zebrafish genome. Like in other vertebrates, e.g. human and 
mouse (Fukao et al., 2007), zebrafish mir-223 gene is organized in three exons 
and its precursor sequence is contained in the third exon, demonstrating a 
structural genomic conservation. Nonetheless, human and mouse mir-223 
genes are more compact than that of zebrafish, with two alternative splicing 
forms already described (Fukao et al., 2007), while only one transcript was so 
far identified in zebrafish through this study. The question of whether this 
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transcript was in fact an ortholog of the human miR-223 led to a comparison of 
the genomic context between zebrafish (Chr 5) and human (Chr X). Gene 
synteny analysis revealed a block of 8 genes upstream of mir-223 locus that 
was preserved in the same order between the two species, whereas 
downstream mir-223 the order of syntenic genes was less preserved. 
Therefore, gene synteny analysis, a valuable tool to determine orthologs 
(Postlethwait, 2000), confirmed that zebrafish mir-223 is likely to be a true 
ortholog of the corresponding human gene. To further investigate the 
conservation of miR-223, important features such as its pre-miRNA primary 
(Auyeung et al., 2013; Saetrom et al., 2006) and secondary structures (Gu et 
al., 2012; Han et al., 2006; Park et al., 2011; Wostenberg et al., 2012; Zeng and 
Cullen, 2005; Zeng et al., 2005b; Zhang and Zeng, 2010) were analyzed in a 
broad group of species following established guidelines. While nucleotide 
sequence identity was less than 70% between zebrafish and other vertebrate 
species, sequence alignment showed a remarkable conservation of the mature 
miR-223. In particular, the seed region, which is a key element in target 
recognition and translation inhibition (Doench and Sharp, 2004), was 100% 
preserved, suggesting a conservation of miR-223 putative targets and most 
likely of its function among vertebrates. Furthermore, the flanking sequences of 
both mature and star miR-223 were highly preserved, which might indicate that 
miR-223 processing is also conserved. This is further supported by the 
conservation of secondary structures in the miR-223 hairpin: i) a terminal loop, 
which is critical for Drosha and Dicer optimal processing, and contributes to 
determine the cleavage site by the distance to the loop (Gu et al., 2012; Zeng et 
al., 2005b; Zhang and Zeng, 2010); ii) single-stranded extensions on the pri-
miRNA hairpin in the basal segment, which are vital for DGCR8 binding and 
distance counting for Drosha cleavage (Han et al., 2006; Zeng and Cullen, 
2005; Zeng et al., 2005b); iii) 2 helix turns (~22 nt) that encode the 
miRNA:miRNA* duplex; and iv) 1 helix turn (~11 nt) of the lower stem, which is 
also important for processing (Han et al., 2006; Zeng et al., 2005b). Although 
the precise role of the various miRNA structures is not yet fully understood, 
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maintenance of these features provides further evidence for conservation of 
miR-223 processing.  
In general, structural information pointed towards a notable conservation 
of miR-223 throughout evolution, raising the hypothesis that its function could 
also be maintained.  
 
2.5.2. MiR-223 expression is correlated with hematopoiesis in zebrafish 
In mammalian models, miR-223 is known to play critical roles in 
hematopoiesis, promoting granulocyte differentiation (Fazi et al., 2005; Fukao et 
al., 2007) and suppressing erythrocytic differentiation (Yuan et al., 2009a). To 
shed some light into the putative functions of miR-223 in other vertebrates, the 
expression pattern of this miRNA was investigated in zebrafish. According to 
our data, zebrafish miR-223 was up-regulated between 31 and 36 hpf, which 
could be related in particular with two important hematopoietic events: i) 
formation of committed erythromyeloid progenitors in the PBI, known to occur 
between 24 and 48 hpf (Bertrand et al., 2007); and ii) the formation of 
hematopoietic precursors in the AGM, occurring from 30-36 hpf (Bertrand et al., 
2008). Furthermore, miR-223 was also up-regulated between 4 and 6 dpf, and 
from 30 dpf to adulthood, which could be associated, respectively, to the 
seeding of the head kidney by HSCs and to definitive hematopoiesis support 
(Bertrand and Traver, 2009; Cumano and Godin, 2007; de Jong and Zon, 2005; 
Paik and Zon, 2010; Sood and Liu, 2012). The finding that miR-223 was highly 
expressed in the primary hematopoietic organs of both zebrafish and mouse 
further supported its putative role in hematopoiesis and emphasized the 
zebrafish usefulness for elucidation of miR-223 function. In addition to 
hematopoiesis, a 10-fold induction of miR-223 expression after 30 dpf might as 
well be related to osteoclastogenesis and bone remodeling, which in zebrafish 
normally occur from 20-30 dpf onwards (Witten and Huysseune, 2009b; Witten 
et al., 2001). Although osteoclasts derive from the hematopoietic lineage, the 
molecular pathway(s) involved in this process are still not completely elucidated 
in mammals or zebrafish. However, miR-223 was previously shown to be a key 
factor in osteoclast differentiation in mammals, being differentially expressed 
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during the different phases of osteoclast differentiation (Kagiya and Nakamura, 
2013; Shibuya et al., 2013; Sugatani and Hruska, 2007, 2009). Because of its 
similarities with mammals in terms of gene structure and targets, zebrafish 
might be an important model to clarify the exact function of miR-223 microRNA 
in osteoclastogenesis. In that sense, transgenic lines that allow in vivo imaging 
of osteoclasts maturation and migration (as already available in medaka 
(Chatani et al., 2011)) could be crossed with other lines, in which miR-223 
promoter could drive expression of a fluorescent reporter gene thus providing 
relevant in vivo tools to further understand miR-223 function in vertebrates. 
 
2.5.3. Evidences for conservation of miR-223 targets and regulatory 
functions in mammals and zebrafish 
In general, in order to fully elucidate miRNAs functions, it is essential to 
identify their target transcripts. In mammals, the miR-223 major function 
appears to be the regulation of hematopoietic cell fate speciation and 
differentiation. Accordingly, several of the previously validated miR-223 target 
transcripts in mammalian systems were related to hematopoiesis. In this study, 
prediction of miR-223 putative targets in zebrafish strongly suggested once 
more an evolutionary conservation of its function in vertebrates. For instance, 
LMO2 has a well-known and conserved function in hematopoiesis and is 
required for primitive and definitive hematopoiesis and for angiogenesis in 
mammals and zebrafish (Patterson et al., 2007; Wang et al., 2008; Yamada et 
al., 1998, 2000; Zhu et al., 2005). Furthermore, it was shown to be down-
regulated by miR-223 in humans, suppressing differentiation of erythroid cells 
(Felli et al., 2009; Yuan et al., 2009a) and increasing megakaryocytic 
differentiation (Yuan et al., 2009a). NFIA is another gene that has been shown 
to be down-regulated by miR-223 to promote granulocytic differentiation (Fazi et 
al., 2005), and during osteoclastic differentiation (Sugatani and Hruska, 2009). 
Ablation of MEF2C, which modulates cell-fate decision of HSCs in mammals 
(Schüler et al., 2008; Stehling-Sun et al., 2009), suppresses proliferation of 
granulocyte progenitors, correcting the mice phenotype promoted by miR-223 
knockout (Johnnidis et al., 2008), while ablation of miR-223 was shown to 
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increase proliferation of eosinophil progenitors through an up-regulation of 
IGF1R (Lu et al., 2013). Both MEF2C and IGF1R genes were validated as miR-
223 targets (Jia et al., 2011; Johnnidis et al., 2008). Although NFIA, MEF2C and 
IGF1R were not linked to zebrafish hematopoiesis so far, a possibility which 
should be further investigated in detail, previous studies indicate that several 
other functions attributed to those genes are conserved in zebrafish (Hinits and 
Hughes, 2007; Hinits et al., 2012; Pistocchi et al., 2013; Schlueter et al., 2007) 
and thus it is possible that their function in hematopoiesis could also be 
conserved.  
Another process that has been linked to miR-223 activity is 
tumorigenesis, including malignant hematopoiesis. In cancer, miR-223 is 
commonly deregulated either being silenced or over-expressed (Haneklaus et 
al., 2013; Vasilatou et al., 2010) and, it targets important cell cycle regulators 
such as E2F1, STMN1, FOXO1, FBXW7 (Kang et al., 2012; Kurashige et al., 
2012; Mansour et al., 2013; Pulikkan et al., 2010; Wong et al., 2008; Wu et al., 
2012), suggesting that miR-223 might function as an oncomiR or a tumor 
suppressor miRNA. Since transgenic mutant zebrafish lines are already 
available, either modelling lymphoblastic leukemia (ALL) or myeloid leukemia 
and myeloproliferative disorder (AML/MDS) (Shen et al., 2013; Teittinen et al., 
2012), these could be useful tools to help unveil the regulatory mechanisms of 
miR-223 in leukemia.  
Finally, miR-223 also seems to play an important role in vascular 
development. Accordingly, miR-223 is expressed in vascular smooth muscle 
cells (VSMCs), and its overexpression was shown to increase proliferation and 
migration, probably by targeting MEF2C and ras homolog family member B 
(RHOB) (Rangrez et al., 2012). From the pool of genes that were previously 
validated as miR-223 targets in other processes, several have functions 
associated to angiogenesis and cardiovascular development, both in mammals 
and zebrafish including RASA1 (Kranenburg et al., 2004; Ren et al., 2013), 
LMO2 (Yamada et al., 2000; Zhu et al., 2005), FBXW7 (Izumi et al., 2012), 
MEF2C (Edmondson et al., 1994; Hinits et al., 2012) and IGF1R (Galer et al., 
2011; Huang et al., 2013). Although the role of miR-223 in those processes is 
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still uncharacterized, the number of known targets with established roles in one 
of the mentioned processes suggests that this miRNA could have a 
physiological or pathological role in at least one of them. Once more, zebrafish 
could be a valuable model to investigate the possible involvement of miR-223 in 
those pathways. In that sense, several studies have already clearly 
demonstrated the suitability of zebrafish to investigate miRNAs in vascular and 
heart development (Gays and Santoro, 2013). 
 
2.6. Conclusions 
Our data revealed that miR-223 structural and functional features have 
been conserved throughout evolution. Its genomic organization and context are 
maintained between human and zebrafish, and conservation of primary and 
secondary structures of miR-223 precursors suggests that processing and 
function of miR-223 might be maintained across vertebrates. We provide 
additional evidence supporting the use of zebrafish as model to study miR-223 
function by showing that its expression pattern during development is consistent 
with a role in primitive and definitive hematopoiesis and by predicting as 
putative targets of zebrafish miR-223 genes with mammalian orthologs already 
shown to be involved in hematopoiesis. The data presented here contributes 
decisively to define a pool of miR-223 target genes and physiological processes 
including hematopoiesis, osteoclastogenesis, malignancy and cardiovascular 
development, that should be further investigated in order to clarify the role of 
miR-223. Furthermore, we provide evidence supporting the, use of zebrafish as 
model to study those putative functions.  
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Supplementary Table 2.1. List of primers used in this study. 
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Supplementary Figure 2.1. Pairwise percent identities of pre-miR-223 (a) and mature miR-
223 (b) sequences in different vertebrate species. Different groups of organism are indicated by 
shaded areas with corresponding letters: M - mammals, A - amphibians, B- birds, R - reptiles 
and F - fish. The identity values were calculated from alignments using Clustal Omega. 
Sequences were obtained from the following species: Anolis carolinensis (Aca), Bos taurus 
(Bta), Canis familiaris (Cfa), Danio rerio (Dre), Equus caballus (Eca), Gallus gallus (Gga), 
Gorilla gorilla (Ggo), Homo sapiens (Hsa), Macaca mulatta (Mml), Monodelphis domestica 
(Mdo), Mus musculus (Mmu),  Oryzias latipes (Ola), Ornithorhynchus anatinus (Oan), Pan 
paniscus (Ppa), Pongo pygmaeus (Ppy), Pan troglodytes (Ptr), Rattus norvegicus (Rno), 
Saguinus labiatus (Sla), Taeniopygia guttata (Tgu), Takifugu rubripes (Fru), Tetraodon 
nigroviridis (Tni), Xenopus laevis (Xla) and Xenopus tropicalis (Xtr). 
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3.1. Abstract 
MicroRNAs (miRNAs) provide a mechanism for fine-tuning of intricate 
cellular processes through post-transcriptional regulation. Emerging evidences 
indicate that miRNAs play key roles in the regulation of osteogenic 
differentiation and bone formation. The miR-29 family was previously implicated 
in osteoblast differentiation of mammals by targeting extracellular matrix 
molecules and modulating Wnt signalling through a feedback loop. 
Nevertheless, the function of miR-29 in bone formation and homeostasis is not 
completely understood. Here, we provide novel insights into the biological effect 
of miR-29a overexpression in a cell model capable of in vitro mineralization 
(ABSa15 cells). The phenotype obtained from miR-29a gain of function 
experiments was a significant increase of extracellular matrix mineralization, 
probably due to accelerated differentiation. We also demonstrated for the first 
time that miR-29a promotes an induction of -catenin protein levels, implying a 
stimulation of canonical Wnt signalling. It was further shown that SPARC is a 
conserved putative target of miR-29, and thus may contribute to the phenotype 
observed in ABSa15 cells. Finally, we provide evidences for miR-29 
conservation throughout evolution based on sequence homology, synteny 
analysis and expression patterns. Concluding, miR-29a is a key player in 
osteogenic differentiation, leading to increased mineralization in vitro, and this 
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function seems to be conserved throughout vertebrate evolution by interaction 
with canonical Wnt signalling and conservation of targets.  
 
3.2. Introduction  
Skeletogenesis is a tightly regulated process orchestrated by numerous 
molecular determinants and cellular activities (Karsenty, 2008; Karsenty and 
Wagner, 2002). Although this process has been greatly investigated, its post-
transcriptional regulators are generally unknown. MicroRNAs (miRNAs), an 
abundant class of small noncoding RNAs, provide a mechanism for fine-tuning 
of complex cellular processes through binding to the 3’-untranslated region (3’-
UTR) of mRNA transcripts to attenuate protein synthesis (Tétreault and De 
Guire, 2013). Known to control numerous biological processes (Guarnieri and 
DiLeone, 2008), miRNAs were recently implicated in skeletogenesis and, in 
combination with key transcription factors and signalling molecules, help to 
control the complex program of bone formation (Zhao et al., 2013). This was 
evidenced by studies where conditional deletion of Dicer, an enzyme crucial for 
miRNA biogenesis, in osteoprogenitor cells and in chondrocytes resulted in 
abnormal formation of bone and cartilage of mouse (Gaur et al., 2010; 
Kobayashi et al., 2008). Other studies have identified a panel of miRNAs that 
act as negative regulators of bone formation. For instance, miR-206 targeting of 
connexin43 (Cx43) was shown to impede osteoblast differentiation both in vitro 
and in vivo (Inose et al., 2009). A set of 11 miRNAs was found to target the 
master regulator of osteogenesis, RUNX2, in both osteoblasts and 
chondrocytes, and to inhibit osteoblast differentiation (Zhang et al., 2011c). 
Furthermore, miR-214 was shown to repress ATF4, a transcription factor that 
orchestrates osteoblast differentiation and function, which consequently 
inhibited osteoblast activity and matrix mineralization in vitro and bone formation 
in vivo (Wang et al., 2013a). The opposite effect of miRNAs in bone, i.e. positive 
regulation of osteoblast differentiation, was also demonstrated. For instance, 
miR-2861 overexpression enhanced osteoblastogenesis in mouse bone marrow 
stromal cells, whereas its silencing in vivo decreased Runx2 protein levels and 
inhibited bone formation, by targeting HDAC5 (Li et al., 2009a). Zhang and co-
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workers demonstrated that miR-335-5p down-regulates DKK1, thus activating 
Wnt signalling and promoting osteogenic differentiation (Zhang et al., 2011b). 
Among this group of miRNAs is the miR-29 family, which expression was shown 
to increase during mouse osteoblast differentiation (Kapinas et al., 2009; Li et 
al., 2009b). This family is composed by miR-29a, miR-29b and miR-29c, which 
share the same seed sequence and collectively target several genes associated 
to extracellular matrix (ECM) in bone, including several collagens, matrix 
metalloproteinase 2 (MMP2), MMP9 and SPARC (secreted protein acidic and 
rich in cysteine) (Kapinas et al., 2009; Li et al., 2009b; Rossi et al., 2013). In this 
regard, miR-29b was also found to target known inhibitors of osteoblast 
differentiation, i.e. HDAC4, TGF3, ACVR2A, CTNNBIP1, and DUSP2 (Li et al., 
2009b), and to promote osteogenesis in mouse. More recently, miR-29b was 
shown to target osteo-inhibitory genes CDK6, HDAC4 and CTNNBIP1, in 
human somatic stem cells and to accelerate osteogenic differentiation 
(Trompeter et al., 2013). MiR-29a was suggested to positively regulate 
osteoblast differentiation by repression of SPARC, an important protein for ECM 
assembly and deposition (Kapinas et al., 2009). Furthermore, in mammalian 
osteoblasts, the transcription of miR-29a was shown to be induced by a key 
pathway of bone formation, the Wnt signalling, and in turn, miR-29a was shown 
to repress three antagonists of Wnt, thus potentiating its signalling cascade and 
contributing for differentiation (Kapinas et al., 2010). Despite all evidences 
concerning miR-29 effect on mammalian osteogenic differentiation, 
characterization of its function and regulatory mechanisms in other organisms is 
far from being understood, which could help to elucidate the intricate and 
extensive role of this miRNA family. In this regard, teleost fish not only present 
several anatomic, physiologic and genetic similarities with mammals, but also 
present several experimental advantages, such as transparent larvae (crucial 
for developmental characterization of systems), large progeny or easy 
manipulation (transgenic preparation), which make them suitable models to 
investigate vertebrate development, including skeletogenesis (Spoorendonk et 
al., 2010). In fact, several miRNAs have been investigated in fish models, both 
in vivo and in vitro (He et al., 2011; Tiago et al., 2014) and contribute to 
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elucidate their roles in skeletal formation, demonstrating the suitability of these 
models.  
In this work, we investigated the biological effects of miR-29a 
overexpression in a fish bone-derived cell line, the ABSa15, capable of in vitro 
mineralization and suitable for miRNA studies (Marques et al., 2007; Tiago et 
al., 2014). We bring novel data regarding miR-29a effect on in vitro mineral 
deposition and osteogenic differentiation as determined by specific marker 
genes. We also provide information regarding conservation of miR-29a 
mechanisms of action and regulation in vertebrates. 
 
3.3. Materials and Methods 
 
3.3.1. Cell culture maintenance 
The ABSa15 cell line was recently deposited in the European Collection 
of Cell Cultures (Ref. 13112201). This cell line was previously developed in our 
laboratory from calcified branchial arches of the gilthead seabream (Sparus 
aurata, Linnaeus, 1758) and is capable of in vitro mineralization (Marques et al., 
2007). Also, ABSa15 cells express several genes known as markers for 
differentiation and mineralization (Tiago et al., 2014). ABSa15 cells were 
cultured in DMEM medium supplemented with 10% fetal bovine serum 
(SIGMA), 1% penicillin/streptomycin, 0,2% Fungizone and 2 mM L-Glutamine 
(all from GIBCO BRL, Gaithersburg, MD) at 33ºC in 10% CO2. Cells were sub-
cultured every 2-3 days through trypsinization.  
 
3.3.2. Extracellular matrix (ECM) mineralization  
ASBa15 cells were seeded at a density of 2 x 104 cells/ well in 24-well 
plates. ECM mineralization was induced in confluent cultures through the 
addition of L-ascorbic acid (50 μg/ml), β-glycerophosphate (10 mM) and CaCl2 
(4 mM) to the growth medium. Differentiation medium was renewed every 3-4 
days. At appropriate times, mineral deposition was revealed through von Kossa 
staining and quantified by densitometry analysis or through alizarin red S 
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staining and spectrophotometric quantification as described elsewhere 
(Pombinho et al., 2004; Stanford et al., 1995; Tiago et al., 2014). 
 
3.3.3. RNA extraction and quantitative real-time PCR (qPCR) analysis 
Total RNA was extracted from confluent cultures, at appropriate times, as 
previously described (Chomczynski and Sacchi, 1987) and quantified by UV 
spectrophotometry (NanoDrop ND-1000). Quantitative real-time PCR (qPCR) 
analysis of miRNAs and mRNAs was performed using the StepOnePlus system 
(Applied Biosystems). For qPCR analysis of miRNAs, total RNA (1 μg) was 
treated with RQ1 RNase-free DNase (Promega), then polyadenylated, reverse-
transcribed and amplified using miRNA-specific primers (Supplementary Table 
1) and the NCode miRNA First-Strand cDNA Synthesis and NCode SYBR 
miRNA qRT-PCR kits (Invitrogen), according to manufacturer’s instructions. For 
qPCR analysis of mRNAs, 1 μg of total RNA was treated with RQ1 RNase-free 
DNase, then reverse-transcribed using MMLV-RT (Invitrogen) and oligo-d(T)-
adapter primer (Sup. Table 1), according to manufacturer’s instructions. For 
analysis of miRNAs, PCR amplifications were performed using 1.6 ng of cDNA, 
gene-specific primers (Sup. Table 1) and Platinum SYBR Green qPCR 
SuperMix-UDG (Invitrogen), according to manufacturer’s instructions. For 
analysis of mRNAs, PCR amplifications were performed using 10 ng of cDNA, 
gene-specific primers (Sup. Table 1) and SsoFast EvaGreen Supermix (Bio-
Rad), according to manufacturer’s instructions. Relative mRNA and miRNA 
expression was calculated using the ΔΔCt method (Livak and Schmittgen, 
2001) and normalized using expression levels of ribosomal protein L27a 
(RPL27a) and U6 small nuclear RNA (U6), respectively.  
 
3.3.4. Establishment of stable fish cell clones overexpressing miR-29a 
For miR-29a overexpression, oligonucleotides containing forward and 
reverse sequences of zebrafish pre-miR-29a were annealed and inserted into 
pcDNA6.2-GW/EmGFP-miR vector downstream of GFP coding sequence using 
the BLOCK-iT Pol II miR RNAi Expression Vector kit (Invitrogen), according to 
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manufacturer’s instructions. Identity and integrity of inserted fragments were 
confirmed through sequencing.  
ABSa15 cells were seeded in 6-well plates at 2x105 cells/well, cultured 
for 14-16 hours and transfected with 2.4 μg of pcDNA6.2/EmGFP-miR29a 
construct and FugeneHD (Roche), according to manufacturer’s instructions. 
After 24 h, cells were sub-cultured into a 10-cm culture dish and blasticidin 
selection antibiotic was added to cell culture medium (optimal concentration of 2 
μg/ml of medium). The amount of antibiotic to be used was determined as 
described in the manual of BLOCKiT Pol II miR RNAi Expression Vector kit. 
After 30 days in selective medium (renewed twice a week), cell colonies 
expressing GFP were identified using Olympus IX-81 fluorescence microscope, 
and then sequentially sub-cultured into 48-well, 24-well, 6-well and 10-cm 
culture dishes. Positive clones were assessed for miR-29a expression by qPCR 
analysis and further characterized for ECM mineralization, as described above. 
 
3.3.5. Transient overexpression of miR-29a during ECM mineralization 
miRIDIAN microRNA mimic for dre-miR-29a (denominated MmiR-29 from 
now on) or negative control 1 (NC) (both obtained from Dharmacon) were 
delivered in triplicates to ASBa15 cells at a final concentration of 50 nM using 
EzWay (Koma Biotech) transfection reagent, according to manufacturer’s 
instructions. ASBa15 cells were seeded at a density of 2 x 104 cells/ well in 24-
well plates and transfected 16 hours later. When cells reached confluence (3 
days after), mineralization cocktail (described above) was added to medium 
(T0). A second transfection was performed after 14 days (T14), using the same 
procedure. After 28 days (T28), ECM mineralization was revealed and 
quantified through alizarin red S staining, as described above. In parallel, total 
RNA was extracted from transfected cells and further analysed by qPCR.  
 
3.3.6. Vector constructions  
For luciferase assays, the 3’- UTR of gilthead seabream SPARC (also 
known as osteonectin) transcript was inserted into XbaI site of pGL3-Control 
vector (Promega) downstream of firefly luciferase (F-Luc) coding sequence. 
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3’UTR was amplified from Marathon cDNA libraries (Clontech) using gene-
specific primers (listed in Table 1) and Klen Taq Polymerase mix (Clontech). p-
CT, p-SPARC-S and p-SPARC-AS will be used from this point forward to 
denominate the pGL3-Control vector empty or containing either the sense or 
antisense SPARC 3´UTR, respectively. 
 
3.3.7. Dual-Luciferase Reporter Assays 
ABSa15 cells were seeded in 12-well plates at 8×104 cells/well, further 
cultured for 14–16 hours and transfected with 600 ng of p-CT, p-SPARC-S or p-
SPARC-AS and 600 ng of pRL-SV40 vector (Promega) using FuGene HD 
(Roche), according to manufacturer’s instructions. After 48 hours, cells were 
lysed in appropriate buffer and luciferase activities measured using Dual-
Luciferase Reporter Assay system (Promega), according to manufacturer’s 
instructions. Relative luciferase activity was determined from the ratio F-Luc/R-
Luc. 
 
3.3.8. Western Blot analysis 
Cell extracts were prepared in lysis buffer containing Tris (50 mM), 
sodium chloride (150 mM), NP-40 (1% m/v), glycerol (10% v/v), magnesium 
chloride (10 mM), sodium orthovanadate (10mM) and protease inhibitor cocktail 
(cOmplete, Roche). After centrifugation (15,000 g, 15 min, 4ºC), pellet was 
discarded and protein content was determined in the supernatant using the 
Bradford reagent (Bio-Rad), according to manufacturer’s instructions. Proteins 
were fractioned by electrophoresis using NuPAGE Novex Bis-Tris Gels 
(Invitrogen; 4-12% acrylamide) and transferred onto PVDF 0.45 m membranes 
(Millipore) using the XCell SureLock blot module (Invitrogen). The following 
antibodies were used for identification of respective proteins: anti-human -
Catenin rabbit IgG conjugate (Santa Cruz Bio- technology; 1:500 dilution), anti-
avian b-Actin mouse IgG conjugate (Santa Cruz Bio- technology; 1:500 
dilution), anti-rabbit IgG peroxidase conjugate (Sigma–Aldrich; 1:30,000 
dilution) and anti-mouse IgG-peroxidase conjugate (Sigma–Aldrich; 1:30,000 
dilution). Protein – antibody peroxidase conjugates were detected using the 
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Western Lightning ECL kit (Perkin Elmer). Chemiluminescent signal was 
detected using Hyperfilm ECL (Amersham, GE Healthcare) and quantified by 
densitometry analysis. 
 
3.3.9. Statistical analysis  
Statistical analysis was performed with GraphPad Prism 5 (GraphPad, La 
Jolla, CA). Comparisons between two groups were made using a two-tailed 
Student’s t-test. For comparisons between multiple groups, one-way ANOVA 
followed by Newman-Keuls’s HSD post-hoc test, was used. Differences were 
considered statistically significant for p<0.05. 
 
3.4. Results 
 
3.4.1. miR-29 family conservation in vertebrates  
 The miR-29 family has three mature miRNA members, encoded in two 
clusters. MiR-29b is present in both clusters, preceding either miR-29a or miR-
29c So, miR-29b has two different precursors, miR-29b-1 and miR-29b-2, which 
produce identical mature sequences called miR-29b. Exceptionally, additional 
variants belonging to this family can be found in some species (miR-29d - 
Xenopus tropicalis, Bos taurus, Petromyzon marinus - and miR-29e - B. taurus). 
Although mature miRNAs of miR-29 family were shown to be highly conserved 
between human, mouse and rat, so far this feature was not analysed in other 
vertebrate species. Thus, in order to further characterize miR-29 family 
conservation among vertebrates, mature miR-29 sequences (available in 
miRbase database release 20; http://www.mirbase.org) were collected and 
aligned using Clustal Omega tool (http://www.ebi.ac.uk/Tools/msa/clustalo/). 
According to this analysis, miR-29a and miR-29c showed higher homology, 
being aligned together, whereas miR-29b was somewhat different due to 
specific features observed in the 3’ end regions (Supp. Fig. 3.1). It was 
concluded that miR-29 family is remarkably conserved among vertebrates and 
that the seed region (nucleotides 2-8), a feature with a key role in target 
interaction, is 100% identical for the three miRNAs in 28 analysed species. 
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Interestingly, it was noted that mammalian miR-29a is different from other 
species in one middle position. Therefore, although miR-29a is present in other 
non-mammalian taxa, its sequence is identical to mammalian miR-29c (Sup. 
Fig. 3.1). This fact raised the hypothesis that non-mammalian miR-29a could be 
an ortholog of mammalian miR-29c. To test this hypothesis, a gene synteny 
analysis of both clusters (miR-29b/a and miR-29b/c) was performed in six 
species belonging to five different taxa (mammalian, reptiles, birds, amphibian 
and teleosts) (Fig. 3.1). In humans, the gene encoding the cluster miR-29b-1/a 
is located in chromosome (Chr) 7, and syntenic genes identified upstream this 
location included potassium voltage-gated channel, Shal-related family, 
member 2 (KCND2), tetraspanin 12 (TSPAN12), inhibitor of growth family, 
member 3 (ING3), cadherin-like and PC-esterase domain containing 1 (CPED1) 
and wingless-type MMTV integration site family, member 16 (WNT16). 
Conversely, muskelin 1, intracellular mediator containing kelch motifs (MKLN1), 
plexin A4 (PLXNA4), coiled-coil-helix-coiled-coil-helix domain containing 3 
(CHCHD3), exocyst complex component 4 (EXOC4) and leucine-rich repeats 
and guanylate kinase domain containing (LRGUK) were shown to be present 
downstream this location (Fig. 3.1a). The order and orientation of this gene 
arrangement was fully preserved in zebrafish Chr 4, the chromosomic location 
of the miR-29b-2/a cluster. In chicken, xenopus and medaka, the orientation of 
this miR-29 cluster is reversed as well as some syntenic genes. All syntenic 
genes were present in Carolina anole but located downstream this cluster. Their 
orientations were preserved in comparison to human and zebrafish. All clusters 
analysed in this group included miR-29a, suggesting that miR-29a of non-
mammalian species is a true ortholog of mammalian miR-29a (Fig. 3.1a). 
Regarding miR-29b/c cluster, syntenic genes were only found downstream of 
miR-29 genomic location in human Chr 1: CTTNBP2 N-terminal like 
(CTTNBP2NL), wingless related MMTV integration site 2b (WNT2B), capping 
protein (actin filament) muscle Z-line, alpha 1 (CAPZA1), ras homolog family 
member C RHOC, solute carrier family 16 (monocarboxylate transporter), 
member 1 (SLC16A1), synaptonemal complex protein 1 (SYCP1), thyroid 
stimulating hormone, beta TSHB, nerve growth factor (beta polypeptide) (NGF),
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Figure 3.1. Gene synteny analysis in vertebrates relative to the host genes encoding (a) 
miR-29a/b and (b) miR-29c/b clusters. Representation of the genomic regions flanking 
vertebrate miR-29 clusters were obtained using data from the Ensembl project and Synteny 
database (http://syntenydb.uoregon.edu/synteny_db/). The physical localization and orientation 
of the genes present in the vicinity of human miR-29 clusters is indicated for mammalian, reptile, 
sauropsidian, amphibian and teleost fish species. Taxa are labelled as: Hsa (Homo sapiens), 
Aca (Anolis carolinensis), Gga (Gallus gallus), Xtr (Xenopus tropicalis), Ola (Oryzias latipes), 
Dre (Danio rerio). SCGL in Xenopus tropicalis and GL in Anolis carolinensis represent 
sequences that have not been allocated to a specific chromosome. Chr - chromosome.  
 
 
CD34 molecule (CD34), plexin A2 (PLXNA2) (Fig. 3.1b). Again, from all 
analysed species, only zebrafish showed a complete conservation in the order 
and orientation of syntenic genes when compared to human. In zebrafish, this 
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cluster was located in Chr 6 and contained only one miRNA, miR-29b-1. In 
chicken, miR-29b-2/c cluster is located in Chr 26 and although all ten syntenic 
genes were present downstream this location and gene order was preserved, 
gene orientation was different in half of these genes. The other three species 
analysed showed the lowest synteny conservation, being identified only 2-4 
syntenic genes (Fig. 3.1b). In general, this analysis strongly suggested that in 
non-mammalian species, miR-29a is a true ortholog of mammalian miR-29a. 
Furthermore, this analysis revealed a remarkable genomic conservation, in both 
order and orientation, between human and zebrafish chromosomes.  
 
3.4.2. Zebrafish and mouse have similar miR-29 expression patterns 
To further elucidate the putative conservation between non-mammalian 
and mammalian miR-29a, the expression patterns of this miRNA were 
investigated in zebrafish and mouse adult tissues. Thus, miR-29a expression 
was analysed by qPCR in zebrafish and mouse soft tissues, i.e. brain, heart and 
muscle, in zebrafish calcified tissues, i.e., branchial arches, vertebrae and skull, 
and in mouse calcified tissues, i.e. ear, femur, vertebrae and calvaria (Fig. 3.2). 
In zebrafish, miR-29a was detected in all analysed tissues although its 
expression was higher in brain (over 2-folds comparing to other tissues) (Fig. 
3.2a). Like in zebrafish, mouse miR-29a was also detected in all analysed 
tissues and though its levels of expression were high in the brain, the highest 
expression was found in heart (3-fold change over the brain) (Fig. 3.2b). In 
mouse, the muscle had similar levels of expression as in brain, whereas in 
calcified tissues miR-29a relative expression was considerably lower (Fig. 3.2b). 
Mouse miR-29c expression pattern resembled the one observed for miR-29a 
(Sup. Fig. 3.2), in agreement with previous results (Kapinas et al., 2009). These 
data indicate that miR-29a has a similar pattern of expression in zebrafish and 
mouse, and further confirm that, in mouse, both miR-29a and miR-29c share 
the same sites of expression.  
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Figure 3.2. Relative miR-29a expression in (a) zebrafish and (b) mouse adult tissues. 
Levels of miR-29a expression were measured by miRNA specific qPCR analysis, using total 
RNA samples of zebrafish and mouse adult tissues, and normalized using U6 small RNA and 
brain as reference sample. Values are the mean of at least 3 independent replicates. B. arches 
– Branchial arches. 
 
 
3.4.3. miR-29a is up-regulated during ECM mineralization of ABSa15 cells  
Since in mammals miR-29 was previously shown to promote osteoblast 
differentiation through a variety of mechanisms (Kapinas et al., 2009, 2010; Li et 
al., 2009b), and here it was shown that (i) miR-29 is highly conserved between 
fish and mammals, and (ii) zebrafish and mouse share similar patterns of 
expression, we asked whether miR-29 could promote similar effects in fish. To 
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address this question we used ABSa15 cells, a cell line derived from calcified 
branchial arches of the gilthead seabream, that is capable of in vitro 
mineralization (Marques et al., 2007; Tiago et al., 2014). Furthermore, this cell 
line was recently proven to be a suitable cell line to investigate miRNA effects 
on fish osteogenic differentiation and mineralization (Tiago et al., 2014). First, 
the pattern of expression of miR-29a was characterized during ABSa15 cell 
differentiation, i.e. at confluence (day 0), and after 7, 14, 21 and 28 days of 
treatment with mineralogenic medium (Fig. 3.3). According to qPCR analysis, 
the expression of mature miR-29a was strongly increased during differentiation 
of ABSA15 cells, approximately a 10-fold change comparing 0 and 7 days (Fig. 
3.3). These levels of expression were maintained high during ECM 
mineralization, which occurred between days 14 and 28 (as determined by von 
Kossa staining, data not shown). This expression pattern suggested that miR-
29a is required to support ABSa15 cell differentiation and ECM mineralization. 
 
 
Figure 3.3. Relative miR-29a expression during ABSa15 cell differentiation. Levels of miR-
29a expression were determined by qPCR analysis, using total RNA samples collected from 
differentiating ABSa15 cells and normalized using U6 small RNA expression and control time 0 
(C0) as reference. Asterisks (*) indicate values statistically different from C0 at specific time of 
differentiation. Values are the mean of at least 3 independent replicates. (Student’s t-test, p < 
0.001). 
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3.4.4. miR-29a promotes ECM mineralization in ABSa15 cells 
To study the functional activity of miR-29a during ECM mineralization, clones of 
ABSa15 cells overexpressing miR-29a were generated through stable 
transfection of pcDNA6.2-GW/EmGFP-miR-29a constructs. Although seven 
clones homogeneously expressing GFP (data not shown) were obtained, only 
one clone was confirmed to overexpress miR-29a by qPCR with a ~ 3-fold 
increase over wild type (WT) cells (Fig. 3.4a). Generation of stable cell lines 
overexpressing miR-29 was previously attempted by other authors, without 
success, and it was suggested that miR-29 could enforce a strong negative 
selection against cell growth in vitro (Chang et al., 2008; Kapinas et al., 2009). 
The obtained clone (OE-miR-29a) was then cultured in mineralogenic medium 
for 28 days and mineral deposition evaluated once a week through von Kossa 
staining. ECM mineralization was evident in WT cells after 21 days of treatment 
and, at that time, mineral deposition was significantly increased in OE-miR-29 
cells by 4-fold (Fig. 3.4b, c). By day 28, mineral deposition in WT and OE-miR-
29a cells were still significantly different, although to a lower extent (Fig. 3.4b, 
c). These findings suggested that miR-29a is either able to induce ECM 
mineralization or to accelerate differentiation of fish bone-derived cells. In order 
to further confirm this result, and since we could obtain only one stable clone 
overexpressing miR-29a, miR-29a was transiently delivered into ABSa15 cells, 
and its effects investigated during ECM mineralization. Thus, ABSa15 cells 
were transfected with either miR-29a mimic or negative control and, at 
confluence, cells were exposed to the mineralogenic cocktail for 28 days. To 
ensure the delivery and activity of miR-29a mimic during the mineralogenic 
period, expression levels of miR-29a were determined by qPCR after 28 days of 
mineralogenic treatment. Transfections with miR-29a mimic resulted in an 
average increase of mature miR-29a expression of 2.5-fold change over the 
control (Fig. 3.5a). Regarding ECM mineralization, transient overexpression of 
miR-29a promoted a significant increase of approximately 70% of mineral 
deposition over the control, as revealed by alizarin red S staining (Fig. 3.5b, c). 
This result was in agreement with the findings for OE-miR29a, i.e. significant 
increase of ECM mineralization.  
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Figure 3.4. Effect of miR-29a stable overexpression in ABSa15 cells undergoing ECM 
mineralization. (a) Relative miR-29a expression in wild-type cells (WT) and one clone 
overexpressing miR-29a (OE-miR-29); levels of miR-29a expression were determined by qPCR 
analysis using total RNA from confluent cultures and normalized using U6 small RNA 
expression and WT as reference. (b) ECM mineralization in WT cells comparing to OE-miR-29; 
mineral deposition was revealed by von Kossa staining, after 21 and 28 days of mineralogenic 
treatment. (c) Densitometry analysis of ECM mineralization in WT and OE-miR-29; WT cells at 
21 days was set as reference. All values in OE-miR-29 were statistically different from values in 
WT cells. Values are the mean of at least 3 independent replicates. (Student’s t-test, *** p < 
0.001; * p < 0.05). 
 
 
To better understand the mechanisms underlying this effect, a set of markers of 
bone cell differentiation/mineralization were assessed by qPCR analysis after 
28 days of mineralogenic treatment in cells transfected with miR-29a mimic and 
control. Among analysed genes (bone morphogenetic protein 2, bmp2; -
catenin, ctnnb1; collagen type I alpha 1, col1a1; matrix Gla protein, mgp; 
osteocalcin 1 and 2, oc1 and oc2; secreted phosphoprotein 1, spp1, or also 
known as osteopontin, opn; runt related transcription factor 2, runx2, and tissue 
non-specific alkaline phosphatase from liver/bone/kidney, tnap, only the levels 
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Figure 3.5. Effect of 
transient miR-29a 
overexpression in 
Absa15 cells 
undergoing ECM 
mineralization. Mimic 
of miR-29a (MmiR-29) 
or a negative control 
(NC) were transfected 
into ABSa15 cells and 
ECM mineralization 
was induced 3 days 
later (T0). After 28 
days of treatment 
(T28), (a) expression of 
miR-29a, (b) ECM 
mineralization revealed 
by alizarin red S 
staining and (c) 
respective 
quantification of 
staining in both NC and 
MmiR-29 were 
assessed. Levels of 
miR-29a expression 
were determined by 
qPCR analysis using 
total RNA from T28 
and normalized using 
U6 small RNA 
expression and NC as reference. (d) Relative expression of marker genes for ABSa15 cell differentiation/mineralization in MmiR-29 and NC after 28 
days of mineralogenic treatment (T28): alkaline phosphatase (tnap), collagen, type I, alpha 1 (col1a1), matrix Gla protein (mgp), osteocalcin 2 (oc2), 
bone morphogenic protein 2 (bmp2) and osteopontin (op). Levels of gene expression were determined by qPCR analysis using total RNA samples from 
NC and MmiR-29 at T28, and normalized with RPL27a housekeeping gene expression (similar expression data was collected using 18S housekeeping 
gene; data not shown) and NC as reference. Asterisks indicate values statistically different from NC. Values are the mean of at least 3 independent 
replicates. (Student’s t-test, *** p < 0.001; ** p < 0.01, * p < 0.05). 
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of expression of col1a1, mgp, bmp2, tnap, oc2 and opn were shown to be 
significantly altered, being up-regulated (Fig. 3.5d). These data provided 
additional evidences for miR-29a stimulation of ABSa15 cells ECM 
mineralization and differentiation.  
 
3.4.5. Seabream sparc is putatively regulated by miR-29a in ABSa15 cells  
The miR-29 family was found to promote osteogenic differentiation by 
targeting inhibitors of osteoblastic differentiation, inhibitors of the canonical Wnt 
signalling and bone matrix RNAs (Kapinas et al., 2009; Li et al., 2009b; 
Sengupta et al., 2008). In this regard, SPARC, the most abundant non-collagen 
ECM protein in bone, is a known target of miR-29 during mammalian osteoblast 
differentiation (Kapinas et al., 2009). In order to investigate whether sparc is 
also a target of miR-29 in fish, thus contributing for the phenotype observed in 
miR-29 gain-of-function experiments in ABSa15 cells during ECM 
mineralization, we first verified the evolutionary conservation of the binding sites 
described by Kapinas and colleagues (Kapinas et al., 2009) using 
TargetScanMouse Release 6.2 (http://www.targetscan.org/mmu_61/). The two 
binding sites for miR-29 were highly conserved in twenty mammalian species, 
one reptile, one bird and one amphibian present in the database (data not 
shown). Since this database did not contain any sparc transcripts of fish origin, 
to overcome this issue, GenBanK sequence database 
(http://www.ncbi.nlm.nih.gov/) was searched for vertebrate SPARC transcripts. 
This search allowed the identification of SPARC sequences from seven fish, 
two amphibian and four bird species that were used to expand our analysis. The 
3´UTR region of each collected transcript was then searched for miR-29 binding 
sites using PITA algorithm (http://genie.weizmann.ac.il/pubs/mir07/index.html) 
and RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/). The two 
binding sites for miR-29a predicted by both algorithms are represented in Fig. 
3.6 (a and b), where 3’ UTRs of all analysed species were aligned along with six 
mammalian species using Clustal Omega tool 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). According to this analysis, the two 
previously identified binding sites for miR-29 appeared to have been highly
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Figure 3.6. Prediction of miR-29a binding sites (BS) in the 3’UTR of gilthead seabream SPARC and respective functional characterization in 
ABSa15 cells. (a) Alignment of 3‘UTR region of mammalian (M), sauropsids (S), amphibian (A) and fish (F) SPARC transcripts showing two 
consecutive and conserved miR-29 seed regions (gray box); BS of miR-29 were predicted using TargetScanHuman Release 6.2 and RNAhybrid 
algorithms; asterisks (*) indicate 100% conserved nucleotide positions; gilthead seabream sequence is in bold. (b) Schematic representation of 
consensus SPARC transcript and positions of both BS for miR-29 family. (c) Specific site within 3’UTR of gilthead seabream SPARC transcript where 
dre-miR-29a is predicted to bind, as determined by RNAhybrid. (d) Relative luciferase activities in ABSa15 cells transfected with constructs containing 
sense (p-SPARC-S) and antisense (p-SPARC-AS) sequences of 3’UTR of gilthead seabream SPARC transcript, and respective control vector (p-CT). 
Luciferase activity was calculated as the ratio of firefly and renilla luciferase activities. Asterisks indicate values statistically different from respective 
3’UTR value. Values are the mean of at least 3 independent replicates. (one-way ANOVA, ** p < 0.01, * p < 0.05).  
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conserved throughout evolution and were clustered in the proximal SPARC 
3´UTR. In seabream, the specie from which ABSa15 cells were obtained, each 
sparc binding site contained 7 nucleotides pairing to the seed of miR-29, 
corresponding to minimal free energies of -19.5 and -17.2 kcal/mol (Fig. 3.6c), 
as predicted by RNAhybrid algorithm. In order to investigate whether seabream 
sparc could be regulated by miR-29, a reporter vector containing the seabream 
sparc 3´UTR region downstream of luciferase gene was transfected into 
ABSa15 cells, which endogenously express miR-29a. Controls included 
transfection of the reporter vector alone and a construct where sparc 3´UTR 
was in the antisense orientation downstream of luciferase gene (Fig. 3.6d). The 
relative luciferase activity of sparc 3´UTR construct was significantly reduced by 
more than 70% over the vector alone and by approximately 60% over the 
construct with the sparc 3´UTR antisense (Fig. 3.6d). Differences between the 
relative luciferase activity of the vector alone and the construct containing the 
antisense strand of sparc were not statistically significant. Although other 
miRNAs could be targeting sparc in ABSa15 cells, the conservation and 
clustering of putative miR-29 binding sites, and its relatively high expression in 
this cell line, indicate that miR-29 is a strong candidate to post-transcriptionally 
regulate seabream sparc in this system. Furthermore, this regulation could 
account for the observed phenotype upon miR-29 overexpression. 
 
3.4.6. -catenin protein levels are up-regulated in ABSa15 cells 
overexpressing miR-29 
In mammals, miR-29 modulates canonical Wnt signalling through a 
positive feedback loop and, consequently, contributes to osteoblast 
differentiation (Kapinas et al., 2010). In this regulatory circuit, canonical Wnt 
signalling induces miR-29 transcription, which in turn potentiates this pathway 
by down-regulating three antagonists: Dkk1, Kemen2 and sFRP2 (Kapinas et 
al., 2010). Since in ABSa15 cells miR-29a was able to induce ECM 
mineralization and/or accelerate cell differentiation, we hypothesized that 
canonical Wnt signalling could also be potentiated by miR-29a thus contributing 
to promote ABSa15 cell differentiation towards mineralization. To test this 
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theory, -catenin protein levels were assessed in the OE-miR-29a ABSa15 
clone and compared to those in WT cells. Indeed, western-blot data showed 
that -catenin protein levels were significantly up-regulated by approximately 
40% in cells overexpressing miR-29a, demonstrating that canonical Wnt 
signalling is stimulated in this condition (Fig. 3.7). This result suggests that the 
positive feedback loop Wnt signalling/miR-29a was conserved throughout 
evolution. Furthermore, as in mammalian models, this mechanism is also likely 
to participate in osteogenic differentiation in fish. 
 
 
 
Figure 3.7. Levels of -catenin protein production in wild type ABSa15 cells (WT) and 
stable clone overexpressing miR-29a (OE-miR-29). Production of -catenin protein was 
determined in confluent cultures by densitometry analysis of western-blot signals (a) and 
normalized using -actin signals (b). Asterisk (*) indicates value statistically different from WT. 
Values are the mean of at least 3 independent replicates. (Student’s t-test, p < 0.05). 
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3.5. Discussion 
MiRNAs have recently been implicated in skeletogenesis, through 
regulation of different molecules and pathways. Here, we analysed the effect of 
miR-29a overexpression in a skeletal derived-fish cell line and provided further 
insights into the conservation of miR-29 family across vertebrates, as well as in 
the conservation of miR-29 mechanism of action. 
 
3.5.1. miR-29 is a generally conserved family of miRNAs 
According to our analysis, sequence homology of each miR-29 family 
member was highly conserved among vertebrates, with higher similarity 
between miR-29a and miR-29c than miR-29b, in all species analysed. In fact, 
the 3’-end nucleotides of miR-29b, distinct from miR-29a and miR-29c, seem to 
be required for nuclear localization, where miR-29b was previously found to be 
enriched (Hwang et al., 2007; Liao et al., 2010). Conservation of miR-29b 3´-
end across species suggests that this sub-cellular distribution might be 
evolutionary maintained. In mammals, miR-29a and miR-29c differ in one 
central nucleotide and, interestingly, both miR-29a and miR-29c of non-
mammalian species are identical to miR-29c of mammals. This could indicate 
that miR-29a is specific of mammals. Strikingly, synteny analysis suggested that 
miR-29a of non-mammalian species is a true ortholog of mammalian miR-29a. 
These data raised the hypothesis that a mutation in mammalian miR-29a might 
have occurred, possibly after a gene duplication event, leading to the origin of a 
new miR-29 in mammals. Although this theory needs to be confirmed, gene 
duplication events succeeded by functional change/acquisition are considered a 
main source for emergence of novel miRNA genes (Berezikov, 2011).  
Despite small differences in sequence, all members of miR-29 family 
shared a common seed region, suggesting a functional redundancy. 
Importantly, this seed region, which determines target binding and regulation, is 
preserved throughout evolution further suggesting a conservation of targets, 
and functions across species. In order to explore this putative conservation in 
vertebrates, the expression patterns of miR-29a were investigated in zebrafish 
and mouse. In both species, miR-29a levels of expression were higher in soft 
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tissues, but still present in calcified tissues, which corroborated previous results 
and showed that miRNAs belonging to the miR-29 family were expressed in 
several cell types and tissues, including muscle, heart, brain, lung and bone 
cells (Cushing et al., 2011; Kapinas et al., 2009; Ouyang et al., 2013; Rossi et 
al., 2013; Winbanks et al., 2011; Zhang et al., 2014). 
 
3.5.2. miR-29a promotes ECM mineralization 
In order to investigate the putative osteogenic role of miR-29 family in 
non-mammalian species, we have used a fish cell line (ABSa15) capable of in 
vitro mineralization. First we have analysed miR-29a expression during cell 
differentiation, mainly in the first 2 weeks of mineralogenic treatment, and 
throughout mineralization, from the second to the fourth week, as described 
previously (Tiago et al., 2014). MiR-29a strong up-regulation during cell 
differentiation and its maintenance during ECM mineralization suggested an 
important function in both processes. Not only this was in agreement with 
previous studies showing similar patterns of expression for miR-29a,c in 
mammalian osteoblasts (Kapinas et al., 2009, 2010; Li et al., 2009b), but also 
revealed a conservation of the regulatory mechanisms of this miRNA family. In 
order to further elucidate the role of miR-29a in ABSa15 cells, a stable clone 
overexpressing miR-29a was prepared. Obtaining this system, i.e. stable miR-
29a overexpression, proved to be a challenge, not only in this study but also in 
previous reports (Chang et al., 2008; Kapinas et al., 2009). This difficulty could 
be associated to a probable inhibition of cell proliferation through direct 
repression of several cell growth regulators (Li et al., 2011b; Park et al., 2009; 
Zhao et al., 2010). Nevertheless, we were able to maintain this clone and treat 
with mineralogenic cocktail. Strikingly, after 3 weeks of treatment, we could 
already observe up to 4-folds induction in mineral deposition comparing with 
WT cells. One week later, ECM mineralization was still higher than WT cells, 
but this difference was attenuated, probably reflecting an end-stage of this 
process. These data suggested that miR-29a accelerates ABSa15 cell 
differentiation leading to premature mineral deposition. Although this was the 
first time that miR-29a was shown to directly influence ECM mineralization in a 
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bone-derived system, it lacked confirmation from either alternative clones or 
alternative methods for miRNA overexpression. Therefore, a transient 
overexpression of miR-29a was performed using miRIDIAN microRNA mimics, 
which resulted also in significant increase of mineral deposition relative to the 
negative control. This result confirmed that miR-29a induces ECM 
mineralization in ABSa15 cells, possibly by stimulating cell differentiation. 
Previous works in human and mouse in vitro models reported that transient 
transfections of miR-29b accelerated osteogenic differentiation (Li et al., 2009b; 
Trompeter et al., 2013), but data regarding overexpression of miR-29a is still 
missing in mammalian models. Here, not only we have show that miR-29a is 
also capable to induce osteogenesis, but also we show that exogenous 
expression of this miRNA promote differentiation as inferred by increased levels 
of osteogenic markers such as bmp2, opn, tnap and oc2. Elevated expression 
of these markers is consistent with the observed phenotype of ABSa15 cells, 
since they are well characterized osteogenic markers in mammalian systems 
(Ducy et al., 1996; Kaartinen et al., 1997; Murshed et al., 2005; Oliveira et al., 
2003). Within teleosts, two different isoforms of osteocalcin have been 
described (Oc1 and Oc2) (Laizé et al., 2006) and, although both isoforms are 
able to bind calcium mineral phase of teleost bone (Cavaco et al., 2013), 
differences in their expression patterns suggested association of Oc1 to early 
mineralization events and Oc2 to mature osteoblast activity and bone formation 
(Bensimon-brito et al., 2012), further supporting our result on oc2 up-regulation. 
Furthermore, BMP pathway is known to favour osteoblast differentiation and 
ECM mineralization thus partially explaining our results (Chen et al., 2012; 
Rafael et al., 2006; Tiago et al., 2014). Interestingly, although COL1A1 is 
considered to be a miR-29 target in mammalian systems (Li et al., 2009b), it 
was here shown to be also up-regulated in miR-29a overexpressing cells. 
However, a complementary sequence to miR-29 seed region was not found in 
the seabream col1a1 3´UTR and so it was not predicted here as a miR-29a 
target in ABSa15 cells (confirmed by searching in PITA and RNAhybrid 
prediction algorithms; data not shown). This information sets an important 
difference between fish and mammals. Another remarkable effect was the up-
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regulation of mgp expression, which was also likely to be indirect. This protein is 
an inhibitor of soft-tissue calcification in mammals (Luo et al., 1997) and its 
expression in soft tissues from teleost fish suggested a conservation of that 
function (Gavaia et al., 2006; Pinto et al., 2003; Roberto et al., 2009). MGP is 
generally associated with the organic matrix of cartilage and bone in vivo in both 
mammals and fish (Hale et al., 1988; Price et al., 1983; Roberto et al., 2009). In 
ABSa15 cells, as well as in other fish bone-derived cells (Pombinho et al., 
2004), MGP is also a marker for ECM mineralization (Tiago et al., 2014), and 
therefore its increase in cells overexpressing miR-29a is in agreement with the 
associated phenotype.  
 
3.5.3. As in mammals, miR-29a is also capable to regulate SPARC and Wnt 
signalling in fish bone-derived cells  
To further dissect the possible mechanisms of miR-29a action in ABSa15 
differentiation/ECM mineralization, we briefly surveyed a possible effect on 
SPARC, a known target of miR-29 in mammalian osteoblast differentiation 
(Kapinas et al., 2009). SPARC has a key role in ECM assembly and deposition 
due to its binding to a number of different ECM components (Bradshaw, 2009). 
Controlled expression of this protein seems to be essential for normal 
osteoblastic differentiation and skeletogenesis in mammals (Delany and 
Hankenson, 2009; Delany et al., 2003; Mansergh et al., 2008) and fish (Estêvão 
et al., 2005, 2011; Laizé et al., 2005). In that sense, SPARC was shown to 
display several conserved features throughout evolution, mainly related to its 
protein structure, function and regulation (Laizé et al., 2005). Here, we bring 
data suggesting that SPARC post-transcriptional regulation should be 
conserved in fish. The two binding sites for miR-29 located in the proximal 
region of SPARC 3´UTR, previously described in mouse (Kapinas et al., 2009), 
were found to be strongly conserved among vertebrates, suggesting a 
functional regulation preserved during evolution. In seabream, luciferase 
functional assays further indicate that SPARC is also regulated in ABSa15 cells, 
most probably by miR-29a, which we show that is endogenously expressed in 
these cells. To support the idea that SPARC is a target of miR-29a in ABSa15 
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cells, we attempted to explore differences of SPARC protein levels when miR-
29a was increased, and although our preliminary results point to a decrease of 
SPARC in OE-miR-29a cells, antibodies available at the moment were unable 
to provide a clear signal in fish cells (data not shown). Nevertheless, data 
regarding miR-29 indicates that the function of each member of this family might 
have some degree of redundancy and that it also regulates several different 
collagens and inhibitors of osteoblast differentiation (Li et al., 2009b; Liu et al., 
2010; Sengupta et al., 2008), evidencing that miR-29 exerts a fine tuned 
regulation of this process by the control of several targets. Interestingly, miR-29 
was shown to regulate and to be regulated by molecules of the most important 
signalling pathways in osteoblast differentiation, including bone morphogenetic 
proteins (BMPs) and transforming growth factor (TGF)-β (Luna et al., 2011; Qin 
et al., 2011), Hedgehog (Mott et al., 2010), insulin-like growth factor-1 (Smith et 
al., 2013) and Wnt (Kapinas et al., 2010). Particularly, Wnt/-catenin (canonical) 
pathway, which is a major player in several steps of bone formation, essential 
for commitment of osteo-precursors, positive regulation of osteoblast 
proliferation, maturation and mineralization, but also important for regulation of 
osteoclast differentiation and activity (reviewed in Bodine, 2007; Hartmann, 
2006), was shown not only to induce transcription of miR-29a, but also to be 
positively regulated by this miRNA. Indeed, miR-29a was proven to directly 
repress three antagonists of Wnt signalling, Dkk1, Kemen2 and sFRP2, in 
osteoblasts, thus contributing for the enhancement of this pathway and 
promoting osteoblastic differentiation (Kapinas et al., 2010). Here, we have 
shown that -catenin, the only non-redundant and obligatory component of the 
canonical Wnt signalling, was significantly up-regulated in the ABSa15 cell 
clone overexpressing miR-29a, evidencing a stimulation of Wnt signalling. This 
result prompted us to hypothesize that miR-29a might be repressing Dkk1, 
Kemen2 and sFRP2 in ABSa15 cells, as described in mammals, thus 
increasing the binding of Wnt ligand to its receptors, inhibiting -catenin 
phosphorilation by GSK-3, thus increasing -catenin levels in the cells, as we 
demonstrate here. This increase most likely up-regulates expression of 
downstream targets important for cell differentiation towards osteoblastogenesis 
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in ABSa15 cells ultimately contributing for an accelerated differentiation and 
premature/augmented mineralization (Fig. 3.8). Finally, the increased levels of 
-catenin in fish cells overexpressing miR-29a, suggested that regulation of 
canonical Wnt signalling by miR-29a in bone is a conserved mechanism in 
vertebrates. 
 
 
Figure 3.8. Proposed mechanism for miR-29a action on osteogenic differentiation by 
stimulation of canonical Wnt signalling. In the presence of miR-29a, a putative inhibition of 
DKK1, SFRP2 and Kremen allows the binding of Wnt ligand to its receptors (Frizzled and 
LRP5/6) and consequent inhibition of GSK3b/Axin/APC complex and -catenin proteosomal 
degradation. -catenin is stabilized and translocated/accumulated in the nucleus, thus activating 
TCF/LEF-mediated transcription of target genes such as connexin43, Col1A1, OC, OPG, 
Runx2, giving rise to augmented differentiation and mineralization capacity.
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3.6. Conclusions 
Our findings show that increased expression of miR-29a in fish bone-
derived cells promotes ECM mineralization, probably by inducing cell 
differentiation, as reflected by stimulated canonical Wnt signalling and elevated 
expression of osteogenic marker genes, such as tnap and oc2. Conservation of 
miR-29 family sequence and organization, expression patterns and target 
genes further evidence a conserved function for this miRNA throughout 
evolution. In that sense, models other than the mammalian could help to unveil 
miR-29 function in bone formation as well as miR-29 function in the crosstalk 
between osteoblasts and osteoclasts since two recent studies demonstrated 
that miR-29 might also have a function in bone homeostasis (Franceschetti et 
al., 2013; Rossi et al., 2013). Considering these and other studies, an in vivo 
model to study miR-29 function in skeletogenesis would certainly elucidate the 
intricate network of genes, pathways and processes that this miRNA regulates. 
For this purpose, given the conservation of miR-29 regulatory action between 
mammals and fish, here demonstrated, and its advantages as a model 
organism, zebrafish seems to be a suitable model to further unveil miR-29 role 
in skeletogenesis.  
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3.7. Supplementary Material 
 
Supplementary Table 3.1. List of primers and oligoduplexes used in this study.
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Supplementary Figure 3.1. 
Sequence alignment of mature 
miRNAs from miR-29 family. 
Sequences from mammalian, 
reptiles, birds, amphibian and 
teleost fish of (a) miR-29a/c and (b) 
miR-29b, were aligned using 
Clustal Omega. Consensus 
nucleotides to all species analysed 
are highlighted in dark grey. A 
distinct nucleotide in mammalian 
miR-29a/c is highlighted in white 
(C) for mammalian miR-29a and in 
soft grey (U) for mammalian miR-
29c and miR-29a from sauropsids 
and teleosts. The consensus seed 
sequence of miR-29 family is in 
bold at the bottom the alignments.  
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Supplementary Figure 3.2. Relative miR-29c expression in mouse adult tissues. Levels of 
miR-29c expression were measured by miRNA specific qPCR analysis, using total RNA 
samples of mouse adult tissues, and normalized using U6 small RNA and brain as reference 
sample. Values are the mean of at least 3 independent replicates. 
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4.1. Abstract 
Skeletogenesis is a complex process under the control of several key 
transcriptional factors, hormones and signalling pathways. The regulation of this 
process has been greatly investigated but its post-transcriptional regulation 
remains generally unknown. Although microRNAs were recently shown to be 
important regulators of skeletogenesis, so far only few of these players have 
been identified and most of their targets remain unknown. Recently, miR-214 
was shown to play a role in skeletal development through inhibition of 
osteogenesis in mammals, but data regarding other vertebrates is still scarce. A 
possible role in chondrogenesis remains to be demonstrated. Here, we have 
investigated miR-214 expression in zebrafish development and identified a 
possible association with skeletal formation. High expression of miR-214 in 
zebrafish calcified structures confirmed this hypothesis. Additionally, we showed 
that both human and zebrafish promoters of miR-199a-2/214 cluster are active 
and similarly regulated in chondrocyte cells. More importantly, overexpression 
of miR-214 in ATDC5 cells mitigated chondrocyte differentiation probably by 
targeting activating transcription factor 4 (Atf4). The key skeletal markers Matrix 
Gla Protein (Mgp) and osteocalcin (Oc) were simultaneously decreased upon 
miR-214 overexpression in ATDC5 cells, suggesting that mineralization, the late 
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stage of chondrocyte differentiation, might be compromised. We propose that 
miR-214 exerts a key role in skeletal development not only by inhibition of 
osteogenesis but also by affecting chondrogenesis, regulating and promoting a 
concerted action of important molecules for bone and cartilage formation.  
 
4.2. Introduction 
Skeletogenesis, essential in vertebrate development, is a complex 
process under the control of several key transcriptional factors, hormones and 
signalling pathways (Goldring et al., 2006; Karsenty, 2008; Véronique and 
Bhattaram, 2010). Although in the last two decades advancements in molecular 
and genetic research have uncovered diverse regulatory processes of skeleton 
formation, many still remain to be identified. In this context, a recently identified 
class of molecules belonging to the family of small non-coding RNAs, the 
microRNAs (miRNAs), have emerged as important regulators of various 
developmental, physiological and pathological processes, including the strict 
control of skeleton formation (Hong et al., 2012; Zhao et al., 2013). At the 
cellular level, miRNAs repress protein expression either by translation inhibition 
or by promoting messenger RNA (mRNA) degradation, both processes 
involving complementary binding to the 3´ untranslated region (UTR) of mRNA, 
mediated by the RNA-induced silencing complex (RISC). Because of this 
sophisticated manner of regulation, one miRNA can regulate hundreds of 
transcripts, whereas one mRNA can have several binding sites for distinct 
miRNAs. In fact, miRNAs are thought to control numerous gene regulatory 
networks concurrently. Moreover, as the majority of genes, miRNAs are 
themselves transcribed (in most cases) by RNA Polymerase II (Pol II) and 
therefore regulated at the transcriptional level by factors involved in multiple 
processes (Corcoran et al., 2009; Lee et al., 2004; Ozsolak et al., 2008). 
Sometimes this process involves feedback loops that further increase miRNA 
regulatory complexity.  
Regarding skeletogenesis, miRNAs are known to participate in the major 
steps of bone formation either by regulating proliferation, differentiation or 
functional activity of cells that constitute the skeleton [9]. In this context, while 
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more then twenty miRNAs were identified as inhibitors or promoters of 
osteogenesis, only few were shown to regulate osteoclast differentiation and 
chondrogenesis (Lian et al., 2012). Recently, a particular miRNA previously 
associated to carcinogenesis, tumour progression and metastasis (Li et al., 
2012; Poos et al., 2013; Yang et al., 2008), the miR-214, was shown to inhibit 
bone formation and it was suggested as a possible target in the treatment of 
osteoporosis (Wang et al., 2013a) since a negative correlation was observed 
between miR-214 levels and degree of bone formation in elder patients with 
fractures. In that study, osteoblast-specific manipulation of miR-214 levels in 
different mouse models revealed that miR-214 inhibitory effect was probably 
mediated by targeting of Atf4, a transcription factor (TF) crucial for osteoblast 
differentiation and function (Wang et al., 2013a). Curiously, miR-214 was for the 
first time implicated in skeleton formation when Dnm3os, the gene encoding this 
miRNA, was knocked-out in mice thus promoting severe skeletal defects 
(Watanabe et al., 2008). This transcript was then known to encode a cluster of 
three miRNAs, miR-214, miR-199a-2 and miR-199* (and now also including 
miR-214*) which are processed from two precursor stem loops, pre-miR-214 
and pre-miR-199a-2 (Desvignes et al., 2014). Although all miRNAs of these 
cluster were then thought to contribute for the defective skeletal phenotype 
observed in that mouse model, only now the function of miR-214 was clearly 
associated to bone formation (Wang et al., 2013a). Furthermore, Lee and co-
workers demonstrated that the TF Twist1 drives the expression of Dnm3os 
during mouse development (Lee and Yutzey, 2011) but, even though Twist1 
plays an important role in skeleton formation of mammals and fish (Danciu et 
al., 2012; Reinhold et al., 2006; Yang et al., 2011b), the transcriptional 
regulation of Dnm3os has not been investigated in that process. Despite the 
known involvement of miR-214 in skeletal formation, data about its role in 
chondrogenesis is missing, although this miRNA was shown to be differentially 
regulated during mesenchymal stromal cells (MSCs) chondrogenic 
differentiation (Sorrentino et al., 2008). Therefore, understanding its 
involvement in chondrogenesis would contribute to further characterize the role 
of miR-214 in skeletogenesis. In that regard, we investigated the expression of 
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miR-214 in zebrafish development, from embryo to adulthood. We further 
explored miR-214 transcriptional regulation by studying the promoter of its 
primary transcript, Dnm3os, in human and zebrafish for the presence of 
conserved binding sites for TFs that are putatively involved in osteogenesis 
and/or chondrogenesis. More importantly, we studied the effects of miR-214 
overexpression in mouse chondrocytic ATDC5 cell line unveiling, for the first 
time, a putative role for miR-214 in chondrocyte differentiation, in vitro. So, we 
propose that miR-214 exerts a key role in skeletogenesis not only by inhibiting 
osteogenesis but also by affecting chondrogenesis, regulating and promoting a 
concerted action of essential molecules for bone and cartilage formation. 
 
4.3. Materials and Methods 
 
4.3.1. Analysis of miRNAs expression  
Zebrafish eggs were obtained from natural spawning of wild-type 
breeding fish and larvae were maintained and raised by standard methods 
(Westerfield, 2000). Following the Chomczynski and Sacchi method 
(Chomczynski and Sacchi, 1987) total RNA was extracted from a pool of up to 
twenty zebrafish larvae and juvenile at 1 k-cell (approximately 3 hours post 
fertilization, hpf), 18 somites (approximately 16 hpf), 24, 36 hpf, 2, 4, 6, 15, 30, 
45, 60 and 81 days post fertilization (dpf), and from adult male and female. RNA 
was also isolated from different adult tissues of zebrafish specimens (muscle, 
branchial arches, skull and vertebra) and mice specimens (muscle, ear, femur, 
calvaria and vertebra). Total RNA quantity and quality were assessed by UV 
spectrophotometry (NanoDrop ND-1000) and agarose gel electrophoresis, 
respectively. For quantitative real-time PCR (qPCR) analysis of miRNAs 
expression, total RNA (1 μg) was polyadenylated, reverse-transcribed and 
amplified using miRNA-specific primers (Supplementary Table 1) using the 
NCode miRNA First-Strand cDNA Synthesis and NCode SYBR miRNA qPCR 
kits (Invitrogen), according to manufacturer’s instructions. QPCR analysis was 
performed using the StepOnePlus system (Applied Biosystems) and relative 
expression of miRNAs was calculated using the ΔΔCt method (Livak and 
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Schmittgen, 2001) and normalized using expression levels of U6 small nuclear 
RNA (U6).  
 
4.3.2. In Situ Hybridization (ISH) 
Zebrafish specimens of 10, 20 and 90 dpf were euthanized with a lethal 
dose of MS222 (Sigma) and fixed for 24 hours (h) in 4% paraformaldehyde 
(PFA) at 4 ºC. Specimens were further decalcified in a 10% 
ethylenediaminetetraacetic acid (EDTA)/2% PFA solution for a minimum of 2 
weeks and up to 2 months depending on their size. Samples were then washed 
in phosphate buffered saline (PBS) and maintained in 100% methanol at -20ºC 
until processing. For ISH, specimens were embedded in paraffin and sectioned 
(4-6 m thick). Detection of dre-miR-214 was performed using an ISH protocol 
adapted from the method described by Kloosterman et al. (Kloosterman et al., 
2006) using LNA (Locked Nucleic Acid)-modified oligonucleotide 5’-Digoxigenin 
(DIG) labelled probe. Briefly, sections were fixed in 4% PFA and treated with 
10, 20 or 40 g/ml of proteinase K for zebrafish specimens with 10, 20 and 90 
dpf, respectively. After 2h in pre-hybridization solution (50% formamide, 5x 
saline sodium citrate buffer (SSC), 500 g tRNA, 50 g Heparin, 0.1%Tween 
and 9.2 mM of citric acid), sections were incubated with 40 nM of LNA ISH 
probe (Exiqon) specific for detection of dre-miR-214 (Supp. Table 1). For 
negative control, sections were hybridized with a scramble probe (Supp. Table 
1). After 16 h incubation in a humidified chamber (5x SSC) at 55ºC, sections 
were washed with decreasing concentrations of formamide/SSC, then with 
PBST (PBS with 0.1% Tween-20) and incubated again for 1 h with blocking 
buffer (2% blocking solution from Roche diluted in Maleic Acid, 2% (v/v) sheep 
serum and 2% (m/v) bovine serum albumin (BSA)). Then, anti-DIG antibody 
conjugated with alkaline phosphatase (Roche, diluted 1:1600) was added to 
each section and incubated for 16h at 4ºC. Each section was washed 5 times 
with PBST, 3 times with AP buffer (100 mMTris, 100 mM NaCl, 50 mM MgCl2, 
pH 9.5) and incubated with 75 vmg/mL NBT/50 vmg/mL BCIP in AP buffer for 
signal detection. Sections were air-dried, mounted with Eukitt (Sigma) and 
imaged by microscopy (Olympus IX-81 inverted microscope).  
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4.3.3. Identification and analysis of miR-214 promoter sequences 
Since miR-214 is encoded in the Dnm3os gene, its putative promoter 
should correspond to the region immediately upstream the transcriptional start 
site (TSS) of Dnm3os. Although, Dnm3os TSS was an uncertainty for most 
species here analysed. Because of that, we used the known precursor 
sequence of miR-199a-2 (pre-miR-199a-2) as reference since it is in close 
proximity to the TSS of Dnm3os. So, pre-miR-199a-2 sequences were retrieved 
from miRbase database for: Homo sapiens (human), Mus musculus (mouse), 
Xenopus tropicalis (frog), Takifugu rubripes (fugu), Oryzia latipes (medaka), 
Gasterosteus aculeatus (stickleback), Tetraodon nigroviridis (pufferfish) and 
Danio rerio (zebrafish). Then, each pre-miR-199a-2 was blasted against the 
genome of each species using BLAST tool at Ensembl genome browser 
(www.ensembl.org) and genomic sequences with 2.5 kilobase (Kb) were 
collected, starting immediately upstream of pre-miR-199a-2, for further analysis. 
Then, a multiple sequence alignment of Dnm3os promoter was performed using 
CHAOS/DIALIGN (http://dialign.gobics.de/chaos-dialign-submission) and fed to 
ConTra v2 (http://www.dmbr.ugent.be/prx/bioit2-public/contrav2/) for search of 
putative conserved TF binding sites (TFBSs). Stringency parameters were set 
to: core match=0.95 and similarity matrix=0.85. Additionally, presence of 
conserved TFBSs in corresponding human, mouse and zebrafish sequences 
was also confirmed using MatInspector (Genomatix Software GmbH, Germany). 
The Genome Browser at UCSC (http://genome.ucsc.edu/) was used for 
identification of TFs previously validated through Chromatin 
Immunoprecipitation (ChIP assay).  
 
4.3.4. Cloning of zebrafish miR-214 5´ end  
The 5’ end of zebrafish miR-214 was achieved by rapid amplification of 
cDNA ends (RACE) using Advantage cDNA polymerase mix (Clontech) 
according to manufacturer’s conditions, and using a zebrafish Marathon cDNA 
library as template, previously prepared in our laboratory according to 
manufacture’s instructions (Clontech). Specific reverse primers (Dre Cluster 
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Rev1 and 2 listed in Supp. Table 1) were designed into the dre-pre-miR-199a-2 
sequence available in miRbase (http://www.mirbase.org/) and combined with 
universal adapter primers (AP1 and AP2 universal primers; Supp. Table 1). 
Amplified PCR products were subsequently inserted into pCRII-TOPO 
(Invitrogen) and further analysed by standard DNA sequencing. 
 
4.3.5. Plasmid Constructs 
A 2.3 kb fragment and a 2.4 kb fragment of the zebrafish and the human 
Dnm3os promoter were amplified using specific primers (Dre PR Fw and Dre 
PR Rev, Has PR Fw and Has PR Rev, listed in Supp. Table 1) and genomic 
DNA as template. These PCR products were then cloned into the pCRII-TOPO 
vector (Invitrogen), confirmed by DNA sequencing, and further used as 
templates to amplify new cDNA fragments containing specific deletions of the 
promoter of each species. Forward and reverse primers used to amplify these 
fragments contained 5’ ends with NheI and BglII restriction site sequences, 
respectively, which were used for cloning into pGL3-Basic luciferase reporter 
gene vector (Promega). Constructs generated in pGL3-basic were as follow: 
full, partial and TATA less zebrafish promoters (-1926bp/+244bp, 657bp/+244bp 
and -1926bp/-140bp, respectively) and full, partial and TATA less human 
promoters (-2299bp/+190bp, -641bp/+190bp and -2299bp/-30bp, respectively).  
The pCMX-ETS1 and pCMX-TWIST1 constructs were obtained by 
cloning cDNA fragments of zebrafish open reading frame (ORF) of v-ets avian 
erythroblastosis virus E26 oncogene homolog 1 (ets1) (nucleotides 129-1427, 
GenBank accession KF774190) and twist1a (nucleotides 114-629, GenBank 
accession NM_130984.2), from 48 hpf larvae and 69 dpf juveniles respectively, 
into pCMX-PL2 expression vector (kindly provided by Dr. Roland Schüle, 
Universitats-Frauenklinik, Klinikum der Universitat Freiburg, Freiburg, 
Germany). BamHI and NheI restriction site sequences were incorporated into 
the forward and reverse primers, respectively, and the resulting PCR products 
were digested and cloned into the corresponding sites in pCMX-PL2 vector. 
Plasmids used to express TFs in mammalian systems were kind gifts 
from Dr. Joseph P. Stains (Niger et al., 2011) University of Maryland, School of 
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Medicine, Baltimore, MD, for pcDNA3-SP1 and pcDNA3 control plasmid, from 
Dra. Ann Ehrlund (Pettersson et al., 2010) Karolinska Institutet, Department of 
Medicine, Huddinge, Stockholm for pcDNA3.1-TWIST1 and from Dr. José 
Bragança, CBME, University of Algarve (Bamforth et al., 2001) for pcDNA3.1-
AP2. The identity of all constructs was confirmed by DNA sequence analysis. 
 
4.3.6. Cell culture  
ABSa15 cells were cultured in DMEM supplemented with 10% fetal 
bovine serum (FBS) and 0.2% fungizone, and incubated at 33ºC in 10% CO2. 
MC3T3-E1 and ATDC5 cells were cultured in α-MEM (supplemented with 10% 
FBS) and DMEM:F12 (supplemented with 5% FBS) respectively, and incubated 
at 37ºC in 5% CO2. Cells were sub-cultured every 2-3 days by trypsinisation. All 
culture media were supplemented with 1% penicillin/streptomycin and 2 mM L-
Glutamine. Cell culture media and FBS were obtained from Sigma and all other 
supplements and antibiotics were obtained from Gibco BRL, Gaithersburg, MD. 
 
4.3.7. Dual-Luciferase Reporter Assays 
For luciferase assays, cells were seeded in 12-well plates, further 
cultured for 14–16 h and transfected with X-tremeGENE HP (Roche), according 
to manufacturer’s instructions. ABSa15 (8×104 cells/well) were transfected with 
500 ng of luciferase construct and 300 ng of pRL-SV40 vector (Promega), 
ATDC5 (1×105 cells/well) were transfected with 500 ng of luciferase constructs 
and 50 ng of pRL-null vector (Promega) and MC3T3 (8×104 cells/well) were 
transfected with 500 ng of luciferase construct and 200 ng of pRL-null vector 
(Promega). For co-transfection experiments of TFs in ATDC5 and MC3T3, 50 
ng of each construct was added to previous conditions. As control, the same 
amount of empty vector was added to a subsequent well. After 48 h, transfected 
cells were lysed and luciferase activities were measured using Dual-Luciferase 
Reporter Assay system (Promega) in a Synergy 4 microplate reader (Biotek). 
Relative luciferase activity was determined from the ratio of firefly/renilla (F-
Luc/R-Luc). 
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4.3.8. miR-214 overexpression during ATDC5 cell differentiation 
For ATDC5 transfection, cells were seeded at a density of 2.5 x 104 cells/ 
well in 24-well plates and incubated for 16 h. Subsequently, cells were 
transfected with miRIDIAN microRNA mimic for mmu-miR-214 (from now on 
designated MmiR-214) or negative control 1 (NC) (both obtained from 
Dharmacon) at a final concentration of 50 nM and using EzWay (Koma Biotech) 
transfection reagent, according to manufacturer. Then, cells were grown until 
confluence (T0) and differentiation was induced by supplementing medium with 
ITS mixture (10 g/mL Insulin, 5.5 μg/ml transferring, 6.7 ng/ml sodium selenite, 
Gibco) and replaced every 2-3 days. A second transfection was performed 10 
days after the first one, using the same procedure. At appropriate times, total 
RNA was extracted from cells using TRI Reagent (Sigma) according to 
manufacturer’s protocol. For gene expression analysis, qPCR was performed 
using the StepOnePlus system (Applied Biosystems), a 1:10 dilution of MMLV-
RT (Invitrogen) reverse transcribed cDNA, gene-specific primers (Supp. Table 
1) and SsoFast EvaGreen supermix (Bio-Rad), according to manufacturer’s 
instructions. miRNA qPCR analysis was performed using NCode SYBR miRNA 
qRT-PCR kit (Invitrogen). Relative expression was calculated using the ΔΔCt 
method (Livak and Schmittgen, 2002) and normalized using expression levels 
of hypoxanthine phosphoribosyltransferase 1 (HPRT1) for mRNA and U6 for 
miRNA. 
 
4.4. Results 
 
4.4.1. miR-214 is expressed in the skeleton of zebrafish  
MiR-199a-2 and miR-214 are miRNAs that were shown to be transcribed 
from the opposite strand of Dnm3, in a common primary transcript called 
Dnm3os (Desvignes et al., 2014; Loebel et al., 2005; Watanabe et al., 2008). 
Conversely, this transcript was shown to be essential for normal growth and 
skeletal development in mice (Watanabe et al., 2008). In zebrafish, miR-214 
expression was recently investigated during embryonic development 
(Desvignes et al., 2014; Flynt et al., 2007), but these studies failed to 
CHAPTER 4  miR-214 in chondrogenesis 
144  
demonstrate a clear association to tissue calcification. In this regard, we 
initiated this study by analysing miR-214 expression in several zebrafish 
developmental stages from blastula to adulthood, focusing in crucial stages of 
skeletal development. In early development, from 18 somite stage to 36 hpf, 
miR-214 was expressed at very low levels (Fig. 4.1). These levels dramatically 
increased from 2 dpf until 6 dpf (over 30-fold change comparing to 24 hpf), 
reaching a peak at this time period. The highest level of expression was 
however observed at 60 dpf (110-fold increase compared to 24 hpf). In adults, 
levels of miR-214 ranged from 20- to 35- fold change compared to 24 hpf and 
both male and female showed similar levels of expression (Fig. 4.1). Analysing 
miR-199a expression resulted in a similar pattern of expression (Supp. Fig. 4.1), 
which was consistent with the association of both miRNAs to the same 
transcript (cluster).  
 
 
Figure 4.1. Relative expression of mature miR-214 during developmental stages of 
zebrafish. Levels of miR-214 expression were measured by miRNA specific qPCR analysis, 
using total RNA samples from different stages of zebrafish development, and normalized using 
zebrafish U6 small RNA and 24 hpf as reference sample. Values are the mean of at least 3 
independent replicates, hpf hours post fertilization, dpf days post fertilization. N.D. indicates 
non-detected. Gap in the y axis separates two different scales. 
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In order to complement this analysis, miR-214 expression was further 
investigated by in situ hybridization in the following developmental stages: i) 10 
dpf, corresponding to the onset of vertebra calcification; ii) 20 dpf, the time in 
which vertebra calcification is completed; and iii) 90 dpf, corresponding to young 
adult fish with active bone modelling. Our results show that miR-214 is widely 
expressed throughout the zebrafish body, being detected both in soft tissues 
and skeletal related tissues (Fig. 4.2). Regarding soft tissues, miR-214 was 
detected in several layers of the zebrafish eye, from the lens to the retina (Fig. 
4.2a, b), in brain (Fig. 4.2a), in kidney (Fig. 4.2d) and in muscle (Fig. 4.2e). 
Regarding cartilaginous structures, miR-214 expression was evident in the 
chondrocranium (Fig. 4.2a, b), in the pharyngeal cartilage, in the basal region of 
branchial filaments (Fig. 4.2a, c), in the ceratohyal (Fig. 4.2a), and in the basis 
of pectoral fins (Fig. 4.2f). Furthermore, miR-214 was detected in areas of new 
forming bone, either in arches (Fig. 4.2h) or in vertebral bodies’ growth zones 
(Fig. 4.2i). MiR-214 was also expressed in the notochordal sheath (Fig. 4.2g) 
and in the scales (Fig. 4.2e). Altogether, these results suggest, for the first time, 
an association of miR-214 to zebrafish skeletogenesis.  
In order to get further insight into a putative association of miR-214 to 
calcification, miR-214 expression was investigated in several calcified tissues of 
zebrafish and mouse: i) branchial arches, vertebra and skull of zebrafish; and ii) 
ear, vertebra, calvaria and femur of mouse. Given the role of miR-214 in 
zebrafish myogenesis (Flynt et al., 2007), muscle was used as positive control 
in this analysis. Not only miR-214 was detected in the zebrafish and mouse 
muscle, being the tissue with the highest levels of expression, but it was also 
always detected in the remaining tissues of both species (Fig. 4.3). Among 
zebrafish calcified tissues, miR-214 levels were higher in vertebra and skull, 
followed by branchial arches. In mouse, all skeletal tissues analysed presented 
similar levels of expression except for femur, which levels were considerably 
lower (Fig. 4.3). These results confirm miR-214 expression in skeletal structures 
of zebrafish and show a conserved pattern of expression between zebrafish and 
mouse. This analysis suggests that, as in mouse, miR-214 might also play a 
role in zebrafish skeletogenesis.
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Figure 4.2. Detection of mature miR-214 in zebrafish larvae by miRNA specific in situ hybridization. Expression of mature miR-214 was analysed 
in specimens with 10 (a), 20 (b,c,d) and 90 dpf (e,f, g, h, i). From head to tail, miR-214 was detected in eye lens (arrowhead, a,b), retina (white 
arrowheads, a,b), brain (arrow, a), chondrocranium (asterisk, a, b), pharyngeal cartilage (white arrows, a and c), kidney (arrows, d), scales (arrow, e), 
muscle myotomes (arrowheads, e), cartilaginous base of pectoral fins (arrows, f), notochordal sheath (arrow, g), osteoid of haemal arches (arrows, h) 
and growth zones of vertebral body (arrowheads, i). Hybridization with negative control (scramble) probe did not produce detectable signal, as observed 
in 90 and 20 dpf specimens (j and k, respectively). Scale bars: 0.2 mm for a, e, f and k; 0.1 mm for b, c, d, h, I and j; and  0.05 mm for g.
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Figure 4.3. Relative expression of mature miR-214 in zebrafish (a) and mouse (b) adult 
tissues. Levels of miR-214 expression were measured by miRNA specific qPCR analysis, using 
total RNA samples of zebrafish and mouse adult tissues, and normalized using U6 small RNA. 
Values are the mean of at least 3 independent replicates. B. arches – Branchial arches. 
 
 
4.4.2. Comparative sequence analysis of the Dnm3os putative promoter 
region 
Although miR-199a-2/214 cluster (Dnm3os) is located on the opposite 
strand of a Dynamin 3 (Dnm3) intron, expression of both miRNAs and Dnm3 
gene was shown to be distinct in both zebrafish and mouse (Desvignes et al., 
2014; Loebel et al., 2005). Apparently, Dnm3os has its own regulatory 
transcription unit, independent from Dnm3, and both in human and mouse, 
TWIST1 was shown to induce miR-199 and miR-214 expression through 
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binding to an E-box in the promoter region upstream of this cluster (Lee et al., 
2009; Yin et al., 2010). So far, this regulatory mechanism was only 
demonstrated in mammals, and its conservation in vertebrates remains to be 
elucidated. Nevertheless, this cluster of miRNAs was shown to be preserved 
across vertebrates and to be specific of that class (Desvignes et al., 2014). In 
order to evaluate a possible conservation of Dnm3os transcriptional regulation 
among vertebrates, the genomic sequences upstream (~2.5 kb) pre-miR-199a 
of human, mouse, xenopus, medaka, stickleback, tetraodon, fugu and zebrafish 
were retrieved from Ensembl database and investigated. These putative 
promoter regions were aligned in CHAOS/DIALIGN algorithm and fed to ConTra 
v2 to search for conserved putative TFBS. According to this analysis, the first 
~850 bp upstream of pre-miR-199a (proximal promoter) were considerably 
more conserved than the remaining regions, and contained most of the 
conserved TFBS (Fig. 4.4a). Therefore, focusing our analysis on the ~850 bp 
proximal promoter allowed us to identify the TWIST1 binding site previously 
described in human and mouse (Lee et al., 2009; Yin et al., 2010), which was 
found to be present/conserved in all analysed species (Fig. 4.4a, b). This 
indicated that the regulation by this TF might be maintained across vertebrates. 
The presence of TWIST1 binding site allowed us to set the parameters for 
subsequent analysis in ConTra v2 (core=0.95, similarity matrix=0.85), and 
search for conserved TFBS that could be related to chondrogenesis or 
osteoblastogenesis, which are functions recently associated to this cluster (Lin 
et al., 2009; Wang et al., 2013a; Watanabe et al., 2008), and also suggested by 
the profile of expression presented in the previous section (Figs. 4.1 to 4.3). 
From this analysis, we identified AP2alpha (transcription factor AP-2 alpha), 
CEBP (CCAAT/enhancer binding protein), ETS1, SP1 (Sp1 transcription factor), 
SRF (serum response factor) and TCF11 (also known as NFE2L1, nuclear 
factor, erythroid 2-like 1) as highly conserved putative binding sites in all 
analysed species. Moreover, a conserved non-canonical TATA box (TATAT) 
was identified 25 bp upstream the human TSS (GenBank accession 
NR_038397.2), also found to be present in seven of the eight species analysed 
and recognized as a putative binding site for TATA box binding protein, TBP
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Figure 4.4.
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Figure 4.4. Schematic representation of Dnm3os promoter region and identification and 
localization of conserved TFBS. Putative promoter sequences of Homo sapiens, Mus 
musculus, Xenopus tropicalis, Takifugu rubripes, Oryzia latipes, Gasterosteus aculeatus, 
Tetraodon nigroviridis and Danio rerio were aligned using CHAOS/DIALIGN, and then fed to 
ConTra v2 to search for conserved TFBS; the following parameters were used: core 
match=0.95, similarity matrix=0.85, TRANSFAC database. (a) Schematic representation of 
Dnm3os gene (not scaled) and promoter region aligned and analysed (~850 bp). Conserved 
TFBS predicted by ConTra v2 are indicated by colour codes. Vertical lines in colour codes 
indicate TFBS previously validated by ChiP assays according to UCSC Genome browser. TSS, 
Transcriptional Start Site based on human sequence. (b) Conserved putative binding sites for 
ETS1 (red), AP2alpha (blue), TWIST1 (green), TBP (yellow) and SP1 (orange) are shown. 
Number of the last nucleotide shown in the alignment is displayed at the right, considering that -
1 nt is the first nucleotide upstream of pre-miR-199a. (c) Sequence logos of positional weight 
matrices for EST1, AP2alpha, TWIST1, TBP and SP1, as provided by ConTra v2 
(http://bioit.dmbr.ugent.be/contrav2/). For TBP, parameters were: core match=0.90, similarity 
matrix=0.75. 
 
 
(core=0.90; matrix similarity=0.75) (Fig. 4.4a, b). To further validate our 
comparative analysis, binding sites for three TFs (E1A binding protein p300 or 
P300; TAF1 RNA polymerase II TBP-associated factor or TAF1; YY1 
transcription factor or YY1), previously validated by ChiP assay as regulators of 
human Dnm3os, were also found to be present in this region and shown to be 
conserved in the eight species analysed (Fig. 4.4a).  
 
4.4.3. Cloning and identification of a functional Dnm3os promoter 
In order to test the functionality of human and zebrafish putative Dnm3os 
promoters, the corresponding genomic regions were cloned and inserted 
upstream the luciferase reporter gene in pGL3-Basic vector (Promega). TSS 
(+1) for human was deduced based on the 5´end of the Dnm3os transcript 
variant 1 available at GenBank (NR_038397.2), whereas for zebrafish this 
information was not available. Therefore, we performed a 5´RACE PCR to 
determine the 5´end of zebrafish Dnm3os and obtained 4 clones of 129 bp and 
2 clones of 244 bp upstream the first nucleotide of pre-miR-199a. The terminus 
of longest 5´end was considered as the TSS. Additionally, considering the 
previous in silico analysis showing two distinct regions in putative Dnm3os 
promoter (proximal and distal), we cloned genomic fragments corresponding to 
full promoters (~2.5 kb) and to partial promoters (~850 bp) in human and 
zebrafish. The following constructs containing putative Dnm3os promoters were 
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prepared in pGl3-Basic vector (upstream the luciferase gene): full, partial and 
TATA less promoters of zebrafish (-1926bp/+244bp, 657bp/+244bp and -
1926bp/-140bp, respectively) and of human (-2299bp/+190bp, -641bp/+190bp 
and -2299bp/-30bp, respectively).  
Zebrafish putative promoter constructs were transfected into a fish bone-
derived cell line (ABSa15) recently developed in our lab (ECACC Ref. 
13112201) (Fig. 4.5a), while human constructs were tested in MC3T3 cell line 
(mouse bone-derived) (Fig. 4.6a). For both species, full and partial putative 
promoters significantly increased luciferase expression over empty vector and, 
while human full and partial promoters showed similar activities (45-fold change 
over promoter-less vector, Fig. 4.6a), activity of zebrafish full promoter was 2 
times higher then partial promoter (Fig. 4.5a). This suggests that the sequence 
between -1926 bp/-657 bp in the zebrafish full promoter might be regulated by 
activators present in ABSa15 cells. Furthermore, deletion of the putative TATA 
box resulted in a significant decrease of luciferase activity, similar to the levels 
displayed by the empty vector, in both species (Fig. 4.5a and 4.6a). This result 
suggested that predicted TATA box is indeed functional in both human and 
zebrafish. Activities of the two functional promoters, partial and full, were then 
assessed in ATDC5 cell line for both species. Interestingly, in this cell line, the 
putative full promoter increased luciferase activity to a higher extent then partial 
promoter for both zebrafish and human (Fig. 4.5b and 4.6b), suggesting that the 
distal region of these promoters, here not analysed in detail, could contain 
regulatory elements important for Dnm3os regulation in ATDC5 cell line. Also, 
the differences in promoter activity observed in ATDC5 and MC3T3 suggest 
that this cluster might be differentially regulated in distinct cell lines. 
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Figure 4.5. Transcriptional regulation of zebrafish Dnm3os putative promoter. Zebrafish 
full (-1926bp/+244bp) and partial (-657bp/+244bp) promoter constructs, and the promoter-less 
vector were transiently transfected either in ABSa15 (a) or ATDC5 (b) cells. Full promoter (-
1926bp/-140bp) construct was also tested in ABSa15 cells (a). A schematic representation of 
each construct and the respective putative TFBS (along with a legend) are indicated in the left. 
(Values are the mean of at least 5 independent experiments; One-way Anova, p < 0.001). Co-
transfection of zebrafish promoter with either TWIST1 (c) or ETS1 (d) were performed in 
ATDC5; cells were transfected with full promoter (-1926bp/+244bp) construct (500 ng/well in 12-
well plates) and either with 50 ng/well of pCMX-TWIST1, pCMX-ETS1 or empty vector together. 
(Values are the mean of at least 5 independent experiments; Student’s t-test, * p < 0.05, ** p < 
0.01). In all experiments, renilla and firefly luciferase activities were determined 48 h after 
transfection; in co-transfection experiments, results are indicated as fold change over the 
control empty vector pCMX-PL2. 
 
 
 
 
 
CHAPTER 4  miR-214 in chondrogenesis 
153  
 
 
Figure 4.6. Transcriptional regulation of human Dnm3os putative promoter. Human full (-
2299bp/+190bp) and partial (-641bp/+190bp) promoter constructs, and the promoter-less vector 
were transiently transfected either in MC3T3 (a) or ATDC5 (b) cells. Full promoter (-2299bp/-
30bp) construct was also tested in MC3T3 cells (a). A schematic representation of each 
construct and the respective putative TFBS (along with a legend) are indicated in the left. 
(Values are the mean of at least 5 independent experiments; One-way Anova, p < 0.001). Co-
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transfection of human promoter with either TWIST1 (c) ETS1 (d) SP1 (e) or AP2alpha (f), were 
performed in ATDC5 and MC3T3; cells were transfected with full promoter (-2299bp/+190bp) 
construct (500 ng/well in 12-well plates) and either with 50 ng/well of pCMX-TWIST1, pCMX-
ETS1, pCDNA3-SP1, pCDNA3-AP2 or empty vector together. (Values are the mean of at least 
3 independent experiments; Student’s t-test, p < 0.01). In all experiments, renilla and firefly 
luciferase activities were determined 48 hours after transfection; in co-transfection experiments, 
results are indicated as fold change over the respective control empty vector pCMX-PL2 or 
pCDNA3. (Values are the mean of at least 3 independent experiments; Student’s t-test, p < 
0.01). 
 
 
 
4.4.4. Transcriptional regulation of miR-214 in skeletal-related cell lines 
Our in silico analysis retrieved several transcription factors that could 
regulate Dnm3os, and thus miR-214, in a conserved manner. TWIST1 was 
previously demonstrated to drive the expression of Dnm3os, in human and 
mouse (Lee et al., 2009; Yin et al., 2010) and by in silico analysis, we show that 
the previously described binding site for TWIST1 was conserved in the eight 
analysed species (Fig. 4.4b). In order to confirm this conservation, TWIST1 was 
co-transfected with human or zebrafish full promoters. These assays were 
performed in ATDC5 and MC3T3 cells for the human promoter (Fig. 4.6c), or 
just in ATDC5 cells (Fig. 4.5c) for the zebrafish promoter. We also tested 
zebrafish promoter in ABSa15 cells but results were inconsistent due to high 
variability of the data regarding renilla luciferase normalization (data not shown). 
For both species, TWIST1 significantly induced luciferase activity over control 
cells co-transfected with a vector without TF cDNA. Interestingly, co-transfection 
with the human promoter construct resulted in a higher increment of luciferase 
activity in ATDC5 (~17-fold induction) comparing to MC3T3 cells (~10-fold 
induction) (Fig. 4.6c). Co-transfection of TWIST1 with the zebrafish promoter 
resulted in a 1.7-fold induction of luciferase activity over the control (Fig. 4.5c). 
These results strongly suggest that Dnm3os transcriptional regulation by 
TWIST1 is preserved across species and is likely to occur in both bone and 
cartilage contexts. 
In addition to TWIST1, several other TFs known to be involved in 
skeletogenesis were identified in the promoters analysed. Three of them, ETS1, 
SP1 and AP2alpha, were selected be also tested. Through in silico analysis, we 
identified three putative binding sites for ETS1, previously shown to be 
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expressed in mesenchymal precursors of newly forming bone, but never 
detected in the cartilage (Kola et al., 1993). While the first and third binding sites 
were detected by one of the eight matrices available in Contra v2 
(CETSP54_02), the second binding site was detected by four matrices (Fig. 
4.4b, c). Co-transfection of ETS1 with the human full promoter in MC3T3 cells 
resulted in a 1.7-fold induction of luciferase activity compared to the control (i.e. 
vector without TF cDNA) (Fig. 4.6d). Interestingly, co-transfection experiments 
using either the human or the zebrafish full promoters in ATDC5 cells produced 
similar results (Fig. 4.6d). Although these results clearly suggest a regulation of 
Dnm3os promoter region by ETS1 in both human and zebrafish, the similar 
effects displayed in both osteoblast and chondrocyte cells was unexpected and 
should be further explored in the future.  
To further dissect the transcriptional regulation of Dnm3os, human full 
promoter construct was co-transfected, in ATDC5 and MC3T3 cells, with either 
SP1 or AP2alpha TFs, both known to play crucial roles in skeletogenesis 
(Ghayor et al., 2001; Niger et al., 2011; Schorle et al., 1996). While for SP1 two 
of the six matrices in ConTra v2 detected the same binding site, for AP2alpha 
we identified three conserved putative binding sites, detected by one of the four 
matrices at ConTra v2 (Fig. 4.4b, c). Co-transfection with SP1 significantly 
increased luciferase activity by 1.5-fold and 3-fold in MC3T3 and ATDC5 cells, 
respectively (Fig. 4.6e). Curiously, while in ATDC5 cells AP2alpha repressed 
Dnm3os promoter by 50% as determined by luciferase activity, in MC3T3 no 
effect was observed (Fig. 4.6f). This result suggests that Dnm3os transcriptional 
regulation might vary in different cell types, depending on the regulatory factors 
present. These results evidenced an involvement of different skeletal related 
TFs in the regulation of Dnm3os promoter, and indicate that this promoter 
contains regulatory elements that are sensitive, in a specific manner, to the 
factors present in different skeletal-related cell types.
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4.4.5. miR-214 is down-regulated during ATDC5 chondrogenic 
differentiation 
Recent studies demonstrated that Dnm3os is essential for normal 
skeletal development and that miR-214 inhibits osteogenesis in vitro and in vivo 
(Wang et al., 2013a; Watanabe et al., 2008). Although miR-214 was previously 
shown to be expressed in cartilage (Desvignes et al., 2014; Loebel et al., 2005; 
Watanabe et al., 2008), its role in chondrogenesis remains to be demonstrated. 
In this regard, we have used ATDC5 cells as an in vitro model that mimics the 
multistep chondrogenic differentiation occurring in endochondral bone formation 
(Shukunami et al., 1997; Yao and Wang, 2013), to investigate a possible role of 
miR-214 in chondrogenesis. Thus, we characterized miR-214 expression in 
critical stages of ATDC5 differentiation (Shukunami et al., 1996): i) at 
confluence, when cells are committed to chondrocyte lineage but are still 
chondroprogenitors (T0); ii) at the beginning of cartilaginous nodules formation 
(T9); iii) during nodule maturation, when chondrocytes are embedded in the 
matrix (T21); and iv) during mineralization, the later phase of differentiation 
(T36). According to qPCR analysis, miR-214 was highly expressed in confluent 
cells but strongly down-regulated (over 10-fold change) during early (T9) 
differentiation (Fig. 4.7).  
 
 
 
Figure 4.7. Relative expression of miR-214 during ATDC5 cell differentiation. Expression 
of miR-214 was determined by qPCR analysis of RNA samples collected from differentiating 
ATDC5 cells, and normalized using U6 small RNA expression and day 0 RNA as reference 
sample. Values are the mean of at least 3 independent replicates. 
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In subsequent stages of differentiation, miR-214 expression was 
somewhat increased, but its levels remained lower than T0 throughout this 
process: during mineralization (T36) miR-214 expression was still 6x lower than 
at confluent stage (Fig. 4.7). This expression pattern suggests that miR-214 
levels need to be tightly controlled for chondrocyte differentiation to proceed.  
 
4.4.6. miR-214 mitigates chondrogenic differentiation of ATDC5 cells  
To investigate the functional activity of miR-214 and the relevance of its 
down-regulation during chondrocyte differentiation, miR-214 was transiently 
overexpressed in ATDC5 cells and its effects investigated through analysis of 
several markers of differentiation. Overexpression was achieved by transfection 
with miR-214 mimic (at seeding) and these experiments were simultaneously 
controlled by transfection with negative control mimic. When confluent, cells 
were cultured in the presence of ITS mixture to induce differentiation. Initially, a 
panel of differentiation markers was characterized in wild type (WT) cells, which 
where cultured and treated equally as transfected cells. Therefore, in WT cells 
collagen type II alpha 1 (Col2a1), collagen type X alpha 1 (Col10a1), Mgp and 
Oc expression levels increased during differentiation, peaking at day 28, while 
Sox9, alkaline phosphatase (Tnap) and Osterix (Osx or Sp7) increased until day 
14 and decreased at day 28 (Fig. 4.8). These patterns of expression were in 
agreement with previous reports (Newman et al., 2001; Shukunami et al., 
1997), which indicated that ATDC5 underwent a typical differentiation process. 
In addition, we have analysed the expression of Atf4, a known target of miR-214 
in osteoblasts (Wang et al., 2013a), which increased during differentiation with a 
peak at day 28 (Fig. 4.8). Subsequently, the expression of markers of 
chondrogenic differentiation and miR-214 itself were assessed in ATDC5 cells 
overexpressing miR-214 and compared to control after 14 days of 
differentiation. Transfections with miR-214 mimic resulted in an average 8-fold 
increase over the control (Fig. 4.9a), thus confirming the delivery and presence 
of miR-214 mimic during the differentiation of ATDC5 cells (T14). Regarding the 
markers of chondrogenic differentiation, the expression levels of Col2a1, 
Col10a1, Tnap, Sox9 and Sp7 were not affected by miR-214 overexpression 
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Figure 4.8. Relative 
gene expression of 
different genes 
associated with 
chondrogenic 
differentiation of 
ATDC5 cells. 
Expressions of type II 
collagen α1 (Col2a1), 
type X collagen α1 
(Col10a1), matrix Gla 
protein (Mgp), sex 
determining region Y-
box 9 (Sox9), alkaline 
phosphatase 
liver/bone/kidney 
(Tnap), osteocalcin 
(Oc), Sp7 and Atf4 
were evaluated by 
qPCR analysis of total 
RNA samples 
collected from 
confluent cultures (T0) 
of ATDC5, and after 
14 (T14) and 28 (T28) 
days of differentiation. 
Gene expression was 
normalized using 
HPRT1 housekeeping 
gene expression 
(similar expression 
data was collected 
using HPRT6 and 
GAPDH 
housekeeping genes; data not shown). Values are the mean of at least 3 independent replicates 
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(data not shown). On the contrary, Mgp and Oc were significantly reduced by 
approximately 20% and 60% respectively, in cells overexpressing miR-214 (Fig. 
4.9b), suggesting that normal cell differentiation was compromised. As for miR-
214 target, Atf4 expression decreased by approximately 40% after miR-214 
overexpression (Fig. 4.9b). The regulation of Atf4 suggested that the miR-214 
mimic introduced in ATDC5 cells was functional and probably controlling Atf4 
during chondrogenesis, as it was already shown in osteogenesis (Wang et al., 
2013a). According to these data, it is likely that miR-214 mitigated chondrocyte 
differentiation (as determined by Mgp and Oc down-regulation) by, at least in 
part, specifically targeting Atf4.  
 
Figure 4.9. Effect of miR-214 overexpression 
in ATDC5 chondrocyte differentiation. Levels 
of miR-214 mature miRNA expression (a), and 
Mgp, Oc and Atf4 gene expressions (b) in 
ATDC5 undergoing differentiation, and 
transfected with mmu-miR-214 mimic (MmiR-
214) or corresponding negative control (NC). 
MmiR-214 or NC were transfected into ATDC5 
cells 16 h after seeding and differentiation was 
induced when cells reached confluence (T0). 
After 14 days of treatment, total RNA samples 
were collected and used to determine the 
expression of miR-214 by miRNA specific qPCR 
analysis, and normalized using U6 small RNA; 
alternatively, collected RNA samples were used 
to determine the expression of Mgp, Oc and Atf4 
by common qPCR analysis and. normalized 
using HPRT1 housekeeping gene (similar 
expression data was collected using HPRT6 and 
GAPDH housekeeping genes; data not shown). 
Results are presented as fold change over NC. 
Asterisks indicate values statistically different 
from NC (Values are the mean of at least 3 
independent replicates; Student’s t-test, *** p < 
0.001; ** p < 0.01, * p < 0.05).  
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4.5. Discussion 
Skeletogenesis is still under study concerning its post-transcriptional 
regulators. Previous reports have shown that miR-214 is an inhibitor of 
mammalian bone formation (Wang et al., 2013a) and that its expression is 
driven by an important skeletal regulator, TWIST1 (Lee et al., 2009). 
Furthermore, miR-214 was shown to be vertebrate specific and evolutionarily 
conserved (Desvignes et al., 2014), suggesting that its function may have been 
maintained. In other studies, miR-214 expression was also associated to 
cartilaginous structures of mouse and zebrafish (Desvignes et al., 2014; 
Watanabe et al., 2008), although its function in chondrogenesis remains 
unknown. To address these issues, we studied miR-214 in zebrafish, mouse 
and human models, investigating its expression, its transcriptional regulation 
and its effect on chondrogenic differentiation.  
 
4.5.1. miR-214 is implicated in skeleton formation of mammals and 
zebrafish  
In zebrafish, miR-214 was initially shown to be involved in muscle cell 
specification through specific regulation of hedgehog signalling (Flynt et al., 
2007). However, hedgehog signalling was also previously demonstrated to play 
key roles in both chondrogenesis and osteogenesis (Goldring et al., 2006; Mak 
et al., 2008), raising the hypothesis that miR-214 could also be implicated in 
those processes. In fact, Watanabe and co-workers showed that the primary 
transcript from which miR-214 is processed (along with miR-199a, miR-199* 
and miR-214* (Desvignes et al., 2014)), Dnm3os, is essential for normal 
skeletal development in mice (Watanabe et al., 2008). Furthermore, expression 
analysis in 72 hpf zebrafish embryos evidenced miR-214 expression in the 
mesenchyme surrounding developing skeletal elements in the craniofacial 
skeleton (Desvignes et al., 2014) and in somites of 1 dpf embryos (Flynt et al., 
2007). In order to clarify a possible involvement of miR-214 in zebrafish 
skeletogenesis, its expression was here investigated throughout development. 
This information was tentatively correlated with particular stages of skeleton 
formation, and although the occurrence of other processes in parallel could not 
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be excluded, interesting patterns were identified. MiR-214 could not be detected 
at 1 K-cell stage, suggesting that it was not maternally inherited, in agreement 
with previous studies (Desvignes et al., 2014; Flynt et al., 2007). In fact, miR-
214 expression was only detected at 18 somite stage and remained low until 2 
dpf, which was comparable to data presented by Flynt and colleagues (Flynt et 
al., 2007). From 2 to 6 dpf miR-214 was substantially up-regulated, suggesting 
a particular requirement for this miRNA in these stages. In this period, zebrafish 
skeleton is mainly composed by cartilaginous elements and otoliths (2 dpf), 
whereas elements from the craniofacial skeleton start to become calcified from 
3 dpf onwards (Gavaia et al., 2006). Therefore, this pattern suggests that miR-
214 could be related to the beginning of skeletal calcification (mainly in the head 
at this stage). At 15 dpf miR-214 was strongly down-regulated and only became 
highly expressed at 60 dpf. At 15 dpf the majority of skeletal elements become 
calcified (Gavaia et al., 2006), and therefore miR-214 decrease could 
hypothetically be associated to a negative effect of this miRNA on 
mineralization, as previously shown in mammalian systems (Wang et al., 
2013a). From 15 to 60 dpf, there is a progressive increase in miR-214 
expression that is concomitant with bone remodelling in zebrafish (Witten et al., 
2001). The recruitment and proliferation of osteogenic and chondrogenic 
precursors could justify this up-regulation. Interestingly, in young adults with 81 
dpf, miR-214 decreased to levels similar to those detected at 6 and 45 dpf. 
These results suggest that miR-214 is required in higher amounts when the 
skeleton is being actively formed. To further understand miR-214 behaviour in 
zebrafish skeletogenesis, we analysed the spatial component of miR-214 by in 
situ hybridization. The three stages analysed, i.e. 10, 20 and 90 dpf, 
corresponds to crucial moments of skeleton formation: onset and complete 
vertebra calcification and active bone modelling, respectively. In these stages, 
miR-214 was detected in both skeletal and non-skeletal components of the 
zebrafish body, in agreement with previous data in mouse (Loebel et al., 2005; 
Watanabe et al., 2008). Regarding non-skeletal developments, we show that 
miR-214 is expressed in the lens of the eye and retina, consistent with data in 
xenopus demonstrating that miR-214 is important for controlling the 
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developmental timing and cell fate in retina (Decembrini et al., 2009). MiR-214 
was also detected in the brain, muscle and kidney consistent with Dnm3os 
expression in mouse development (Loebel et al., 2005) and further suggesting a 
possible conservation of miR-214 mammalian functions in the zebrafish (Chen 
et al., 2010; Denby et al., 2011). Regarding skeletal elements, miR-214 was 
found in several cartilaginous elements, i.e. chondocranium, pharyngeal 
cartilage and basal region of fins, and in locations where new bone is being 
formed, i.e. vertebral column. Dnm3os was previously shown to be expressed in 
mouse cartilage (Watanabe et al., 2008), but to our knowledge it was never 
detected in zebrafish cartilage. Nevertheless, a recent study reported the 
presence of miR-214 in the mesenchyme surrounding craniofacial skeletal 
elements 72 hpf zebrafish embryos (Desvignes et al., 2014), suggesting that 
this miRNA could be relevant to cartilaginous structure formation. Our results 
are therefore the first to provide data consistent with the hypothesis that miR-
214 might have a role in the formation of cartilage in larvae, juvenile and adult 
zebrafish. Interestingly, the detection of miR-214 in zebrafish vertebral column 
not only was in agreement with previous qPCR data, reinforcing the idea that 
miR-214 is important for onset of calcification, but it was also consistent with 
previous data in mammalian systems. Indeed, miR-214 was recently shown to 
regulate important molecules for bone formation such as Sp7 and Atf4 (Shi et 
al., 2013; Wang et al., 2013a). Sp7 is specifically expressed in osteoblasts and 
is required for bone formation (Nakashima et al., 2002). In zebrafish, its 
expression is associated with the formation of newly mineralized matrix 
(Delaurier et al., 2010), co-related with miR-214 expression here described. 
ATF4 plays several crucial roles in osteoblast differentiation and function of 
mammals (Yang et al., 2004) although, to our knowledge, its function in 
zebrafish remains to be established. If the regulation of these genes by miR-
214, and their functions, should be maintained in zebrafish, based on miR-214 
expression, this miRNA could have a major role in the maintenance of normal 
levels of bone formation.  
Finally, we confirmed miR-214 association to bone and cartilage by 
quantifying miR-214 expression in several skeletal related tissues of zebrafish 
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and mouse origin. MiR-214 expression in calcified tissues was comparable (but 
still lower) to that observed in muscle, a tissue in which miR-214 was already 
shown to play an important role (Flynt et al., 2007). Since the patterns of 
expression were again similar in both organisms, it is likely that miR-214 role 
has been conserved throughout evolution in vertebrates.  
 
4.5.2. Cartilage and bone related TFs seem to coordinate miR-214 
transcription  
Temporal and spatial expression patterns of miRNAs provide evidences 
to unravel their functions, but also help to clarify regulatory 
elements/mechanisms controlling miRNA expression. In that sense, we have 
analysed both miR-214 and miR-199a temporal expressions in zebrafish and 
concluded that they share the same pattern of expression and therefore should 
be subjected to similar regulatory mechanisms. These results are in agreement 
with previous reports in mammals and zebrafish (Desvignes et al., 2014; Lee et 
al., 2009; Yin et al., 2010) showing that indeed miR-214 and miR-199a have a 
similar expression profile. The primary transcript of these miRNAs, Dnm3os, is 
encoded in the opposite strand of an intron of Dnm3 gene in vertebrates, 
although gene expression analysis indicate different sites and levels for both 
transcripts, characteristic of independent transcriptional regulation (Desvignes 
et al., 2014; Loebel et al., 2005). In our study, we identified a vertebrate 
conserved Dnm3os promoter region with approximately 2.5 kb and 
demonstrated that zebrafish and human promoters are active in ABSa15 and 
MC3T3 bone-derived cell lines, respectively. A conserved TATA box was 
identified through in silico analysis and suppression of this sequence nearly 
abolished promoter activity indicating that this region is crucial for transcription. 
Interestingly, most of the conserved regulatory sites identified in silico were 
contained within the proximal 850 bp region of these promoters. In that sense, 
removing the remaining distal region of the human promoter did not change the 
associated luciferase activity in MC3T3 cell line. However, in ABSa15 (for 
zebrafish) and in ATDC5 (for human and zebrafish) cell lines the largest 
promoter regions produced somewhat higher luciferase activities. This result 
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indicates that other putative TFBSs or regulatory elements upstream the 850 bp 
proximal region (the one studied here in detail through in silico analysis) might 
be potentiating its activity in those cell lines. In previous studies, TWIST1 was 
shown to drive the expression of Dnm3os in mammals (Lee et al., 2009; Yin et 
al., 2010). Here, we further show that the binding site for this TF is conserved 
among fish, amphibian and mammals, suggesting that TWIST1 might also 
regulate Dnm3os in other vertebrates. This was confirmed in co-transfection 
experiments in ATDC5 cells when Twist1 was shown to significantly increase 
luciferase activity associated to zebrafish Dnm3os promoter. As control, we also 
showed that TWIST1 was able to induce the human promoter activity in both 
ATDC5 and MC3T3 cell lines, confirming data in previous reports. However, this 
was the first time that TWIST1 was shown to regulate a mammalian Dnm3os 
promoter in either osteogenic or chondrogenic contexts, where TWIST1 is 
known to exert inhibitory functions. Indeed, Twist1 was shown to repress 
mammalian chondrogenesis in vivo (Goodnough et al., 2012) and in vitro 
(Reinhold et al., 2006) by specific regulation of either Sox9 or BMP2 pathway. 
Concerning osteogenesis, TWIST1 was also shown to promote repressive 
effects in several systems: overexpression in human osteoblast HSaOS-2 cells 
was shown to block osteoblast differentiation (Lee et al., 1999); Twist1 
interactions with ATF4 and Runx2 specifically inhibited osteocalcin expression 
in osteoblast cultures (Bialek et al., 2004; Danciu et al., 2012). In a similar 
manner, twist1 seemed also to control zebrafish skeletal development by 
specific regulation of runx2 (Yang et al., 2011c), suggesting that TWIST1 
function in skeletogenesis has been maintained in vertebrates. Since TWIST1 
was shown here to positively regulate both human and zebrafish Dnm3os 
promoters in pre-osteoblast (MC3T3) and pre-chondrocyte (ATDC5) cultures, 
we speculate whether this regulation could in part mediate its inhibitory effects 
in skeleton formation. In fact, inhibition of osteogenesis by miR-214 was already 
demonstrated in mouse pre-osteoblasts in a process involving Atf4 repression 
(Bialek et al., 2004; Wang et al., 2013a). It remains to be demonstrated whether 
this effect could also occur in pre-chondrocytes. 
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In order to unravel new regulatory mechanisms of miR-214, other 
transcription factors identified through in silico analysis as being putative 
regulators of Dnm3os were tested for their effect. Concerning ETS1, we have 
identified three conserved binding sites that could be associated to a mild 
induction of luciferase activity after co-transfection in ATDC5 with both zebrafish 
and human Dnm3os promoters and in MC3T3 with only the human promoter, 
providing additional evidence that ETS1 may regulate the expression of this 
cluster in both chondrocytic and osteogenic lineages. ETS1 is a pivotal 
molecule in osteoblast differentiation and although expressed in all stages of 
differentiation, higher levels are found during proliferation stage (Raouf and 
Seth, 2000), suggesting a more important role in this phase. More recently, 
ETS1 was shown to be activated by Erk pathway during chondrogenesis, and to 
promote chondrogenic specification of neural crest cells (Sugiura and Ito, 2010). 
Combined with these studies, our results suggest that ETS1 might be important 
to control vertebrate skeletogenesis through a mechanism involving Dnm3os 
expression. Another TF with important regulatory functions in 
chondro/osteogenic differentiation is SP1. Although only one SP1 binding site 
was identified, our functional assays indicated a significant up-regulation of 
luciferase activity associated to human Dnm3os promoter in both ATDC5 and 
MC3T3 cell lines, although this induction was stronger in ATDC5. SP1, through 
coordination with SP3, was previously shown to selectively regulate the 
expression of different collagen genes in differentiating chondrocytes, 
potentiating Col2a1 expression and inhibiting Col10a1 (Ghayor et al., 2001; 
Magee et al., 2005). Furthermore, SP1 was shown to promote the expression of 
SOX9, a key regulator of chondrogenesis (Piera-Velazquez et al., 2007). Again, 
these studies combined with our results suggest that SP1 could also be 
implicated in the regulation of chondrogenesis (and to a lesser extent in 
osteogenesis according to MC3T3 data) through a mechanism likely to involve 
miR-214 cluster. A different regulation of Dnm3os promoter in osteoblast- and 
chondrocyte-like cells was observed in AP2alpha co-transfection experiments. 
Three potential AP2alpha regulatory elements, proximal to ETS1 binding sites, 
were found to be conserved throughout vertebrates, and co-transfection with 
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Dnm3os promoter resulted in an inhibitory effect on ATDC5 cell line, while no 
effect was observed in MC3T3. AP2 family of transcription factors have crucial 
roles in chondrogenesis and vertebrate skeleton development, playing a dual 
role either as transcriptional repressors or as activators (Wenke and Bosserhoff, 
2010). AP2alpha is with no doubt linked to skeleton formation, since its 
knockout in mice was shown to promote defects in skeletal development 
(Schorle et al., 1996; Zhang et al., 1996). In particular, AP2alpha was shown to 
be a negative regulator of chondrocyte differentiation in mammalian systems 
(Davies et al., 2002; Huang et al., 2004; Wenke and Bosserhoff, 2010). In this 
study, the repression of Dnm3os promoter activity by AP2alpha in ATDC5 is 
somehow inconsistent, since we demonstrate that miR-214 expression levels 
are higher in confluent ATDC5 cells, precisely the stage where AP2alpha was 
shown to be higher (Huang et al., 2004). Considering this, it is likely that other 
TFs simultaneously present in these cells overcome this effect. In sum, 
although further studies are necessary to confirm and expand the regulatory 
network controlling Dnm3os (and thus miR-214) expression in osteoblasts and 
chondrocytes, including the analysis of additional TFs, obtained data provided 
novel evidences regarding the transcriptional regulation of Dnm3os in skeletal-
related systems. These results not only demonstrate that miR-214 is important 
and actively regulated in pre-osteoblasts, which was already demonstrated in 
recent studies (Wang et al., 2013a), but also emphasize the fact that it might 
also be crucial in chondrogenesis. In order to test this hypothesis we have 
investigated miR-214 altered expression in the chondrogenic cell line ATDC5. 
  
4.5.3. miR-214, the most recent putative regulator of chondrogenesis 
MiR-214 was recently found to inhibit in vitro and in vivo bone formation, 
by targeting ATF4 (Wang et al., 2013a), while miR-199*, another miRNA 
encoded in Dnm3os, was identified has a negative regulator of early 
chondrogenic differentiation (Lin et al., 2009). Although previous studies have 
demonstrated the presence of miR-214 in cartilaginous associated structures of 
both zebrafish and mouse (Desvignes et al., 2014; Watanabe et al., 2008; 
Wienholds et al., 2005), its role in chondrogenesis is still not understood. In 
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order to investigate miR-214 function in this process we have used ATDC5, a 
murine chondroprogenitor cell line that mimics chondrocyte differentiation in 
vitro (Shukunami et al., 1996). Expression analysis indicated that miR-214 is 
differentially expressed during chondrocyte differentiation, with higher levels at 
the chondroprogenitor state, before differentiation, suggesting that miR-214 
might be important to maintain chondrocytes in an undifferentiated condition. To 
further explore this possibility, we altered the expression of miR-214 in ATDC5 
cells using miR-214 mimic, and evaluated its impact on the expression of 
selected markers of chondrogenic differentiation. Our results indicated a 
significant down-regulation of both Mgp and Oc, while Col2a1, Col10a1, Sox9 
and Sp7 were unaffected. In differentiating ATDC5 cells (non-transfected), 
expression of Mgp increased at nodule formation and matrix mineralization 
while Oc levels were significantly increased during mineralization, which was 
consistent with previous reports (Idelevich et al., 2011; Newman et al., 2001). 
Although the role of MGP and its molecular mechanisms of action in 
chondrocytes are not fully understood, accumulating data indicate that this 
protein major function is a specific inhibition of soft-tissue calcification (Luo et 
al., 1997). Other putative roles are associated with regulation of proliferation 
and apoptosis of chondrocytes in the cartilage (Newman et al., 2001). 
Nevertheless, MGP is recognized as one of the main markers of chondrogenic 
differentiation (Luo et al., 1995) and its down-regulation in miR-214 
overexpressing cells indicates that ATDC5 differentiation is compromised. Oc is 
another marker of differentiation but mainly synthesized by osteoblasts and 
associated to bone formation. However, it has been shown to be expressed 
also in chondrocytes and VSMC, especially when cells are undergoing 
mineralization (Idelevich et al., 2011). In fact, overexpression of osteocalcin in 
ATDC5 cells was shown to stimulate differentiation and mineralization, as well 
as its metabolic activity (Idelevich et al., 2011). Therefore, in our experimental 
conditions down-regulation of Oc (as well as Mgp decrease) upon miR-214 
overexpression should represent a drawback in the differentiation process, 
probably with consequences at mineralization. Interestingly, precisely in the 
later stage of differentiation miR-214 levels was slightly increased in WT cells, 
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suggesting that miR-214 might have a physiological function during 
mineralization. In that sense, a fine control of molecules responsible for this 
process, such as Mgp and Oc, could contribute for a normal mineral deposition 
in bone or cartilage. Since bioinformatics analysis did not indicate Mgp or 
osteocalcin as direct targets of miR-214 (data not shown), down-regulation of 
these genes is probably indirect. On the contrary, the repression of Atf4 by miR-
214 overexpression in ATDC5 cells is most likely direct, as it was previously 
shown in osteoblasts (Wang et al., 2013a). Atf4 is in fact a TF essential for the 
regulation of osteoblast differentiation and bone development (Yang et al., 
2004) and previously shown to drive Oc, by cooperative interaction with Runx2 
(Dobreva et al., 2006; Xiao et al., 2005), and Sp7, through a PTH-dependent 
mechanism (Yu et al., 2009). It is therefore not surprising to observe a 
simultaneous down-regulation of Atf4 and Oc upon miR-214 overexpression in 
ATDC5 cells. In fact, this suggests that the same mechanism that was observed 
in osteoblasts (Wang et al., 2013a) is also occurring in chondrocytes. Indeed, 
Atf4 was previously shown to play crucial roles not only in osteoblasts but also 
in chondrocytes. For example, ablation of Atf4 (Atf4-/-) in mouse was shown to 
alter both proliferative and hypertrophic growth plate zones through control of 
Indian hedgehog (Ihh) expression (Wang et al., 2009). Regarding Mgp down-
regulation in ATDC5 cells overexpressing miR-214, there are other mechanisms 
that could explain this effect (and also on Oc). Apparently, during skeletal 
development in mice, SATB2 interacts with both ATF4 and Runx2 to enhance 
the expression of crucial genes in skeletogenesis, including Oc (Dobreva et al., 
2006). Since Runx2 was previously shown to be an important regulator of Mgp 
gene expression (Fazenda et al., 2010; Suttamanatwong et al., 2009), we 
speculate whether Atf4 repression by miR-214 could affect both Mgp and Oc 
simultaneously and ultimately compromise chondrogenic differentiation and 
mineralization (Fig. 4.10). 
Finally, alternative pathways for miR-214 action in ATDC5 cells cannot 
be discarded. For instance, in zebrafish, miR-214 was previously shown to 
regulate the Hedgehog pathway through targeting of a negative regulator, 
Supressor of fused (Sufu), and Dispatched Homolog 2, during muscle and 
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Figure 4.10. Proposed regulatory mechanism for miR-214 effect in chondrogenic differentiation. MiR-214 putatively regulates chondrogenesis by 
repressing ATF4, which cooperates with Runx2 and Satb2 to activate gene expression. Consequently, Oc and Mgp expression decrease, which can 
compromise mineralization, the latter stage of chondrogenic differentiation. Attenuated effects, in the presence of miR-214, are represented by smaller 
arrows. Dashed lines of SATB2 and ATF4 in Mgp promoter represent mechanisms not yet identified. 
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central nervous system development, respectively (Flynt et al., 2007; Li et al., 
2008). Although this mechanism was not described in mammals, the regulation 
of this pathway is likely to occur, since putative binding sites for miR-214 are 
present in Sufu 3’UTR of mouse and human (data not shown). With this 
possibility in mind, we tested the effect of miR-214 overexpression on Hh 
pathway. In fact, Patched 1 levels, considered a universal marker for activation 
of this pathway (Murone et al., 1999), were significantly increased in ATDC5 
cells overexpressing miR-214 compared to control cells (Supp. Fig. 4.2), 
suggesting that miR-214 could regulate this pathway also in mammals. This 
possibility and the regulatory mechanisms involved should be addressed in 
future studies. 
 
4.6. Conclusions 
In this study, we investigated several features of miR-214 concerning its 
involvement in skeleton formation. We showed that miR-214, a miRNA that 
belongs to a cluster also containing miR-199a (Dnm3os), has an expression 
pattern that is particularly associated to skeleton development and skeletal 
tissues in both zebrafish and mouse. Furthermore, Dnm3os promoter shares 
several conserved regulatory elements among vertebrate species, and we show 
that skeletal related TFs are likely to regulate this cluster in bone and cartilage 
in vitro systems. We observed that miR-214 has an interesting pattern of 
expression in chondrocyte ATDC5 cells, resembling that observed in osteoblast 
MC3T3 cells, and suggesting a similar mechanism of action in both systems. 
More importantly, we demonstrate that miR-214 attenuates chondrocyte 
differentiation of ATDC5 cell line, possibly by targeting Atf4, and ultimately 
decreasing the levels of both Mgp and Oc, crucial genes for normal cartilage 
and bone formation. These findings should be further confirmed and 
characterized in an in vivo mouse model, for instance, a specific overexpression 
of miR-214 in chondrocytes might answer the questions here raised.  
Nevertheless, this and previous data seems to indicate that miR-214 
physiological function in skeletogenesis might be to coordinate the levels of 
expression of key molecules involved in cell proliferation/differentiation and 
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bone formation, to ultimately contribute to normal skeletal development (Fig. 
4.10). 
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Supplementary Figure 4.1. Relative expression of mature miR-199 during developmental 
stages of zebrafish. Levels of miR-199 expression were measured by miRNA specific qPCR 
analysis, using total RNA samples from different stages of zebrafish development, and 
normalized using zebrafish U6 small RNA and 24 hpf as reference sample. Values are the 
mean of at least 3 independent replicates; hpf, hours post fertilization, dpf, days post 
fertilization. 
 
 
 
 
Supplementary Figure 4.2. Effect miR-214 overexpression on Hedgehog signalling. 
Patched 1 (Ptch1) expression in ATDC5 undergoing differentiation and transfected with mmu-
miR-214 mimic (MmiR-214) or corresponding negative control (NC). MmiR-214 or NC were 
transfected into ATDC5 cells 16 hours after seeding and differentiation was induced when cells 
reached confluence (T0). After 14 days of treatment, collected RNA samples were used to 
determine the expression of Ptch1 and normalized using HPRT1 housekeeping gene (similar 
expression data was collected using HPRT6 and GAPDH housekeeping genes; data not 
shown). Results are presented as fold change over NC. Asterisk indicates value statistically 
different from NC (Values are the mean of at least 3 independent replicates; Student’s t-test, p < 
0.01).
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CHAPTER 5  General Conclusions and  
Future Perspectives  
 
 
5.1. Overview 
 As key regulators of gene expression, miRNAs have been implicated in a 
variety of physiological and pathological processes, including cell proliferation, 
apoptosis, differentiation, cell fate decisions, tumour progression or 
development (Erson and Petty, 2008; Fatica et al., 2008; Ivey and Srivastava, 
2010; Wang et al., 2013b; Wienholds and Plasterk, 2005; Wu et al., 2012; Xiong 
et al., 2010). Emerging evidences indicate that miRNAs also play key roles in 
the regulation of skeletal cells differentiation, bone formation and remodelling 
(Kapinas and Delany, 2011; Lian et al., 2012; Zhao et al., 2013). While more 
then twenty miRNAs were identified as inhibitors or promoters of osteogenesis, 
only few were shown to regulate osteoclast differentiation and chondrogenesis 
(Kapinas and Delany, 2011; Lian et al., 2012; Zhao et al., 2013). In this regard, 
this thesis aimed at the identification and characterization of miRNAs with 
relevant functions in skeletogenesis. The main conclusions and possible future 
directions of the work are described next in separate sections, each one 
corresponding to a different miRNA. 
 
5.2. miR-223 is associated to mammalian 
hematopoiesis and osteoclastogenesis and has 
conserved functions in zebrafish  
In mammals, miR-223 is essential for normal myelopoiesis, promoting 
granulocyte, osteoclast and megakaryocyte differentiation and suppressing 
erythropoiesis (Haneklaus et al., 2013). However, there is a general lack of 
knowledge regarding miR-223 function in other vertebrates, which could help to 
clarify its role in other processes, such as developmental processes. At the 
same time, the role of miR-223 in hematopoiesis is still not fully understood, and 
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the identification of a research model, e.g. zebrafish, where this function has 
been conserved could be important for the clarification of this regulation. 
Therefore, our work aimed initially at analysing zebrafish as a possible and valid 
model to study miR-223. For that, we investigated miR-223 conservation in 
three different perspectives: i) from sequence to structure, ii) from gene 
organization to genomic context, and iii) from levels of expression to mRNA 
targets. Resulting data revealed that miR-223 structural and functional features 
have been conserved throughout evolution. Its genomic organization and gene 
context are maintained between human and zebrafish. In addition, we have 
identified 22 novel miR-223 precursor sequences and demonstrated that it 
contains highly conserved domains among vertebrates suggesting that 
processing and function of miR-223 should be also maintained in vertebrates. 
We also show that miR-223 patterns of expression during development are 
highly correlated with hematopoietic and osteoclastogenic events, providing 
additional evidences supporting the use of zebrafish as model to study miR-223 
function. In the same manner, in adults, zebrafish miR-223 tissue distribution 
resembled that of mice, and it was also correlated with hematopoiesis. Finally, 
the miR-223 target genes that were previously associated with hematopoiesis 
and/or osteoclastogenesis in mammals were also predicted as putative targets 
in zebrafish, supporting a functional conservation of this miRNA.  
In sum, our data shows that all miR-223 analysed features are generally 
conserved between mammals and zebrafish, indicating that the zebrafish can 
be an excellent model to study miR-223 role in hematopoiesis (and possibly 
other processes) throughout development. In future studies, miR-223 target 
genes involved in hematopoiesis (e.g. lmo2) and osteoclastogenesis (e.g. nfia) 
in zebrafish should be validated. The roles of nfia, mef2c and igf1r in zebrafish 
hematopoiesis is still not understood, and for a better understanding of this 
regulatory process in vertebrates, including mammals, these putative miR-223 
targets should be further investigated. Interestingly, transgenic zebrafish lines, 
either modelling lymphoblastic leukemia (ALL) or myeloid leukemia and 
myeloproliferative disorder (AML/MDS) (Shen et al., 2013; Teittinen et al., 
2012), are already available and could be useful tools to further explore the 
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regulatory mechanisms of miR-223 in leukemia. This could help to unravel the 
roles of e2f1, stmn1, foxo1 and fbxw7, all miR-223 targets, in these pathologies.  
The role of miR-223 in osteoclastogenesis is also not yet clear. 
Apparently, both knockdown and overexpression of miR-223 in mouse 
osteoclast-like cells (RAW264.7) induced osteoclastogenesis (Sugatani and 
Hruska, 2007, 2009), suggesting that proper levels of this miRNA are essential 
for this process. However, these studies did not contribute to a better 
understanding of miR-223 function in osteoclast differentiation and activity. In 
that sense, this role of miR-223 should be further addressed, probably by using 
in vivo models, such as mice transgenic models using, for instance, cathepsin k, 
which were proven to be useful in other studies (Mizoguchi et al., 2010; 
Sugatani et al., 2014). Transgenic fish in which osteoclast can be visualized in 
vivo (Chatani et al., 2011) could also be used as models to investigate miR-223 
effect in those cells. However, osteoclastogenesis in fish has some distinct 
features from that of mammals, including predominantly active mononucleated 
vs. multinucleated cells or acellular vs. cellular bone. Therefore, interpretation 
and extrapolation of data between these models should be considered with 
extra care. 
have also been used as models could also be used since in vivo imaging 
of osteoclasts in fish is possible through specific use of transgenic fish lines 
from medaka (but not zebrafish) in which these cells have been “labelled” with a 
reporter gene (Chatani et al., 2011). Although osteoclastogenesis in fish has 
some distinct features from the one of mammals and interpretation and 
extrapolation of data between models should be taken with care.  
Finally, several targets of miR-223 have a function associated to 
angiogenesis and/or cardiovascular development in mammals and zebrafish. 
This prompted us to hypothesize that this miRNA could be involved in those 
processes Once again, zebrafish could help to clarify this possibility, since 
previous studies have clearly demonstrated its usefulness to investigate 
miRNAs involvement in vascular and heart development (Gays and Santoro, 
2013). 
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5.3. miR-29a induces ECM mineralization in bone-
derived systems through conserved mechanisms in 
vertebrates  
The miR-29 family was previously implicated in osteoblast differentiation 
of mammals by targeting ECM molecules and by modulating Wnt signalling 
through a positive feedback loop (Kapinas et al., 2009, 2010; Li et al., 2009b). 
Despite all evidences concerning miR-29 effect on mammalian osteogenic 
differentiation, characterization of its function and regulatory mechanisms in 
other organisms is far from being understood, which could help to elucidate the 
intricate and extensive role of this miRNA family. Furthermore, the putative 
mineralogenic effect of miR-29 has never been demonstrated. Here, we 
investigated the biological effects of miR-29a overexpression in a fish bone-
derived cell line, the ABSa15, capable of in vitro mineralization and suitable for 
miRNA studies (Marques et al., 2007; Tiago et al., 2014), and further explored 
miR-29 conservation in vertebrates.  
Through this study, we provide novel insights into the biological effect of 
miR-29a through gain-of-function experiments in fish bone-derived cells. In 
ABSa15 cells, increased levels of miR-29a significantly boosted ECM 
mineralization, probably due to accelerated differentiation. We also 
demonstrated for the first time that miR-29a promotes an induction of -catenin 
protein levels, implying a stimulation of canonical Wnt signalling. In addition, we 
show that SPARC is most likely conserved as a miR-29a target in bone-derived 
cells. Ultimately, miR-29a was shown to be conserved in terms of sequence 
homology, gene synteny and expression patterns.  
In sum, miR-29a, a miRNA that was previously shown to promote 
osteogenic differentiation, was now demonstrated to be able to 
increase/accelerate mineral deposition in vitro, a function that seems to be 
conserved throughout vertebrate evolution by interaction with canonical Wnt 
signalling and conservation of targets. Due to this conservation, it is now clear 
that fish models could be useful tools to unveil miR-29 function in bone 
formation. For instance, miR-29 was recently suggested to participate in bone 
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homeostasis, but this function is not yet understood: while miR-29 was shown to 
promote osteoclastogenesis in primary cultures of mouse bone-marrow-derived 
macrophages, in RAW264.7 cell line (Franceschetti et al., 2013) it was reported 
to impair human osteoclast differentiation and activity (Rossi et al., 2013). It 
would be interesting to use fish to explore a hypothetical miRNA-mediated 
crosstalk between osteoblasts and osteoclasts. Considering these and other 
studies, an in vivo model to study miR-29 function in skeletogenesis would 
certainly elucidate the intricate network of genes, pathways and processes that 
this miRNA regulates. 
 
5.4. miR-214 affects genes with crucial functions in 
chondrocyte differentiation and mineralization 
MiR-214 was recently shown to inhibit bone formation by repressing 
ATF4 (Wang et al., 2013a). However, information regarding miR-214 function in 
other skeleton structures, including chondrogenesis, or in other vertebrates 
remained, until now, largely unknown. In this work, we investigated miR-214 
expression, transcriptional regulation and its putative role in chondrogenesis. 
According to our results, miR-214 has a similar pattern of expression in 
zebrafish and mouse, and both are particularly associated with skeleton 
formation, suggesting that this miRNA role in skeletogenesis has been 
maintained. Regarding transcriptional regulation, the promoter of this miRNA 
displayed several regulatory elements that are also highly conserved among 
vertebrate species. Additionally, we have found that several skeletal related 
transcription factors are likely to regulate this miRNA in both chondrocytic and 
osteoblastic cells. In agreement with these results, we observed that miR-214 
has a similar pattern of expression in both cell types, being highly expressed in 
undifferentiated cells and down-regulated during differentiation. More 
importantly, we demonstrated that miR-214 attenuates differentiation in 
chondrocytic (ATDC5) cells, probably by repression of Atf4 and also by 
indirectly decreasing Mgp and osteocalcin levels, both genes being crucial for 
normal cartilage and bone formation.  
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These results, combined with previous studies, indicate that miR-214 
physiological function in skeletogenesis may involve the coordination of 
expression levels of key molecules associated with cell 
proliferation/differentiation and bone formation. Ultimately, this should contribute 
for normal bone deposition and skeletal development.  
Finally, several questions that have arisen with this work should be 
addressed in future studies. For instance, several transcription factors binding 
sites have been identified in the Dnm3os promoter (e.g. SRF, CEBP and 
TCF11) and should be experimentally explored in the future. In addition, the set 
of transcription factors that putatively regulate the transcription of Dnm3os 
should be further validated by ChiP-assays in MC3T3 and ATDC5 cells. Also, a 
comprehensive characterization of miR-214 targets in ATDC5 cells should be 
performed in order to demonstrate the regulatory mechanisms for miR-214 
effects on chondrogenesis. Although we hypothesized that cooperation between 
Runx2, SATB2 and ATF4 should activate the expression of both osteocalcin 
and Mgp in chondrogenesis (based on the mechanism already demonstrated 
for osteocalcin), this mechanism still has to be demonstrated. Once more, ChIP 
assays (possibly combined with other experiments involving specific knockdown 
of each transcription factor independently) could help to unveil this mystery. 
This would definitely increase the present knowledge concerning Mgp 
transcriptional regulation in vertebrates.  
 
5.5. Concluding Remarks 
 MiRNAs are thought to have emerged very early in evolution. 
Preservation of their functions might be one of the most powerful indications for 
their relevance in cell function and tissue formation. Furthermore, they 
represent an asset for future usage as possible therapeutic resources in 
disease. Importantly, this study evidenced that the three miRNAs here studied 
in detail have conserved functions across vertebrates and, more striking, 
conserved mechanism of action in achieving those functions. This becomes 
extremely important for disease treatment research, since screening of 
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therapeutic drugs targeting conserved pathways can take advantage of 
zebrafish, which is an excellent model for drug screening. 
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Abstract 
MicroRNAs (miRNAs) are important regulators of vertebrate development 
but their role during skeletogenesis remains unknown. In this regard, we 
investigated the mineralogenic activity of miR-20a, a miRNA associated with 
osteogenesis, in fish bone-derived cells. Expression of miR-20a was up-
regulated during differentiation and its overexpression inhibited mineralization, 
suggesting a role in fish tissue calcification. In this regard, a conserved miR-20a 
binding site was identified in bone morphogenetic protein 2 (BMP-2) 3’UTR and 
its functionality was evidenced through luciferase assays, and further confirmed 
by western-blot and qPCR. Type II BMP receptor (BMPR2) is also targeted by 
miR-20a in mammalian systems and evidence was collected for the presence of 
a binding site in fish sequences. We propose that miR-20a is a regulator of 
BMP pathway through specific action on BMP-2 and possibly BMPR2. 
Overexpression of miR-20a was also shown to up-regulate matrix Gla protein 
(MGP) transcript, a physiological inhibitor of calcification previously found to 
form a complex with BMP-2. We propose that MGP may play a role in the anti-
mineralogenic effect promoted by miR-20a by decreasing availability of BMP-2. 
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This study gives new insights into miRNA-mediated regulation of BMP-2, and 
sheds light into the potential role of miR- 20a as a regulator of skeletogenesis. 
 
Introduction 
Skeletogenesis is a complex process [1,2] and many key players and 
cellular mechanisms still remain to be identified. In this regard, the post-
transcriptional regulation of skeletal genes has been largely under-studied and 
data on the skeletogenic and osteogenic role of microRNAs (miRNAs) are 
scarce. MiRNAs are small non-coding RNAs of ~22 nucleotides that bind to 
target mRNAs preventing their translation or promoting their degradation [3]. 
Through their post-transcriptional activity, miRNAs have been shown to regulate 
a broad range of biological processes [4], including skeletogenesis as 
evidenced by defective bone and cartilage formation resulting from conditional 
inactivation of DICER (the enzyme processing pre-miRNA into mature miRNA) 
in mouse osteoprogenitor cells [5] and in chondrocytes [6]. MiRNAs were also 
shown to specifically affect in vitro differentiation of chondrocytes [7], 
osteoblasts [5,8–10] and osteoclasts [11]. Among those miRNAs, miR-20a was 
recently identified as capable of promoting bone cell differentiation by targeting 
antagonists of the bone morphogenetic protein (BMP) 1 signaling pathway in 
human mesenchymal stem cells [12]. BMP pathway participates in osteoblast 
differentiation and plays a major role in the development of skeletal tissues (a 
mechanism that was shown to be conserved from fish to mammals [13,14]). 
Interestingly, a recent study reported the targeting of intermediates of the BMP 
signaling by miR-20a in biological systems not related to bone or cartilage 
[15,16]. Available results indicate that miR-20a may regulate BMP signaling 
pathway through direct and indirect mechanisms and indicates that 
mechanisms for miR-20a action on bone formation are far from being 
understood. Because they share significant similarities with mammals in 
organ/tissue development, bony fish represent a suitable alternative to 
mammals to investigate mechanisms associated with vertebrate development 
[17], in particular skeletogenesis [18]. The conservation of miRNA-related 
mechanisms throughout vertebrate evolution [19–21] also indicates the 
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suitability of bony fish in vivo and in vitro models to investigate the role of 
miRNA during skeletogenesis/osteogenesis. In this work, the ABSa15 cell line – 
developed from calcified branchial arches of the marine teleost gilthead 
seabream (Sparus aurata, Linnaeus, 1758) and capable of in vitro 
mineralization [22] – was used to investigate the post-transcriptional regulation 
of two key player of BMP signaling pathway by miR-20a. Data collected 
provided evidence for the role of miR-20a in the regulation of skeleton 
development, thus demonstrating the suitability of fish systems to study 
mechanisms of post-transcription. 
 
Materials and methods  
 
Cell culture and extracellular matrix mineralization  
ABSa15 is a cell line previously developed from calcified branchial 
arches of the marine teleost gilthead seabream (Sparus aurata, Linnaeus, 
1758) that is capable of in vitro mineralization [22], and was recently deposited 
in the European Collection of Cell Cultures (Ref. 13112201; see also 
Supplementary Fig. S1). ABSa15 were cultured at 33 ºC in a humidified 10% 
CO2 atmosphere in Dulbecco’s modified eagle medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS), as described previously for VSa13 and 
VSa16 cells [23]. Human Embryonic Kidney 293 (HEK 293) cells were cultured 
at 37 ºC in a humidified 5% CO2 atmosphere in DMEM supplemented with 10% 
FBS. For mineralization experiments, ABSa15 cells were seeded in 24-well 
plates at 2 x 104 cells/well and allowed to proliferate for 1 week. Then, 
extracellular matrix (ECM) mineralization was induced in confluent cultures by 
supplementing medium with 50 lg/ml of L-ascorbic acid, 10mM b-
glycerophosphate and 4mM CaCl2. At appropriate times, mineral deposition 
was revealed through von Kossa staining and quantified by densitometry 
analysis [23]. Culture medium was renewed twice a week. 
 
RNA extraction and gene expression analysis 
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Total RNA was extracted from cell cultures as described by Chomczynski 
and Sacchi [24] and quantified by UV spectrophotometry (NanoDrop ND-1000, 
Thermo Scientific, Madison, WI, USA). Quantitative real-time PCR (qPCR) 
analysis of miRNAs and mRNAs was performed using the StepOnePlus system 
(Applied Biosystems, Invitrogen, Grand Island, NY, USA). For qPCR analysis of 
mRNA expression, total RNA (1 lg) was treated with RQ1 RNase-free DNase 
(Promega), then reverse-transcribed using MMLV-RT (Invitrogen) and oligo-
d(T)-adapter primer (Supplementary Table S1). PCR amplifications were 
performed using 10 ng of cDNA, gene-specific primers (Supplementary Table 
S1) and SsoFast EvaGreen Supermix (Bio-Rad) according to manufacturer 
instructions. For qPCR analysis of miRNA expression, total RNA (1 lg) was 
polyadenylated and reverse-transcribed using NCode miRNA First-Strand 
cDNA Synthesis kit (Invitrogen) according to manufacturer instructions. PCR 
amplifications were achieved using miRNA- specific primers (Supplementary 
Table S1) and NCode SYBR miRNA qRT-PCR kit (Invitrogen). Relative mRNA 
and miRNA expression was calculated using the ΔΔCt method [25] and 
normalized using expression of 3 housekeeping genes (ribosomal protein L27a 
(RPL27a), 18S, and b-actin) for mRNAs, and U6 small nuclear RNA (U6) for 
miRNAs. 
 
Vector construction  
For luciferase assays, the 3’-untranslated region (UTR) of gilthead 
seabream BMP-2 transcript was inserted into XbaI site of pGL3-Control vector 
(Promega) downstream of firefly luciferase (F-Luc) coding sequence. 3’UTR 
was amplified from Marathon cDNA cDNA libraries (Clontech) using gene-
specific primers (Supplementary Table S1) and Klen Taq Polymerase mix 
(Clontech). Mutations in polyadenylation signal and miR-20a binding sites were 
achieved using 50 ng of pGL3–3’UTR constructs, specific primers containing 
point mutations (designed according to manufacturer instructions; 
Supplementary Table S1) and the QuickChange Lightning Site-Directed 
Mutagenesis kit (Agilent Technologies). PCR reaction was treated with DpnI 
restriction endonuclease to cut methylated template DNA and used to transform 
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XL10-Gold cells (Agilent Technologies) according to manufacturer instructions. 
For miR-20a overexpression, oligonucleotides containing forward and reverse 
sequences of zebrafish pre-miR-20a (Supplementary Table S1) were annealed 
then inserted into pcDNA6.2-GW/EmGFP-miR vector downstream of GFP 
coding sequence using the BLOCK-iT Pol II miR RNAi Expression Vector kit 
(Invitrogen). The BMP-responsive luciferase reporter vector (BRE-Luc) was 
kindly provided by Dr. Peter ten Dijke (Leiden University Medical Center, 
Leiden, The Netherlands) [26]. 
 
Luciferase assays  
HEK 293 cells were seeded in 24-well plates at 8 x 104 cells/well, further 
cultured for 14–16 h and transfected with 5 ng of the pGL3–3’UTR construct 
and 12.5 ng of pRL-TK vector (Promega) carrying renilla luciferase gene (R-
Luc) using 1.5 ll of X-treme- GENE HP transfection reagent (Roche). When 
appropriate, 5 ng of pcDNA6.2-miR20a vector was co-transfected in HEK 293 
cells. ABSa15 cells were seeded in 12-well plates at 8 x 104 cells/well, further 
cultured for 14–16 h and transfected with 600 ng of BRE- Luc vector and 600 ng 
of pRL-SV40 vector using 1.5 ll of FuGene HD (Roche). After 48 h, transfected 
cells were lysed and luciferase activities were measured using Dual-Luciferase 
Reporter Assay system (Promega). Relative luciferase activity was determined 
from the ratio F-Luc/R-Luc. 
 
Establishment of cell clones overexpressing miR-20a  
ABSa15 cells were seeded in 6-well plates at 2 x 105 cells/well, further cultured 
for 14–16 h and transfected with 2.4 g of pcDNA6.2-miR20a vector using 3 l 
of FuGeneHD (Roche). After 24 h, cells were sub-cultured into a 10-cm culture 
dish containing DMEM supplemented with 2 g/ml of blasticidin (determined as 
described in the manual of BLOCK-iT Pol II miR RNAi Expression Vector kit). 
After approximately 30 days in selective medium (renewed once a week), cell 
colonies expressing GFP were identified using Olympus IX-81 fluorescence 
microscope and sequentially sub-cultured into 24-well, 6-well and 10-cm culture 
dishes. 
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Protein extraction and western-blot analysis 
Proteins were extracted from cell cultures using lysis buffer containing 
Tris (50 mM), sodium chloride (150 mM), NP-40 (1% m/v), glycerol (10% v/v), 
magnesiumchloride (10 mM), sodium orthovanadate (10 mM) and protease 
inhibitor cocktail (cOmplete, Roche). Protein concentrations were determined 
using the Bradford protein assay (Bio-Rad). Proteins were fractioned using 4–
12% acrylamide NuPAGE Novex Bis-Tris gels (Invitrogen) and transferred onto 
PVDF membranes (Millipore) using the XCell SureLock Blot module 
(Invitrogen). The following antibodies were used for western-blot: anti-zebrafish 
BMP-2b rabbit IgG conjugate (AnaSpec; 1:500 dilution), anti-avian b-Actin 
mouse IgG conjugate (Santa Cruz Biotechnology; 1:500 dilution), anti-rabbit IgG 
peroxidase conjugate (Sigma–Aldrich; 1:30,000 dilution) and anti-mouse IgG-
peroxidase conjugate (Sigma–Aldrich; 1:30,000 dilution). Chemiluminescent 
signals were detected using the Western Lightning ECL kit (Perkin Elmer) and 
Hyperfilm ECL (Amersham, GE Healthcare) then quantified through 
densitometry analysis. 
 
Results and discussion 
 
Expression of miR-20a is up-regulated during in vitro mineralization in 
fish 
Levels of miR-20a expression and ECM mineralization were determined 
by qPCR and von Kossa staining, respectively, in confluent cultures of gilthead 
seabream ABSa15 cells exposed to mineralogenic cocktail for 4 weeks or left 
untreated (Fig. 1). While expression of miR-20a remained basal and constant in 
control non-mineralizing cultures, it was strongly up-regulated (up to 6- folds) 
during the first 2 weeks cultured in mineralogenic medium, a period 
corresponding to the onset of in vitro mineralization, then remained constant as 
ECM mineralization progressed in the following 2 weeks, suggesting a role for 
miR-20a in mechanisms of cell differentiation towards a phenotype of ECM 
mineralization. 
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Fig. 1. Relative expression of miR-20a in mineralizing gilthead seabream ABSa15 cells. 
Extracellular matrix mineralization was induced in confluent cultures by supplementing medium 
with 50 g/ml of L-ascorbic acid, 10mM b-glycerophosphate and 4mMCaCl2. Control cultures 
were left untreated. Expression of miR-20a was determined by qPCR and normalized using U6 
small RNA expression. Representative pictures of von Kossa-stained cultures are presented 
above qPCR data. Asterisks(*) indicate values statistically different from respective control at 
specific specific time of mineralization (n≥3; Student’s t-test, p < 0.01). 
 
 
Overexpression of miR-20a decreases ECM mineralization and the activity 
of BMP canonical pathway 
To further study this role, clones of ABSa15 cells overexpressing miR-
20a were developed through the stable transfection of pcDNA6.2-GW/EmGFP-
miR-20a construction. Three clones, homogeneously expressing GFP and 
therefore miR-20a (data not shown), were isolated and overexpression of miR-
ANNEX I  Tiago et al. (2014) 
226  
20a was confirmed by qPCR (6.3, 11.9 and 10.9-fold increase in clones 1, 2 
and 3, respectively; Fig. 2A). Overexpressing (OE) clones were exposed to 
mineralogenic cocktail for 4 weeks and mineral deposition was evaluated once 
a week. Onset of ECM mineralization occurred after 2 weeks of exposure; at 
that time mineral deposition was significantly reduced by 44, 48 and 51% in 
clones 1, 2 and 3, respectively (Fig. 2B). Comparative analysis of these results 
with those presented in Fig. 1 suggests that miR-20a could have a specific role 
in early cell differentiation, i.e., from 0 to 2 weeks of mineralogenic treatment, 
progressively inhibiting this process and allowing for mineralogenic mechanisms 
to occur. To support this hypothesis, ECM mineralization in cells overexpressing 
miR-20a was delayed but not impaired. In fact, at later stages of ECM 
mineralization (3 and 4 weeks), mineral deposition remained lower in OE clones 
than in wild-type cells, but differences were not as accentuated (results not 
shown), indicating a partial recovery. It has been recently reported that bone 
morphogenetic protein (BMP) pathway is targeted by miR-20a [15]; BMP 
pathway is central to osteogenesis, promoting osteoblast differentiation and 
ECM mineralization in fish [14,27–29] and mammals[27,30], and its repression 
would certainly impair ECM mineralization in ABSa15 cell line. To test this 
hypothesis, wild-type ABSa15 cells and clones OE-1, -2 and -3, were 
transfected with the BRE-Luc vector, a construct recently developed to 
investigate the activation of BMP-pathway and where BMP responsive elements 
(BRE) control the expression of firefly luciferase gene [26]. Luciferase activity 
was significantly reduced in OE clones (Fig. 2C), indicating that BMP canonical 
pathway was affected upon overexpression of miR-20a. Expression of miR-20a 
was also silenced in ABSa15 cells using a construct where a siRNA against 
miR-20a was cloned into pcDNA6.2-GW/EmGFP vector. Two cell clones 
displaying reduced miR-20a expression were isolated and treated for 
mineralization. Surprisingly, no significant changes in ECM mineralization were 
observed in these clones versus wild-type ABSa15 cells (data not shown), 
suggesting that compensatory mechanisms may exist.  
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Fig. 2. Effect of miR-20a overexpression in gilthead seabream ABSa15 cells. Relative 
expression of miR-20a (a) ECM mineralization (b) and reporter gene analysis of the canonical 
BMP signaling pathway (c) in wild-type cells (WT) and clones overexpressing miR-20a (OE-1, -2 
and -3). Expression of miR-20a was determined in confluent cultures by qPCR and normalized 
using U6 small RNA expression. Mineral deposition was revealed after 2 weeks by von Kossa 
staining and evaluated by densitometry analysis. Reporter gene analysis was performed in cells 
transfected with BRE-Luc vector containing BMP-responsive elements upstream of luciferase 
gene. Relative luciferase activity was calculated as the ratio of firefly and renilla luciferase 
activities (F-Luc/R-Luc). All values in OE clones were statistically different from values in WT 
cells (n≥3; one-way ANOVA, p < 0.05). 
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BMP-2 transcripts contain an evolutionary conserved binding site for miR-
20a 
To further investigate the anti-mineralogenic action of miR-20a through 
BMP pathway, the 3’UTR of gilthead seabream BMP-2 transcript was analyzed 
in silico for the presence of miRNA binding sites. A search in GenBank 
sequence database using on-site blast facilities identified 2 transcript variants 
different in the length of their 3’UTR (GenBank accession numbers AY500244 
and JF261172). A canonical polyadenylation signal (AAUAAA) was identified in 
both transcripts 16–24 nt upstream of poly(A) tail (Fig. 3A). Approximately 50% 
of mammalian protein-coding genes have more than one polyadenylation signal 
and can code for transcripts that differ in their 3’UTR [31]. Since 3’UTRs contain 
binding sites for proteins that regulate mRNA stability [32] and for miRNAs that 
regulate mRNA translation [33], alternative polyadenylation has been 
associated with post-transcriptional regulation of transcripts. Thus the 3’UTR 
region of the long variant of gilthead seabream BMP-2 transcript was searched 
for miRNA binding sites using PITA algorithm (genie.weizmann.ac.il) and 
respective on-site miRNA database. Since PITA database only contained 
mammalian miRNA sequences, the conservation of predicted miRNAs (from 
mammals to zebrafish) was assessed using miRBase (http:// www.mirbase.org). 
A binding site for miR-20a was predicted with a ΔΔG score of -10.48 J/mole 
(sites with a score below -10 J/mole are likely to be functional if miRNA is 
endogenously expressed [34]). BMP-2 transcript was further analyzed using 
TargetScanFish release 6.2 (http://www.targetscan.org/fish_62), an online tool 
recently developed to search miRNAs binding sites in zebrafish sequences, and 
the presence of a miR-20a binding site was confirmed in BMP-2 3’UTR. 
Although TargetScanFish analysis also predicted the presence of binding sites 
for other members of the miR-17 family, which share similar seed regions, low 
binding energies were calculated by PITA for these binding sites, suggesting 
that that they are less likely to bind miRNA binding site than miR- 20a. The 
conservation of miR-20a binding site in BMP-2 transcripts throughout vertebrate 
evolution, a critical feature in miRNA binding predictions [35,36], was 
investigated using BMP-2-related sequences available in GenBank database. 
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Fig. 3. Prediction of miR-20a binding sites in the 30 untranslated region (UTR) of BMP-2 
transcripts using PITA algorithm and TargetScanFish release 6.2. (a) schematic representation 
of the 3’UTR of gilthead seabream BMP-2 transcript where polyadenylation signals (PA) and 
miR-20a binding site are indicated. (b) Sequence logos of the 30 untranslated region of 
mammalian, sauropsidian, amphibian and fish BMP-2 transcripts; miR-20a seed region 
(CACTTT) is indicated on top of the logo and arrows indicate nucleotides mutated for functional 
analysis of miR-20a binding; overall height of each letter corresponds to level of nucleotide 
conservation among species at that position; black letters indicate 100% conservation. 
 
 
Nineteen 3’UTR sequences of mammalian (10), sauropsidian (2), amphibian (3) 
and bony fish (4) BMP-2 transcripts were collected, aligned using ClustalW 
(align.genome.jp; Supplementary Fig. S2), then displayed as sequence logos 
using Weblogo (weblogo.berkeley.edu). A remarkable conservation of putative 
miR-20a binding site, in particular the seed region, was observed (Fig. 3B), 
further evidencing the probable post-transcriptional regulation of BMP-2 
transcript by miR-20a. A second seed region for miRNAs of the miR-17 family 
(including miR-20a) was identified in the 3’UTR of mammalian, birds and 
amphibians BMP-2 transcripts; it was however absent in fish BMP-2 transcripts. 
Although its ΔΔG score was low (-6.76 J/mole in human sequence), which may 
indicate a false positive, future studies should aim at determining whether any 
miRNA of the miR-17/92 cluster, in particular miR-20a, bind to this tetrapod-
specific site and whether post-transcriptional regulation of BMP-2 transcripts 
has evolved throughout vertebrate evolution towards a tighter control by miR-17 
family. Following the report by Brock et al. [15] evidencing the presence of a 
binding site for miR-20a in the 3UTR of human BMPR2 transcript, GenBank 
database was searched for vertebrate BMPR2-related sequences. Fourteen 
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sequences were collected (mammals (8), sauropsids (3), and bony fish (3)) and 
aligned using ClustalW. A remarkable conservation of miR-20a binding site was 
observed, in particular the seed region (Supplementary Fig. S3). Although both 
PITA and TargetScanFish returned low scores for the binding of miR-20a to the 
miRNA site identified in zebrafish BMPR2 transcript, the remarkable 
conservation of the seed region suggests that this site could be functional in 
fish. Although this remains to be demonstrated, we propose that BMP signaling 
pathway and downstream processes are regulated by miR-20a through its 
action on BMP-2 but also on BMPR2 transcripts.´ 
 
Seabream BMP-2 transcript is post-transcriptionally regulated by miR- 20a 
In silico prediction of miRNAs binding sites in BMP-2 3’UTR sequences 
clearly indicated miR-20a as a strong candidate for the post-transcriptional 
regulation BMP-2 transcript. To validate this hypothesis, firefly luciferase activity 
was measured in extracts of HEK 293 cells transfected with reporter vector 
carrying 3’UTR region downstream of luciferase gene and, when appropriate, 
with expression vector carrying miR-20a downstream of CMV promoter (Fig. 4). 
Polyadenylation signal upstream of miR-20a binding site was mutated to avoid 
premature termination of the fusion transcript. Since miR-20a expression was 
recently reported in HEK 293 cells [37], possible suppressive effects of 
endogenous miR- 20a in control conditions were considered in these 
experiments. While luciferase activity of BMP-2 construction was slightly 
reduced (19%) upon miR-20a overexpression, it was up-regulated (62%) upon 
mutation of the binding site, suggesting a pre-existing repression by 
endogenous miR-20a and therefore a post-transcriptional regulation of BMP-2 
through miR-20a binding site. Although a slight decrease of luciferase activity 
was observed upon overexpression of miR-20a, we could not exclude that other 
members of the miR-17 family, which share the same binding sites with miR-
20a and are expressed at similar levels in HEK 293 cells [37], may also regulate 
seabream BMP-2 transcript. However, as stated previously, according to PITA 
analysis binding of other members of miR-17 family to BMP-2 transcript is less 
probable due to their association to lower binding energies. Nevertheless, to 
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better understand the specific effect of miR-20a, protein and transcript levels of 
gilthead seabream BMP-2 were determined in OE clones. In all OE clones, 
overexpression of miR-20a resulted in a slight reduction of BMP-2 production at 
0 weeks (from 18% to 46%; Fig. 5A) and in a strong reduction after 2 weeks 
(from 80% to 100%; Fig. 5A). A strong reduction (from 60% to 80%) of BMP-2 
transcript levels (long transcript) was also observed after 2 weeks in all OE 
clones (Fig. 5B). These data further demonstrated the regulation of BMP-2 by 
miR-20a and also suggested that miR-20a action on BMP-2 is probably related 
to mRNA degradation. Due to the lack of a suitable antibody to detect fish 
BMPR2, the action of miR- 20a on this protein in fish is still unknown. 
Furthermore, qPCR analysis of BMPR2 transcripts in WT ABSa15 cells and OE 
clones did not reveal any significant changes. Data collected in mammalian 
systems pointed towards the inhibition of protein translation Brock et al. [15], but 
whether this mechanism applies also in fish remains to be confirmed. 
 
 
Fig. 4. Interaction between miR-20a and the 3’UTR of gilthead seabream BMP-2 
(SauBMP-2) transcript. HEK 293 cells were transfected with pGL3 vector carrying the 3’UTR of 
SauBMP-2 transcript (3’UTR) or the 3’UTR mutated for miR-20a binding sites (3’UTR mut) 
downstream of luciferase gene. HEK 293 cells were also co-transfected with 3’UTR constructs 
and pcDNA6.2 carrying miR-20a (3’UTR miR20a) downstream of CMV promoter. Relative 
luciferase activity was calculated as the ratio of firefly and renilla luciferase activities. Asterisks 
(*) indicate values statistically different from respective 3’UTR value (n≥3; one-way ANOVA, p < 
0.05). 
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The role of miR-20a in bone formation is far from being understood. On 
one hand, the nature of known targets of miR-20a, either identified through this 
study – BMP-2 – or identified in a previous study – BMPR2 [15] – suggest that 
miR-20a can repress bone cell differentiation and ECM mineralization [30]. On 
the other hand, miR-20a repression of MAPK [38], a pathway that was shown to 
inhibit bone cell differentiation in mammals and fish [27–29], suggests that miR-
20a could also promote bone cell differentiation in fish. Accordingly, miR-20a 
was recently shown to induce osteogenic differentiation in human mesenchymal 
stem cells (hMSC) through repression of antagonists of BMP pathway Bambi, 
Crim1 and PPAR-c [12]. In contrast, the role of miR-20a in bone formation was 
further investigated in vivo in a study using mouse knockout models for the miR-
17/92, a cluster of miRNAs in which miR-20a is included [39]. While the 
development of homozygotic miR-17/ 92 knockouts is severely compromised 
due to lethal cardiac and lung defects, heterozygous models showed 
significantly reduced trabecular and cortical bone formation, and impaired 
osteoblast differentiation [40]. Data collected within the scope of this work is in 
favor of miR-20a inhibiting bone cell differentiation/mineralization through the 
repression of BMP pathway. This discrepancy could be related to distinct 
regulatory mechanisms in different cell systems: ABSa15 is a skeletal cell line 
established from calcified cartilage of branchial arches of a teleost fish; it 
displays gene expression patterns resembling those of chondrocyte-like cell 
types, including: (i) mild up-regulation of TNAP (tissue non-specific bone-related 
alkaline phosphatase), COL1A1 (type I collagen a1), SPARC (secreted protein 
acidic cysteine-rich; also known as osteonectin) and SOX9a (SRY-box 
containing gene 9a) earlier in differentiation and down-regulation later during 
mineralization; (ii) strong up-regulation of MGP (matrix Gla protein) and SPP1 
(secreted phosphoprotein 1; also known as osteopontin) from non- 
differentiated to mineralized cells; and (iii) absence of osteocalcin expression in 
all stages (Supplementary Fig. S4). Supporting the dual effect of miR-20a, a 
recent study showed that miR-17, a miRNA that belongs to miR-17/92 cluster 
and shares the same ‘‘seed’’ and predicted targets with miR-20a, could either 
inhibit or promote osteogenic differentiation in human periodontal ligament 
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Fig. 5. Levels of BMP-2 protein production (a) and gene expression (b) in wild-type ABSa15 
cells (WT) and clones overexpressing miR-20a (OE-1, -2 and -3). Production of BMP-2 protein 
was determined in cell cultures at time 0 and after 2 weeks of mineralization by densitometry 
analysis of western-blot signals and normalized using b-actin signals. Expression of BMP-2 
gene was determined by qPCR and normalized using RPL27a housekeeping gene expression 
(n.b. similar expression data were collected using 18S and b-actin housekeeping genes; data 
not shown). Asterisks (*) indicate values statistically different from WT (n≥3; one-way ANOVA, 
p<0.05). 
 
tissue stem cells depending on whether these where collected from healthy 
donors or patients suffering from inflammatory process, respectively [41]. 
Interestingly, this opposite effect was associated with the differential expression 
of Smad ubiquitin regulatory factor one (Smurf1), a regulator of BMP pathway 
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and a direct target of miR-17. In another study, Brock and colleagues evidenced 
in human and mouse the post-transcriptional regulation of the cell surface 
receptor BMPR2 by miR-20a and proposed that the up- regulation of miRNA 
expression may be a key feature in the development of pulmonary arterial 
hypertension (PAH), through the action of BMP signaling pathway on 
endothelial and smooth muscle cell differentiation and matrix formation [15,16]. 
These authors showed that antagonizing miR-20a using an antagomiR restored 
BMPR2 mRNA/protein levels and a functional BMP signaling in a mouse model 
of hypoxia-induced PAH [16]. Consequently disease development was reduced 
and pulmonary arterial haemodynamics were improved in antagomiR-20a 
treated animals [16]. Smad5, an intermediate of BMP signaling pathway, was 
also proposed to be targeted by miR-20a but this hypothesis was never 
confirmed either by luciferase reporter assays or western-blot analysis [16]. 
Interestingly, miR-17/92 cluster, in particular miR- 20a, has been shown to 
repress type II transforming growth factor b receptor (TGFBR2) [42], which is 
involved in osteogenesis (and chondrogenesis) through the action of TGFb 
signaling on osteoblast recruitment and proliferation, and matrix formation [43]. 
Since BMPR2 and TGFBR2 belong to the same cell surface receptor family and 
activate similar transduction pathways, it will be interesting to address in future 
studies the role of their post-transcriptional regulation by miR-20a during 
osteogenesis (and in a more general manner during skeletogenesis) and 
whether a deregulation of this mechanism could lead to bone/skeletal diseases. 
 
Overexpression of miR-20a up-regulates the expression of the matrix Gla 
protein, a calcification inhibitor 
In order to better understand the underlying mechanisms of miR-20a 
inhibitory role on ECM mineralization of ABSa15 cells, expression of several 
markers of bone cell differentiation/mineralization was investigated in wild-type 
cells and in clones overexpressing miR-20a. Initially, the expression of each 
bone-related marker was investigated during ECM mineralization of ABSa15 
cells, and as mentioned before, this analysis suggested a possible association 
of ABSa15 cells to a chondrocytic lineage (Supplementary Fig. S4). After 2 
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weeks of treatment, when overexpression of miR-20a strongly inhibited mineral 
deposition, expression levels of TNAP, COL1A1 and MGP were significantly up-
regulated in all three OE clones, ranging between 3.7–6.4-fold, 3.1–5.5-fold and 
2.1–5.1-fold, respectively (Fig. 6), while other bone-related genes did not reach 
significant differences or remained undetected (data not shown). The strong up-
regulation of MGP, a well-known inhibitor of arterial calcification in mammals 
[44] which has been also associated with ECM mineralization in fish [23,45–47], 
could explain miR-20a inhibitory effects in ABSa15 cell mineralization. In 
mammalian systems, MGP was demonstrated to bind BMP-2 and prevent its 
association with BMPR2, which is necessary for the activation of BMP pathway 
and consequent stimulation of bone formation [48,49]. Furthermore, in calcifying 
vascular cells this mechanism involved a feedback control regulation, where 
MGP expression levels appear to be negatively correlated with BMP-2 
availability [50]. Therefore, an up-regulation of MGP in ABSa15 OE clones is 
likely to increase its binding to BMP-2 and thus contribute to block BMP 
pathway, enhancing the effect of post-transcriptional regulation of BMP-2 by 
miR-20a. Regarding TNAP and COL1A1, these are promoters of ECM 
formation and mineralization [51] and it is therefore difficult to explain the anti-
mineralogenic effect of miR-20a through their up-regulation. Since data 
available on literature regarding regulation of TNAP and COL1A1 by miR-17/ 92 
is still contradictory [40], this effect should be addressed in future studies. 
 
Fig. 6. Levels of alkaline phosphatase (TNAP), type I collagen a1 (COL1A1) and matrix Gla 
protein (MGP) gene expression in mineralizing wild-type ABSa15 cells (WT) and clones 
overexpressing miR-20a (OE-1, -2 and -3). Gene expression was determined after 2 weeks of 
mineralization by qPCR and normalized with RPL27a housekeeping gene expression (n.b. 
similar expression data were collected using 18S and b-actin housekeeping genes; data not 
shown). Asterisks (*) indicate values statistically different fromWT (n≥3; one-way ANOVA, p < 
0.05).
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Conclusions 
We present here novel data (i) describing the up-regulation of miR-20a 
during ECM mineralization of a fish mineralogenic cell line (ABSa15), (ii) 
evidencing the anti-mineralogenic effect of miR-20a in this cell line, (iii) showing 
inhibition of the BMP pathway by miR-20a, (iv) identifying binding sites for miR-
20a in the 3’UTR of gilthead seabream BMP-2 and zebrafish BMPR2 transcripts 
that were conserved in vertebrate and (v) demonstrating the post-transcriptional 
regulation of BMP-2 by miR-20a (binding site in BMPR2 transcript may also be 
active but this remains to be demonstrated). We propose that low levels of 
expression of miR-20a in undifferentiated cells may account for a higher activity 
of BMP signaling and consequent osteogenic differentiation. Then, in the course 
of ECM mineralization, miR-20a becomes more expressed to inhibit this 
process through BMP-2 (and possibly also BMPR2) regulation (Fig. 7). 
Alternative mechanisms of action, such as activation of MAPK pathway either 
directly by miR-20a or indirectly through non-canonical BMP pathway, cannot 
be excluded but remain to be demonstrated in ABSa15 cells. Furthermore, 
effect on MGP suggests that this protein is likely to play a role in the inhibitory 
mechanism observed. Results obtained from previous studies combined with 
data hereby demonstrated, suggest that miR-20a preferentially targets BMP 
pathway to promote (hMSC) or inhibit (ABSa15 cells) osteogenic differentiation. 
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Fig. 7. Putative mechanisms of action for miR-20a anti-mineralogenic effect. Arrows and 
intersected lines indicate activation and repression, respectively. Solid arrows indicate pathways 
likely to be activated during differentiation of ABSa15 cells. Dashed arrows indicate pathways 
most probably not activated in ABSa15 cells. Smads 1, 5, 8 and 4 are intermediates of the BMP 
canonical pathway. TAK1 (TGF-b-activated kinase 1) is an intermediate of the BMP non-
canonical pathway. MAPK, MAPKK and MAPKKK are intermediates of the mitogen-activated 
protein kinase (MAPK) pathway. 
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